oryzalin profile

oryzalin: a dinitroaniline; preemergence herbicide; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

oryzalin : A sulfonamide that is benzenesulfonamide substituted at positions 3 and 5 by nitro groups and at position 4 by a dipropylamino group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

ID Source	ID
PubMed CID	29393
CHEMBL ID	295960
CHEBI ID	73163
SCHEMBL ID	55377
MeSH ID	M0059502

Synonym
NCI60_016826
dirimal
nsc648479
nsc-648479
benzenesulfonamide, 4-(dipropylamino)-3,5-dinitro-
surflan
4-(dipropylamino)-3,5-dinitrobenzenesulfonamide
rycelon
el119
4-(dipropylamino)-3,5-dinitro-benzenesulfonamide
oryzalin
ryzelan
rycelan
19044-88-3
NCGC00163815-02
NCGC00163815-01
einecs 242-777-0
hsdb 6858
n4,n4-dipropyl-3,5-dinitrosulfanilamide
epa pesticide chemical code 104201
oryzalin [ansi:bsi:iso]
dirimal extra
el 119
sulfanilamide, 3,5-dinitro-n(sup 4),n(sup 4)-dipropyl-
3,5-dinitro-n4,n4-dipropylsulphanilamide
3,5-dinitro-n(sup 4),n(sup 4)-dipropylsulfanilamide
el-119
dinitrodipropylsulfanilamide
brn 2177305
caswell no. 623a
compound 67019
3,5-dinitro-n4,n4-dipropylsulfanilamide
NCGC00163815-03
CHEMBL295960
chebi:73163 ,
bdbm81743
oryzalin, 1
NCGC00163815-04
NCGC00163815-05
C18877
unii-662e385dwh
662e385dwh ,
cas-19044-88-3
dtxsid8024238 ,
dtxcid904238
tox21_400078
3,5-dinitro-n(4),n(4)-dipropylsulfanilamide
4-(dipropylamino)-3,5-dinitrobenzene-1-sulfonamide
AKOS015888415
oryzalin [iso]
oryzalin [hsdb]
oryzalin [mi]
SCHEMBL55377
4-(dipropylamino)-3,5-dinitrobenzenesulfonimidic acid #
rizelan
nsc 648479
UNAHYJYOSSSJHH-UHFFFAOYSA-N
sulfanilamide, 3,5-dinitro-n4,n4-dipropyl-
3,5-dinitro-n4,n4-dipropyl sulfanilamide
oryzalin, pestanal(r), analytical standard
oryzalin, analytical standard
J-012294
FT-0751602
Q410996
4-dipropylamino-3,5-dinitrobenzenesulfonamide
AMY22334
HY-147092
AS-76251

Excerpt	Reference
"Oryzalin (ORY) is a dinitroaniline derivative that inhibits the microtubule polymerization in plants and parasitic protozoa by selectively binding to the α-tubulin subunit. "	( Aguayo-Ortiz, R; Dominguez, L; Flores-León, CD, 2022)
"Oryzalin is a dinitroaniline pesticide for the control of weed growth via suppression of microtubule synthesis. "	( Ham, J; Lim, W; Song, G; Song, J, 2023)
"Oryzalin is a much-used pre-emergence herbicide which causes microtubules (Mt) to depolymerize. "	( Langhans, M; Niemes, S; Pimpl, P; Robinson, DG, 2009)
"Oryzalin is a dinitroaniline drug that has attracted recent interest for the treatment of leishmaniasis. "	( Almeida, AJ; Cruz, ME; Eleutério, CV; Gonçalves, LM; Lopes, R, 2012)
"Oryzalin (ORZ) is a dinitroaniline that has attracted increasing interest for the treatment of leishmaniasis. "	( Carvalheiro, MC; Corvo, ML; Cruz, ME; Eleutério, CV; Lopes, RM; Scoulica, E, 2012)

Excerpt	Reference
"Oryzalin has also been found to be an inhibitor of intracellular free Ca2+ signaling in mammalian cells and to have antitumor activity in animals."	( Dorr, RT; Dvorakova, K; Gallegos, A; McClure, T; Powis, G, 1997)

Excerpt	Reference
"Oryzalin treatment (3 h) decreased activity of soluble lectins, increased activity of cell wall lectin mitotic index."	( Chulkova, IuIu; Garaeva, LD; Khokhlova, LP; Timofeeva, OA, 2005)
"In oryzalin treated subsidiary mother cells the prophase nuclei move away from the polar site."	( Apostolakos, P; Galatis, B; Panteris, E, 2006)
"Treatment with oryzalin doubled the VC ratio in the duodenum, jejunum and ileum following doses of 5 mg, 50 mg and 200 mg/kg respectively."	( Armson, A; MacDonald, LM; Menon, K; O'Hara, A; Read, CM; Reynoldson, JA; Sargent, K; Thompson, RC, 2002)

Role	Description
herbicide	A substance used to destroy plant pests.
agrochemical	An agrochemical is a substance that is used in agriculture or horticulture.
antimitotic	Any compound that inhibits cell division (mitosis).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Class	Description
sulfonamide	An amide of a sulfonic acid RS(=O)2NR'2.
C-nitro compound	A nitro compound having the nitro group (-NO2) attached to a carbon atom.
aromatic amine	An amino compound in which the amino group is linked directly to an aromatic system.
tertiary amino compound	A compound formally derived from ammonia by replacing three hydrogen atoms by organyl groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein	Taxonomy	Measurement	Average (µ)	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	Homo sapiens (human)	Potency	28.1838	0.0040	23.8416	100.0000	AID485290
acetylcholinesterase	Homo sapiens (human)	Potency	81.3793	0.0025	41.7960	15,848.9004	AID1347395; AID1347398
pregnane X receptor	Rattus norvegicus (Norway rat)	Potency	22.3872	0.0251	27.9203	501.1870	AID651751
hypoxia-inducible factor 1 alpha subunit	Homo sapiens (human)	Potency	58.9929	3.1890	29.8841	59.4836	AID1224846; AID1224894
RAR-related orphan receptor gamma	Mus musculus (house mouse)	Potency	45.6318	0.0060	38.0041	19,952.5996	AID1159521; AID1159523
SMAD family member 2	Homo sapiens (human)	Potency	51.3658	0.1737	34.3047	61.8120	AID1346859; AID1346924
Fumarate hydratase	Homo sapiens (human)	Potency	39.8107	0.0030	8.7949	48.0869	AID1347053
GALC protein	Homo sapiens (human)	Potency	50.1187	28.1838	28.1838	28.1838	AID1159614
SMAD family member 3	Homo sapiens (human)	Potency	51.3658	0.1737	34.3047	61.8120	AID1346859; AID1346924
TDP1 protein	Homo sapiens (human)	Potency	49.6137	0.0008	11.3822	44.6684	AID686978; AID686979
GLI family zinc finger 3	Homo sapiens (human)	Potency	28.6087	0.0007	14.5928	83.7951	AID1259368; AID1259369; AID1259392
AR protein	Homo sapiens (human)	Potency	33.5350	0.0002	21.2231	8,912.5098	AID1259243; AID1259247; AID743035; AID743036; AID743042; AID743053; AID743054; AID743063
caspase 7, apoptosis-related cysteine protease	Homo sapiens (human)	Potency	51.7849	0.0133	26.9810	70.7614	AID1346978
estrogen receptor 2 (ER beta)	Homo sapiens (human)	Potency	56.8755	0.0006	57.9133	22,387.1992	AID1259377; AID1259378
nuclear receptor subfamily 1, group I, member 3	Homo sapiens (human)	Potency	37.2397	0.0010	22.6508	76.6163	AID1224838; AID1224839
progesterone receptor	Homo sapiens (human)	Potency	40.4529	0.0004	17.9460	75.1148	AID1346784; AID1346795
cytochrome P450 family 3 subfamily A polypeptide 4	Homo sapiens (human)	Potency	5.0250	0.0123	7.9835	43.2770	AID1645841
glucocorticoid receptor [Homo sapiens]	Homo sapiens (human)	Potency	44.2939	0.0002	14.3764	60.0339	AID588533; AID720691; AID720692; AID720719
retinoic acid nuclear receptor alpha variant 1	Homo sapiens (human)	Potency	55.1999	0.0030	41.6115	22,387.1992	AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alpha	Homo sapiens (human)	Potency	38.5086	0.0008	17.5051	59.3239	AID1159527; AID1159531
estrogen-related nuclear receptor alpha	Homo sapiens (human)	Potency	51.5381	0.0015	30.6073	15,848.9004	AID1224819; AID1224820; AID1224821; AID1224841; AID1224842; AID1224848; AID1224849; AID1259403
farnesoid X nuclear receptor	Homo sapiens (human)	Potency	53.5742	0.3758	27.4851	61.6524	AID743217; AID743220
pregnane X nuclear receptor	Homo sapiens (human)	Potency	3.8236	0.0054	28.0263	1,258.9301	AID1346982; AID720659
estrogen nuclear receptor alpha	Homo sapiens (human)	Potency	44.3061	0.0002	29.3054	16,493.5996	AID1259244; AID1259248; AID1259383; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091
G	Vesicular stomatitis virus	Potency	2.2446	0.0123	8.9648	39.8107	AID1645842
cytochrome P450 2D6	Homo sapiens (human)	Potency	25.1846	0.0010	8.3798	61.1304	AID1645840
polyprotein	Zika virus	Potency	39.8107	0.0030	8.7949	48.0869	AID1347053
peroxisome proliferator-activated receptor delta	Homo sapiens (human)	Potency	62.1795	0.0010	24.5048	61.6448	AID743212; AID743215
peroxisome proliferator activated receptor gamma	Homo sapiens (human)	Potency	35.9630	0.0010	19.4141	70.9645	AID588536; AID743094; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptor	Homo sapiens (human)	Potency	16.2433	0.0237	23.2282	63.5986	AID743222; AID743223
caspase-3	Homo sapiens (human)	Potency	51.7849	0.0133	26.9810	70.7614	AID1346978
aryl hydrocarbon receptor	Homo sapiens (human)	Potency	29.1208	0.0007	23.0674	1,258.9301	AID743085
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a	Homo sapiens (human)	Potency	29.1208	0.0017	23.8393	78.1014	AID743083
thyroid stimulating hormone receptor	Homo sapiens (human)	Potency	7.6278	0.0016	28.0151	77.1139	AID1224843; AID1224895; AID1259385
activating transcription factor 6	Homo sapiens (human)	Potency	58.6042	0.1434	27.6121	59.8106	AID1159516
thyrotropin-releasing hormone receptor	Homo sapiens (human)	Potency	36.7085	0.1549	17.8702	43.6557	AID1346877; AID1346891
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a	Homo sapiens (human)	Potency	52.2310	19.7391	45.9784	64.9432	AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)	Homo sapiens (human)	Potency	20.8937	0.0578	21.1097	61.2679	AID1159526; AID1159528
Histone H2A.x	Cricetulus griseus (Chinese hamster)	Potency	100.7150	0.0391	47.5451	146.8240	AID1224845
Caspase-7	Cricetulus griseus (Chinese hamster)	Potency	65.1933	0.0067	23.4960	68.5896	AID1346980
vitamin D3 receptor isoform VDRA	Homo sapiens (human)	Potency	19.9526	0.3548	28.0659	89.1251	AID504847
thyroid hormone receptor beta isoform a	Homo sapiens (human)	Potency	0.0178	0.0100	39.5371	1,122.0200	AID588545
caspase-3	Cricetulus griseus (Chinese hamster)	Potency	65.1933	0.0067	23.4960	68.5896	AID1346980
thyroid hormone receptor beta isoform 2	Rattus norvegicus (Norway rat)	Potency	35.2579	0.0003	23.4451	159.6830	AID743065; AID743066; AID743067
heat shock protein beta-1	Homo sapiens (human)	Potency	29.3717	0.0420	27.3789	61.6448	AID743210
nuclear factor erythroid 2-related factor 2 isoform 1	Homo sapiens (human)	Potency	34.8138	0.0006	27.2152	1,122.0200	AID651741; AID743202; AID743219
nuclear receptor ROR-gamma isoform 1	Mus musculus (house mouse)	Potency	35.4813	0.0079	8.2332	1,122.0200	AID2546
Voltage-dependent calcium channel gamma-2 subunit	Mus musculus (house mouse)	Potency	20.6159	0.0015	57.7890	15,848.9004	AID1259244
Interferon beta	Homo sapiens (human)	Potency	25.1545	0.0033	9.1582	39.8107	AID1347407; AID1645842
HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)	Potency	2.2446	0.0123	8.9648	39.8107	AID1645842
Cellular tumor antigen p53	Homo sapiens (human)	Potency	48.5577	0.0023	19.5956	74.0614	AID651631
Glutamate receptor 2	Rattus norvegicus (Norway rat)	Potency	20.6159	0.0015	51.7393	15,848.9004	AID1259244
Inositol hexakisphosphate kinase 1	Homo sapiens (human)	Potency	2.2446	0.0123	8.9648	39.8107	AID1645842
cytochrome P450 2C9, partial	Homo sapiens (human)	Potency	2.2446	0.0123	8.9648	39.8107	AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Tubulin alpha-1A chain	Sus scrofa (pig)	IC50 (µMol)	40.0000	0.0067	2.1603	10.0000	AID1799579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Process	via Protein(s)	Taxonomy
cell surface receptor signaling pathway via JAK-STAT	Interferon beta	Homo sapiens (human)
response to exogenous dsRNA	Interferon beta	Homo sapiens (human)
B cell activation involved in immune response	Interferon beta	Homo sapiens (human)
cell surface receptor signaling pathway	Interferon beta	Homo sapiens (human)
cell surface receptor signaling pathway via JAK-STAT	Interferon beta	Homo sapiens (human)
response to virus	Interferon beta	Homo sapiens (human)
positive regulation of autophagy	Interferon beta	Homo sapiens (human)
cytokine-mediated signaling pathway	Interferon beta	Homo sapiens (human)
natural killer cell activation	Interferon beta	Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT protein	Interferon beta	Homo sapiens (human)
cellular response to interferon-beta	Interferon beta	Homo sapiens (human)
B cell proliferation	Interferon beta	Homo sapiens (human)
negative regulation of viral genome replication	Interferon beta	Homo sapiens (human)
innate immune response	Interferon beta	Homo sapiens (human)
positive regulation of innate immune response	Interferon beta	Homo sapiens (human)
regulation of MHC class I biosynthetic process	Interferon beta	Homo sapiens (human)
negative regulation of T cell differentiation	Interferon beta	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Interferon beta	Homo sapiens (human)
defense response to virus	Interferon beta	Homo sapiens (human)
type I interferon-mediated signaling pathway	Interferon beta	Homo sapiens (human)
neuron cellular homeostasis	Interferon beta	Homo sapiens (human)
cellular response to exogenous dsRNA	Interferon beta	Homo sapiens (human)
cellular response to virus	Interferon beta	Homo sapiens (human)
negative regulation of Lewy body formation	Interferon beta	Homo sapiens (human)
negative regulation of T-helper 2 cell cytokine production	Interferon beta	Homo sapiens (human)
positive regulation of apoptotic signaling pathway	Interferon beta	Homo sapiens (human)
response to exogenous dsRNA	Interferon beta	Homo sapiens (human)
B cell differentiation	Interferon beta	Homo sapiens (human)
natural killer cell activation involved in immune response	Interferon beta	Homo sapiens (human)
adaptive immune response	Interferon beta	Homo sapiens (human)
T cell activation involved in immune response	Interferon beta	Homo sapiens (human)
humoral immune response	Interferon beta	Homo sapiens (human)
positive regulation of T cell mediated cytotoxicity	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
adaptive immune response	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
regulation of T cell anergy	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
defense response	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
immune response	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
detection of bacterium	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
regulation of interleukin-12 production	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
regulation of interleukin-6 production	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
protection from natural killer cell mediated cytotoxicity	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
innate immune response	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
regulation of dendritic cell differentiation	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class Ib	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
negative regulation of cell population proliferation	Cellular tumor antigen p53	Homo sapiens (human)
regulation of cell cycle	Cellular tumor antigen p53	Homo sapiens (human)
regulation of cell cycle G2/M phase transition	Cellular tumor antigen p53	Homo sapiens (human)
DNA damage response	Cellular tumor antigen p53	Homo sapiens (human)
ER overload response	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to glucose starvation	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
regulation of apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of miRNA transcription	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of transcription by RNA polymerase II	Cellular tumor antigen p53	Homo sapiens (human)
mitophagy	Cellular tumor antigen p53	Homo sapiens (human)
in utero embryonic development	Cellular tumor antigen p53	Homo sapiens (human)
somitogenesis	Cellular tumor antigen p53	Homo sapiens (human)
release of cytochrome c from mitochondria	Cellular tumor antigen p53	Homo sapiens (human)
hematopoietic progenitor cell differentiation	Cellular tumor antigen p53	Homo sapiens (human)
T cell proliferation involved in immune response	Cellular tumor antigen p53	Homo sapiens (human)
B cell lineage commitment	Cellular tumor antigen p53	Homo sapiens (human)
T cell lineage commitment	Cellular tumor antigen p53	Homo sapiens (human)
response to ischemia	Cellular tumor antigen p53	Homo sapiens (human)
nucleotide-excision repair	Cellular tumor antigen p53	Homo sapiens (human)
double-strand break repair	Cellular tumor antigen p53	Homo sapiens (human)
regulation of DNA-templated transcription	Cellular tumor antigen p53	Homo sapiens (human)
regulation of transcription by RNA polymerase II	Cellular tumor antigen p53	Homo sapiens (human)
protein import into nucleus	Cellular tumor antigen p53	Homo sapiens (human)
autophagy	Cellular tumor antigen p53	Homo sapiens (human)
DNA damage response	Cellular tumor antigen p53	Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	Cellular tumor antigen p53	Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
transforming growth factor beta receptor signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
Ras protein signal transduction	Cellular tumor antigen p53	Homo sapiens (human)
gastrulation	Cellular tumor antigen p53	Homo sapiens (human)
neuroblast proliferation	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of neuroblast proliferation	Cellular tumor antigen p53	Homo sapiens (human)
protein localization	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of DNA replication	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of cell population proliferation	Cellular tumor antigen p53	Homo sapiens (human)
determination of adult lifespan	Cellular tumor antigen p53	Homo sapiens (human)
mRNA transcription	Cellular tumor antigen p53	Homo sapiens (human)
rRNA transcription	Cellular tumor antigen p53	Homo sapiens (human)
response to salt stress	Cellular tumor antigen p53	Homo sapiens (human)
response to inorganic substance	Cellular tumor antigen p53	Homo sapiens (human)
response to X-ray	Cellular tumor antigen p53	Homo sapiens (human)
response to gamma radiation	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of gene expression	Cellular tumor antigen p53	Homo sapiens (human)
cardiac muscle cell apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
glial cell proliferation	Cellular tumor antigen p53	Homo sapiens (human)
viral process	Cellular tumor antigen p53	Homo sapiens (human)
glucose catabolic process to lactate via pyruvate	Cellular tumor antigen p53	Homo sapiens (human)
cerebellum development	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of cell growth	Cellular tumor antigen p53	Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
mitotic G1 DNA damage checkpoint signaling	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of telomere maintenance via telomerase	Cellular tumor antigen p53	Homo sapiens (human)
T cell differentiation in thymus	Cellular tumor antigen p53	Homo sapiens (human)
tumor necrosis factor-mediated signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
regulation of tissue remodeling	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to UV	Cellular tumor antigen p53	Homo sapiens (human)
multicellular organism growth	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of mitochondrial membrane permeability	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to glucose starvation	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
entrainment of circadian clock by photoperiod	Cellular tumor antigen p53	Homo sapiens (human)
mitochondrial DNA repair	Cellular tumor antigen p53	Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of neuron apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
transcription initiation-coupled chromatin remodeling	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of proteolysis	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of DNA-templated transcription	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of DNA-templated transcription	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assembly	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of transcription by RNA polymerase II	Cellular tumor antigen p53	Homo sapiens (human)
response to antibiotic	Cellular tumor antigen p53	Homo sapiens (human)
fibroblast proliferation	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of fibroblast proliferation	Cellular tumor antigen p53	Homo sapiens (human)
circadian behavior	Cellular tumor antigen p53	Homo sapiens (human)
bone marrow development	Cellular tumor antigen p53	Homo sapiens (human)
embryonic organ development	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylation	Cellular tumor antigen p53	Homo sapiens (human)
protein stabilization	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of helicase activity	Cellular tumor antigen p53	Homo sapiens (human)
protein tetramerization	Cellular tumor antigen p53	Homo sapiens (human)
chromosome organization	Cellular tumor antigen p53	Homo sapiens (human)
neuron apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
regulation of cell cycle	Cellular tumor antigen p53	Homo sapiens (human)
hematopoietic stem cell differentiation	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of glial cell proliferation	Cellular tumor antigen p53	Homo sapiens (human)
type II interferon-mediated signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
cardiac septum morphogenesis	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of programmed necrotic cell death	Cellular tumor antigen p53	Homo sapiens (human)
protein-containing complex assembly	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	Cellular tumor antigen p53	Homo sapiens (human)
thymocyte apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of thymocyte apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
necroptotic process	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to hypoxia	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to xenobiotic stimulus	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to ionizing radiation	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to gamma radiation	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to UV-C	Cellular tumor antigen p53	Homo sapiens (human)
stem cell proliferation	Cellular tumor antigen p53	Homo sapiens (human)
signal transduction by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
reactive oxygen species metabolic process	Cellular tumor antigen p53	Homo sapiens (human)
cellular response to actinomycin D	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondria	Cellular tumor antigen p53	Homo sapiens (human)
cellular senescence	Cellular tumor antigen p53	Homo sapiens (human)
replicative senescence	Cellular tumor antigen p53	Homo sapiens (human)
oxidative stress-induced premature senescence	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
oligodendrocyte apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of execution phase of apoptosis	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of mitophagy	Cellular tumor antigen p53	Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediator	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of miRNA transcription	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of G1 to G0 transition	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of miRNA processing	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvate	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of pentose-phosphate shunt	Cellular tumor antigen p53	Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxia	Cellular tumor antigen p53	Homo sapiens (human)
regulation of fibroblast apoptotic process	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of reactive oxygen species metabolic process	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of reactive oxygen species metabolic process	Cellular tumor antigen p53	Homo sapiens (human)
negative regulation of stem cell proliferation	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of cellular senescence	Cellular tumor antigen p53	Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathway	Cellular tumor antigen p53	Homo sapiens (human)
inositol phosphate metabolic process	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic process	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
negative regulation of cold-induced thermogenesis	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
inositol phosphate biosynthetic process	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
cytokine activity	Interferon beta	Homo sapiens (human)
cytokine receptor binding	Interferon beta	Homo sapiens (human)
type I interferon receptor binding	Interferon beta	Homo sapiens (human)
protein binding	Interferon beta	Homo sapiens (human)
chloramphenicol O-acetyltransferase activity	Interferon beta	Homo sapiens (human)
TAP binding	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
signaling receptor binding	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
protein binding	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
peptide antigen binding	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
TAP binding	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
protein-folding chaperone binding	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
transcription cis-regulatory region binding	Cellular tumor antigen p53	Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA binding	Cellular tumor antigen p53	Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specific	Cellular tumor antigen p53	Homo sapiens (human)
cis-regulatory region sequence-specific DNA binding	Cellular tumor antigen p53	Homo sapiens (human)
core promoter sequence-specific DNA binding	Cellular tumor antigen p53	Homo sapiens (human)
TFIID-class transcription factor complex binding	Cellular tumor antigen p53	Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specific	Cellular tumor antigen p53	Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specific	Cellular tumor antigen p53	Homo sapiens (human)
protease binding	Cellular tumor antigen p53	Homo sapiens (human)
p53 binding	Cellular tumor antigen p53	Homo sapiens (human)
DNA binding	Cellular tumor antigen p53	Homo sapiens (human)
chromatin binding	Cellular tumor antigen p53	Homo sapiens (human)
DNA-binding transcription factor activity	Cellular tumor antigen p53	Homo sapiens (human)
mRNA 3'-UTR binding	Cellular tumor antigen p53	Homo sapiens (human)
copper ion binding	Cellular tumor antigen p53	Homo sapiens (human)
protein binding	Cellular tumor antigen p53	Homo sapiens (human)
zinc ion binding	Cellular tumor antigen p53	Homo sapiens (human)
enzyme binding	Cellular tumor antigen p53	Homo sapiens (human)
receptor tyrosine kinase binding	Cellular tumor antigen p53	Homo sapiens (human)
ubiquitin protein ligase binding	Cellular tumor antigen p53	Homo sapiens (human)
histone deacetylase regulator activity	Cellular tumor antigen p53	Homo sapiens (human)
ATP-dependent DNA/DNA annealing activity	Cellular tumor antigen p53	Homo sapiens (human)
identical protein binding	Cellular tumor antigen p53	Homo sapiens (human)
histone deacetylase binding	Cellular tumor antigen p53	Homo sapiens (human)
protein heterodimerization activity	Cellular tumor antigen p53	Homo sapiens (human)
protein-folding chaperone binding	Cellular tumor antigen p53	Homo sapiens (human)
protein phosphatase 2A binding	Cellular tumor antigen p53	Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor binding	Cellular tumor antigen p53	Homo sapiens (human)
14-3-3 protein binding	Cellular tumor antigen p53	Homo sapiens (human)
MDM2/MDM4 family protein binding	Cellular tumor antigen p53	Homo sapiens (human)
disordered domain specific binding	Cellular tumor antigen p53	Homo sapiens (human)
general transcription initiation factor binding	Cellular tumor antigen p53	Homo sapiens (human)
molecular function activator activity	Cellular tumor antigen p53	Homo sapiens (human)
promoter-specific chromatin binding	Cellular tumor antigen p53	Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activity	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
inositol hexakisphosphate kinase activity	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
inositol heptakisphosphate kinase activity	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
inositol hexakisphosphate 5-kinase activity	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
protein binding	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
ATP binding	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
inositol hexakisphosphate 1-kinase activity	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
inositol hexakisphosphate 3-kinase activity	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activity	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activity	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Process	via Protein(s)	Taxonomy
extracellular space	Interferon beta	Homo sapiens (human)
extracellular region	Interferon beta	Homo sapiens (human)
Golgi membrane	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
endoplasmic reticulum	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
Golgi apparatus	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
plasma membrane	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
cell surface	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
ER to Golgi transport vesicle membrane	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
membrane	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
secretory granule membrane	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
phagocytic vesicle membrane	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
early endosome membrane	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
recycling endosome membrane	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
extracellular exosome	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
lumenal side of endoplasmic reticulum membrane	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
MHC class I protein complex	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
extracellular space	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
external side of plasma membrane	HLA class I histocompatibility antigen, B alpha chain	Homo sapiens (human)
nuclear body	Cellular tumor antigen p53	Homo sapiens (human)
nucleus	Cellular tumor antigen p53	Homo sapiens (human)
nucleoplasm	Cellular tumor antigen p53	Homo sapiens (human)
replication fork	Cellular tumor antigen p53	Homo sapiens (human)
nucleolus	Cellular tumor antigen p53	Homo sapiens (human)
cytoplasm	Cellular tumor antigen p53	Homo sapiens (human)
mitochondrion	Cellular tumor antigen p53	Homo sapiens (human)
mitochondrial matrix	Cellular tumor antigen p53	Homo sapiens (human)
endoplasmic reticulum	Cellular tumor antigen p53	Homo sapiens (human)
centrosome	Cellular tumor antigen p53	Homo sapiens (human)
cytosol	Cellular tumor antigen p53	Homo sapiens (human)
nuclear matrix	Cellular tumor antigen p53	Homo sapiens (human)
PML body	Cellular tumor antigen p53	Homo sapiens (human)
transcription repressor complex	Cellular tumor antigen p53	Homo sapiens (human)
site of double-strand break	Cellular tumor antigen p53	Homo sapiens (human)
germ cell nucleus	Cellular tumor antigen p53	Homo sapiens (human)
chromatin	Cellular tumor antigen p53	Homo sapiens (human)
transcription regulator complex	Cellular tumor antigen p53	Homo sapiens (human)
protein-containing complex	Cellular tumor antigen p53	Homo sapiens (human)
plasma membrane	Glutamate receptor 2	Rattus norvegicus (Norway rat)
fibrillar center	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
nucleoplasm	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
cytosol	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
nucleus	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
cytoplasm	Inositol hexakisphosphate kinase 1	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Assay ID	Title	Year	Journal	Article
AID100412	Inhibitory activity against Leishmania donovani amastigotes	2002	Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17	Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin.
AID156322	In vitro cytotoxicity against mouse PC3 prostate cancer cell line.	2004	Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7	Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID91776	In vitro cytotoxicity against mouse J774 macrophages.	2004	Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7	Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID518932	Inhibition of tubulin in Acanthamoeba castellanii by alamar blue assay	2008	Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3	Molecular basis for resistance of acanthamoeba tubulins to all major classes of antitubulin compounds.
AID522807	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin S6I mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID502117	Antimicrobial activity against Toxoplasma gondii infected in HFF after 8 days by plaque assay	2010	Bioorganic & medicinal chemistry letters, Sep-01, Volume: 20, Issue:17	Synthesis and evaluation of oryzalin analogs against Toxoplasma gondii.
AID537684	Toxicity in po dosed mouse	2010	European journal of medicinal chemistry, Nov, Volume: 45, Issue:11	QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides.
AID518933	Inhibition of tubulin in rabbit corneal cells by alamar blue assay	2008	Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3	Molecular basis for resistance of acanthamoeba tubulins to all major classes of antitubulin compounds.
AID537683	Genotoxicity in Salmonella Typhimurium by Ames test	2010	European journal of medicinal chemistry, Nov, Volume: 45, Issue:11	QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides.
AID522815	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243C mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID537685	Toxicity in po dosed rat	2010	European journal of medicinal chemistry, Nov, Volume: 45, Issue:11	QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides.
AID622161	Antimicrobial activity against Cryptosporidium parvum infected in HCT8 cells assessed as parasite count after 72 to 120 hrs	2011	Bioorganic & medicinal chemistry letters, Oct-15, Volume: 21, Issue:20	Synthesis and evaluation of phosphoramidate and phosphorothioamidate analogues of amiprophos methyl as potential antimalarial agents.
AID100414	Inhibitory activity against Leishmania donovani promastigotes	2002	Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17	Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin.
AID522805	Antimicrobial activity against Toxoplasma gondii RH infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID522810	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin L136F mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID522814	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin T239I mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID100424	Inhibitory concentration against Leishmania donovani axenic amastigotes was determined in vitro	2004	Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7	Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID522808	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin F24H mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID522811	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235L mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID214974	Inhibitory concentration against brucei variant 221 was determined in vitro	2004	Journal of medicinal chemistry, Mar-25, Volume: 47, Issue:7	Synthesis and antitubulin activity of N1- and N4-substituted 3,5-dinitro sulfanilamides against African trypanosomes and Leishmania.
AID518931	Inhibition of tubulin in Acanthamoeba polyphaga by alamar blue assay	2008	Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3	Molecular basis for resistance of acanthamoeba tubulins to all major classes of antitubulin compounds.
AID522816	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin R243S mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID537682	Octanol-water partition coefficient, log P of the compound	2010	European journal of medicinal chemistry, Nov, Volume: 45, Issue:11	QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides.
AID522809	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin H28Q mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID522813	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235V mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID101194	Percentage inhibition against Leishmania tubulin in vitro was determined at 20 uM	2002	Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17	Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin.
AID537681	Antileishmanial activity against Leishmania donovani	2010	European journal of medicinal chemistry, Nov, Volume: 45, Issue:11	QSAR and docking studies of novel antileishmanial diaryl sulfides and sulfonamides.
AID522812	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin I235T mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID522806	Antimicrobial activity against Toxoplasma gondii RH containing alpha1-tubulin V4L mutation infected in HFF cells by plaque assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID522819	Antimicrobial activity against Cryptosporidium parvum by short-term in vitro culture assay	2010	Antimicrobial agents and chemotherapy, Apr, Volume: 54, Issue:4	Dinitroaniline activity in Toxoplasma gondii expressing wild-type or mutant alpha-tubulin.
AID1799579	In Vitro Activity Assay from Article 10.1111/j.1747-0285.2008.00729.x: \\Inhibitors of tubulin assembly identified through screening a compound library.\\	2008	Chemical biology & drug design, Dec, Volume: 72, Issue:6	Inhibitors of tubulin assembly identified through screening a compound library.
AID1347104	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID651635	Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1347102	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347424	RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)	2019	The Journal of biological chemistry, 11-15, Volume: 294, Issue:46	Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1347082	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1346986	P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen	2019	Molecular pharmacology, 11, Volume: 96, Issue:5	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347089	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347106	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347100	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1745845	Primary qHTS for Inhibitors of ATXN expression
AID1347096	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1296008	Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening	2020	SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1	Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347083	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347154	Primary screen GU AMC qHTS for Zika virus inhibitors	2020	Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49	Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347086	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347425	Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1)	2019	The Journal of biological chemistry, 11-15, Volume: 294, Issue:46	Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
AID1346987	P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen	2019	Molecular pharmacology, 11, Volume: 96, Issue:5	A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347098	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347107	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347097	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347407	qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection	2020	ACS chemical biology, 07-17, Volume: 15, Issue:7	High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1508630	Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay	2021	Cell reports, 04-27, Volume: 35, Issue:4	A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347101	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105	qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells	2018	Oncotarget, Jan-12, Volume: 9, Issue:4	Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	7 (2.98)	18.7374
1990's	39 (16.60)	18.2507
2000's	105 (44.68)	29.6817
2010's	71 (30.21)	24.3611
2020's	13 (5.53)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	238 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Description	Relationhip Strength	Studies	Classes	Roles
pentamidine	[no description available]	medium	2	aromatic ether; carboxamidine; diether	anti-inflammatory agent; antifungal agent; calmodulin antagonist; chemokine receptor 5 antagonist; EC 2.3.1.48 (histone acetyltransferase) inhibitor; NMDA receptor antagonist; S100 calcium-binding protein B inhibitor; trypanocidal drug; xenobiotic
n1-phenyl-3,5-dinitro-n4,n4-di-n-propylsulfanilamide	[no description available]	medium	8
suramin	[no description available]	medium	1	naphthalenesulfonic acid; phenylureas; secondary carboxamide	angiogenesis inhibitor; antinematodal drug; antineoplastic agent; apoptosis inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; GABA antagonist; GABA-gated chloride channel antagonist; purinergic receptor P2 antagonist; ryanodine receptor agonist; trypanocidal drug
albendazole	[no description available]	medium	2	aryl sulfide; benzimidazoles; benzimidazolylcarbamate fungicide; carbamate ester	anthelminthic drug; microtubule-destabilising agent; tubulin modulator
colchicine	[no description available]	medium	23	alkaloid; colchicine	anti-inflammatory agent; gout suppressant; mutagen
vinblastine	[no description available]	medium	1
paclitaxel	[no description available]	medium	35	taxane diterpenoid; tetracyclic diterpenoid	antineoplastic agent; human metabolite; metabolite; microtubule-stabilising agent
chlorhexidine	[no description available]	medium	1	biguanides; monochlorobenzenes	antibacterial agent; antiinfective agent
podophyllotoxin	[no description available]	medium	1	furonaphthodioxole; lignan; organic heterotetracyclic compound	antimitotic; antineoplastic agent; keratolytic drug; microtubule-destabilising agent; plant metabolite; tubulin modulator
benefin	[no description available]	high	2	C-nitro compound; organofluorine compound; substituted aniline; tertiary amino compound	agrochemical; herbicide
trifluralin	[no description available]	high	22	(trifluoromethyl)benzenes; C-nitro compound; substituted aniline	agrochemical; environmental contaminant; herbicide; xenobiotic
nitralin	[no description available]	medium	2	C-nitro compound
profluralin	[no description available]	medium	1	C-nitro compound
dinitramine	[no description available]	medium	2	C-nitro compound
fluchloralin	[no description available]	medium	1	C-nitro compound
butralin	[no description available]	medium	2	C-nitro compound
isopropalin	[no description available]	medium	3	C-nitro compound
pendimethalin	[no description available]	high	4	C-nitro compound; secondary amino compound; substituted aniline	agrochemical; environmental contaminant; herbicide
ethafluralin	[no description available]	medium	4	C-nitro compound
amiprophos methyl	[no description available]	medium	9
chlorpropham	[no description available]	medium	2	benzenes; carbamate ester; monochlorobenzenes	herbicide; plant growth retardant
amiprophos	[no description available]	medium	4
dinitrobenzenes	[no description available]	medium	222
artenimol	[no description available]	medium	1
chloroquine	[no description available]	medium	2	aminoquinoline; organochlorine compound; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; autophagy inhibitor; dermatologic drug
primaquine	[no description available]	medium	1	aminoquinoline; aromatic ether; N-substituted diamine	antimalarial
pectins	[no description available]	medium	2	D-galactopyranuronic acid
cellulose	[no description available]	medium	12	glycoside
latrunculin a	[no description available]	medium	5	cyclic hemiketal; macrolide; oxabicycloalkane; thiazolidinone	actin polymerisation inhibitor; metabolite; toxin
thiazolidines	[no description available]	medium	35	thiazolidine
latrunculin b	[no description available]	medium	31	cyclic hemiketal; macrolide; oxabicycloalkane; thiazolidinone	actin polymerisation inhibitor; metabolite; toxin
cyc 202	[no description available]	medium	1	2,6-diaminopurines	antiviral drug; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
brefeldin a	[no description available]	medium	11	macrolide antibiotic	Penicillium metabolite
cordycepin	[no description available]	medium	1	3'-deoxyribonucleoside; adenosines	antimetabolite; nucleoside antibiotic
cycloheximide	[no description available]	medium	1	antibiotic fungicide; cyclic ketone; dicarboximide; piperidine antibiotic; piperidones; secondary alcohol	anticoronaviral agent; bacterial metabolite; ferroptosis inhibitor; neuroprotective agent; protein synthesis inhibitor
bisphenol a	[no description available]	medium	1	bisphenol	endocrine disruptor; environmental contaminant; xenobiotic; xenoestrogen
wortmannin	[no description available]	medium	2	acetate ester; cyclic ketone; delta-lactone; organic heteropentacyclic compound	anticoronaviral agent; antineoplastic agent; autophagy inhibitor; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; geroprotector; Penicillium metabolite; radiosensitizing agent
nocodazole	[no description available]	medium	4	aromatic ketone; benzimidazoles; carbamate ester; thiophenes	antimitotic; antineoplastic agent; microtubule-destabilising agent; tubulin modulator
dimethyl sulfoxide	[no description available]	medium	4	sulfoxide; volatile organic compound	alkylating agent; antidote; Escherichia coli metabolite; geroprotector; MRI contrast agent; non-narcotic analgesic; polar aprotic solvent; radical scavenger
rhamnogalacturonan i	[no description available]	medium	1
adenosine diphosphate	[no description available]	medium	1	adenosine 5'-phosphate; purine ribonucleoside 5'-diphosphate	fundamental metabolite; human metabolite
3-nitrotyrosine	[no description available]	medium	2	2-nitrophenols; C-nitro compound; nitrotyrosine; non-proteinogenic alpha-amino acid
tyrosine	[no description available]	medium	4	amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; proteinogenic amino acid; tyrosine	EC 1.3.1.43 (arogenate dehydrogenase) inhibitor; fundamental metabolite; micronutrient; nutraceutical
cytochalasin d	[no description available]	medium	15
cytochalasin b	[no description available]	medium	13	cytochalasin; lactam; lactone; organic heterotricyclic compound	actin polymerisation inhibitor; metabolite; mycotoxin; platelet aggregation inhibitor
cellulase	[no description available]	medium	2	cellotriose
isoxaben	[no description available]	medium	5	benzamides; isoxazoles	cellulose synthesis inhibitor; herbicide
fusicoccin	[no description available]	medium	2
glycosides	[no description available]	medium	2
ethylene	[no description available]	medium	3	alkene; gas molecular entity	plant hormone; refrigerant
2,3,5-triiodobenzoic acid	[no description available]	medium	1	benzoic acids; organoiodine compound	antiauxins
alpha-naphthylphthalamic acid	[no description available]	medium	3	carboxylic acid; dicarboxylic acid monoamide; N-(1-naphthyl)carboxamide	herbicide
acetonitrile	[no description available]	medium	1	aliphatic nitrile; volatile organic compound	EC 3.5.1.4 (amidase) inhibitor; NMR chemical shift reference compound; polar aprotic solvent
2-propanol	[no description available]	medium	1	secondary alcohol; secondary fatty alcohol	protic solvent
acetazolamide	[no description available]	medium	1	monocarboxylic acid amide; sulfonamide; thiadiazoles	anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor
warfarin	[no description available]	medium	1	benzenes; hydroxycoumarin; methyl ketone
deoxyglucose	[no description available]	medium	1
coumarin	[no description available]	medium	1	coumarins	fluorescent dye; human metabolite; plant metabolite
dichlobanil	[no description available]	medium	2	dichlorobenzene; nitrile	agrochemical; cellulose synthesis inhibitor; environmental contaminant; herbicide; xenobiotic
glucose, (beta-d)-isomer	[no description available]	medium	1	D-glucopyranose	epitope; mouse metabolite
pronamide	[no description available]	medium	11	benzamides; dichlorobenzene; terminal acetylenic compound	agrochemical; herbicide
abscisic acid	[no description available]	medium	8	2-trans-abscisic acid
zeaxanthin	[no description available]	medium	1	carotenol	antioxidant; bacterial metabolite; cofactor
framycetin	[no description available]	medium	1	aminoglycoside	allergen; antibacterial drug; Escherichia coli metabolite
1-butanol	[no description available]	medium	1	alkyl alcohol; primary alcohol; short-chain primary fatty alcohol	human metabolite; mouse metabolite; protic solvent
tripalmitin	[no description available]	medium	1	triglyceride
deoxycholic acid	[no description available]	medium	1	bile acid; C24-steroid; dihydroxy-5beta-cholanic acid	human blood serum metabolite
gibberellins	[no description available]	medium	1
gibberellic acid	[no description available]	medium	1	C19-gibberellin; gibberellin monocarboxylic acid; lactone; organic heteropentacyclic compound	mouse metabolite; plant metabolite
phenyl acetate	[no description available]	medium	1	benzenes; phenyl acetates
methyl jasmonate	[no description available]	medium	1
cyclopentane	[no description available]	medium	2	cycloalkane; cyclopentanes; volatile organic compound	non-polar solvent
chromium	[no description available]	medium	1	chromium cation; monoatomic hexacation
chromium	[no description available]	medium	1	chromium group element atom; metal allergen	micronutrient
carbamates	[no description available]	medium	3	amino-acid anion
mannitol	[no description available]	medium	1	mannitol	allergen; antiglaucoma drug; compatible osmolytes; Escherichia coli metabolite; food anticaking agent; food bulking agent; food humectant; food stabiliser; food thickening agent; hapten; metabolite; osmotic diuretic; sweetening agent
aphidicolin	[no description available]	medium	4	tetracyclic diterpenoid	antimicrobial agent; antimitotic; antineoplastic agent; antiviral drug; apoptosis inducer; Aspergillus metabolite; DNA synthesis inhibitor; EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor; fungal metabolite
dihydrocytochalasin b	[no description available]	medium	1
thiazoles	[no description available]	medium	21	1,3-thiazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
phenylurethane	[no description available]	medium	2
urethane	[no description available]	medium	2	carbamate ester	fungal metabolite; mutagen
indoleacetic acid	[no description available]	medium	3	indole-3-acetic acids; monocarboxylic acid	auxin; human metabolite; mouse metabolite; plant hormone; plant metabolite
amphotericin b	[no description available]	medium	1	antibiotic antifungal drug; macrolide antibiotic; polyene antibiotic	antiamoebic agent; antiprotozoal drug; bacterial metabolite
chlorpromazine	[no description available]	medium	1	organochlorine compound; phenothiazines; tertiary amine	anticoronaviral agent; antiemetic; dopaminergic antagonist; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; phenothiazine antipsychotic drug
diuron	[no description available]	medium	4	3-(3,4-substituted-phenyl)-1,1-dimethylurea; dichlorobenzene	environmental contaminant; mitochondrial respiratory-chain inhibitor; photosystem-II inhibitor; urea herbicide; xenobiotic
hydroxyurea	[no description available]	medium	2	one-carbon compound; ureas	antimetabolite; antimitotic; antineoplastic agent; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor; genotoxin; immunomodulator; radical scavenger; teratogenic agent
sucrose	[no description available]	medium	1	glycosyl glycoside	algal metabolite; Escherichia coli metabolite; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; sweetening agent
monensin	[no description available]	medium	2	cyclic hemiketal; monocarboxylic acid; polyether antibiotic; spiroketal	antifungal agent; coccidiostat; ionophore
mycalolide b	[no description available]	medium	1
oxazoles	[no description available]	medium	1	1,3-oxazoles; mancude organic heteromonocyclic parent; monocyclic heteroarene
glycine	[no description available]	medium	1	alpha-amino acid; amino acid zwitterion; proteinogenic amino acid; serine family amino acid	EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor; fundamental metabolite; hepatoprotective agent; micronutrient; neurotransmitter; NMDA receptor agonist; nutraceutical
clopyralid	[no description available]	medium	1	organochlorine pesticide; pyridines	herbicide
2,4-dinitroaniline	[no description available]	medium	1	nitroaniline
monastrol	[no description available]	medium	1	enoate ester; ethyl ester; phenols; racemate; thioureas	antileishmanial agent; antimitotic; antineoplastic agent; EC 3.5.1.5 (urease) inhibitor
nsc 83265	[no description available]	medium	1	benzenoid aromatic compound
cysteine	[no description available]	medium	2	cysteinium	fundamental metabolite
simazine	[no description available]	medium	1	chloro-1,3,5-triazine; diamino-1,3,5-triazine	environmental contaminant; herbicide; xenobiotic
captan	[no description available]	medium	1	isoindoles; organochlorine compound; organosulfur compound; phthalimide fungicide	antifungal agrochemical
dichlofluanid	[no description available]	medium	1	organochlorine compound; organofluorine compound; phenylsulfamide fungicide; sulfamides	acaricide; antifungal agrochemical
thymidine	[no description available]	medium	1	pyrimidine 2'-deoxyribonucleoside	Escherichia coli metabolite; human metabolite; metabolite; mouse metabolite
calcimycin	[no description available]	medium	2	benzoxazole
pyrimethamine	[no description available]	medium	1	aminopyrimidine; monochlorobenzenes	antimalarial; antiprotozoal drug; EC 1.5.1.3 (dihydrofolate reductase) inhibitor
beta-escin	[no description available]	medium	1
phalloidine	[no description available]	medium	1	homodetic cyclic peptide
diacetyl	[no description available]	medium	1	alpha-diketone	Escherichia coli metabolite; Saccharomyces cerevisiae metabolite
diacetylmonoxime	[no description available]	medium	1
indomethacin	[no description available]	medium	1	aromatic ether; indole-3-acetic acids; monochlorobenzenes; N-acylindole	analgesic; drug metabolite; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; gout suppressant; non-steroidal anti-inflammatory drug; xenobiotic metabolite; xenobiotic
3,3'-dihexyl-2,2'-oxacarbocyanine	[no description available]	medium	1
carbocyanines	[no description available]	medium	1	cyanine dye; organic iodide salt	fluorochrome
pstair peptide	[no description available]	medium	1
phallacidin	[no description available]	medium	1	homodetic cyclic peptide
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene	[no description available]	medium	1	BODIPY compound
indolebutyric acid	[no description available]	medium	1	indol-3-yl carboxylic acid	auxin; plant hormone; plant metabolite
aluminum	[no description available]	medium	1	boron group element atom; elemental aluminium; metal atom
methionine	[no description available]	medium	1	aspartate family amino acid; L-alpha-amino acid; methionine zwitterion; methionine; proteinogenic amino acid	antidote to paracetamol poisoning; human metabolite; micronutrient; mouse metabolite; nutraceutical
tebuthiuron	[no description available]	medium	1	organonitrogen heterocyclic compound; organosulfur heterocyclic compound
verapamil	[no description available]	medium	1	aromatic ether; nitrile; polyether; tertiary amino compound
anisomycin	[no description available]	medium	1	monohydroxypyrrolidine; organonitrogen heterocyclic antibiotic	anticoronaviral agent; antimicrobial agent; antineoplastic agent; antiparasitic agent; bacterial metabolite; DNA synthesis inhibitor; protein synthesis inhibitor
chloroacetic acid	[no description available]	low	0	chlorocarboxylic acid; haloacetic acid	alkylating agent; herbicide
amitrole	[no description available]	medium	0	aromatic amine; triazoles	carotenoid biosynthesis inhibitor; EC 1.11.1.6 (catalase) inhibitor; herbicide
acetochlor	[no description available]	low	0	aromatic amide; monocarboxylic acid amide; organochlorine compound	environmental contaminant; herbicide; xenobiotic
alachlor	[no description available]	low	0	aromatic amide; monocarboxylic acid amide; organochlorine compound	environmental contaminant; herbicide; xenobiotic
atrazine	[no description available]	low	0	chloro-1,3,5-triazine; diamino-1,3,5-triazine	environmental contaminant; herbicide; xenobiotic
bentazone	[no description available]	low	0	benzothiadiazine	environmental contaminant; herbicide; xenobiotic
clofibric acid	[no description available]	low	0	aromatic ether; monocarboxylic acid; monochlorobenzenes	anticholesteremic drug; antilipemic drug; antineoplastic agent; herbicide; marine xenobiotic metabolite; PPARalpha agonist
dicamba	[no description available]	low	0	dichlorobenzene; methoxybenzoic acid	agrochemical; environmental contaminant; herbicide; synthetic auxin; xenobiotic
ethoxyquin	[no description available]	low	0	aromatic ether; quinolines	antifungal agrochemical; food antioxidant; genotoxin; geroprotector; herbicide; Hsp90 inhibitor; neuroprotective agent; UDP-glucuronosyltransferase activator
glyphosate	[no description available]	low	0	glycine derivative; phosphonic acid	agrochemical; EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor; herbicide
juglone	[no description available]	low	0	hydroxy-1,4-naphthoquinone	geroprotector; herbicide; reactive oxygen species generator
prometone	[no description available]	low	0	diamino-1,3,5-triazine; methoxy-1,3,5-triazine	environmental contaminant; herbicide; xenobiotic
prometryne	[no description available]	low	0	diamino-1,3,5-triazine; methylthio-1,3,5-triazine	environmental contaminant; herbicide; xenobiotic
propachlor	[no description available]	low	0	anilide; monocarboxylic acid amide; organochlorine compound	environmental contaminant; herbicide; xenobiotic
propanil	[no description available]	low	0	anilide; dichlorobenzene	herbicide
propazine	[no description available]	low	0	chloro-1,3,5-triazine; diamino-1,3,5-triazine	environmental contaminant; herbicide; xenobiotic
cantharidin	[no description available]	low	0	cyclic dicarboxylic anhydride; monoterpenoid	EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; herbicide
diquat	[no description available]	low	0	organic cation	defoliant; herbicide
barban	[no description available]	low	0	acetylenic compound; carbamate ester; monochlorobenzenes	herbicide
fenuron	[no description available]	low	0	3-(3,4-substituted-phenyl)-1,1-dimethylurea	agrochemical; environmental contaminant; herbicide; photosystem-II inhibitor; xenobiotic
acrolein	[no description available]	low	0	enal	herbicide; human xenobiotic metabolite; toxin
allyl alcohol	[no description available]	low	0	primary allylic alcohol; propenol	antibacterial agent; fungicide; herbicide; insecticide; plant metabolite
2-hydroxyethylhydrazine	[no description available]	low	0	hydrazines	herbicide
monuron	[no description available]	low	0	3-(3,4-substituted-phenyl)-1,1-dimethylurea; monochlorobenzenes	environmental contaminant; herbicide; xenobiotic
linuron	[no description available]	low	0	dichlorobenzene; phenylureas	agrochemical; environmental contaminant; herbicide; xenobiotic
dazomet	[no description available]	low	0	dithiocarbamic ester; thiadiazinane	antibacterial agent; antifungal agrochemical; herbicide; nematicide
4,6-dinitro-o-cresol	[no description available]	low	0	dinitrophenol acaricide; hydroxytoluene; nitrotoluene	dinitrophenol insecticide; fungicide; herbicide
ametryne	[no description available]	low	0	diamino-1,3,5-triazine; methylthio-1,3,5-triazine	environmental contaminant; herbicide
terbutryne	[no description available]	low	0	diamino-1,3,5-triazine; methylthio-1,3,5-triazine	environmental contaminant; herbicide; xenobiotic
simetryn	[no description available]	low	0	diamino-1,3,5-triazine; methylthio-1,3,5-triazine	herbicide
bentranil	[no description available]	low	0	benzoxazine	herbicide
ioxynil	[no description available]	low	0	iodophenol; nitrile	environmental contaminant; herbicide; xenobiotic
bromoxynil	[no description available]	low	0	dibromobenzene; hydroxynitrile; phenols	environmental contaminant; herbicide; xenobiotic
pyrazon	[no description available]	low	0	benzenes; organochlorine compound; primary amino compound; pyridazinone	environmental contaminant; herbicide; xenobiotic
nitrofen	[no description available]	low	0	organic molecular entity	EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
2,4,6-trichlorophenyl 4-nitrophenyl ether	[no description available]	medium	0	aromatic ether; C-nitro compound; chlorobenzenes	EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
paraquat	[no description available]	low	0	organic cation	geroprotector; herbicide
picloram	[no description available]	low	0	aminopyridine; chloropyridine; organochlorine pesticide; pyridinemonocarboxylic acid	herbicide; synthetic auxin
2,6-dichlorobenzamide	[no description available]	low	0	benzamides; dichlorobenzene	herbicide; marine xenobiotic metabolite
lenacil	[no description available]	low	0	cyclopentapyrimidine	agrochemical; environmental contaminant; herbicide; xenobiotic
fluometuron	[no description available]	low	0	(trifluoromethyl)benzenes; 3-(3,4-substituted-phenyl)-1,1-dimethylurea	agrochemical; environmental contaminant; herbicide; photosystem-II inhibitor; xenobiotic
molinate	[no description available]	low	0	azepanes; monothiocarbamic ester	agrochemical; antispermatogenic agent; herbicide
asulam	[no description available]	medium	0	carbamate ester; primary amino compound; substituted aniline; sulfonamide	agrochemical; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; herbicide; xenobiotic
bpmc	[no description available]	low	0	carbamate ester	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; herbicide; insecticide
terbutylazine	[no description available]	low	0	chloro-1,3,5-triazine; diamino-1,3,5-triazine	environmental contaminant; herbicide; xenobiotic
propham	[no description available]	low	0	benzenes; carbamate ester	herbicide; plant growth retardant
desmedipham	[no description available]	low	0	carbamate ester	agrochemical; environmental contaminant; herbicide; xenobiotic
phenmedipham	[no description available]	low	0	carbamate ester	environmental contaminant; herbicide; xenobiotic
chlortoluron	[no description available]	low	0	monochlorobenzenes; phenylureas	agrochemical; environmental contaminant; herbicide; xenobiotic
2,4-dihydroxy-1,4-benzoxazin-3-one	[no description available]	low	0	benzoxazine; cyclic hydroxamic acid; lactol	allelochemical; herbicide; phytotoxin; plant metabolite
methoxuron	[no description available]	low	0	3-(3,4-substituted-phenyl)-1,1-dimethylurea; monochlorobenzenes; monomethoxybenzene	agrochemical; environmental contaminant; herbicide; photosystem-II inhibitor; plant growth regulator; xenobiotic
metribuzin	[no description available]	low	0	1,2,4-triazines; cyclic ketone; organic sulfide	agrochemical; environmental contaminant; herbicide; xenobiotic
cyanazine	[no description available]	low	0	1,3,5-triazinylamino nitrile; chloro-1,3,5-triazine	environmental contaminant; herbicide; xenobiotic
butachlor	[no description available]	low	0	aromatic amide; organochlorine compound; tertiary carboxamide	environmental contaminant; herbicide; xenobiotic
norflurazone	[no description available]	low	0	(trifluoromethyl)benzenes; organochlorine compound; pyridazinone; secondary amino compound	agrochemical; carotenoid biosynthesis inhibitor; herbicide
isoproturon	[no description available]	low	0	3-(3,4-substituted-phenyl)-1,1-dimethylurea	agrochemical; environmental contaminant; herbicide; xenobiotic
metamitron	[no description available]	low	0	1,2,4-triazines	environmental contaminant; herbicide; xenobiotic
oxyfluorofen	[no description available]	low	0	aromatic ether	EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
1-methyl-4-phenylpyridinium	[no description available]	low	0	pyridinium ion	apoptosis inducer; herbicide; human xenobiotic metabolite; neurotoxin
triclopyr	[no description available]	low	0	aromatic ether; chloropyridine; monocarboxylic acid	agrochemical; environmental contaminant; herbicide; xenobiotic
acifluorfen	[no description available]	medium	0	aromatic ether; benzoic acids; C-nitro compound; monocarboxylic acid; organochlorine compound; organofluorine compound	agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
chlorsulfuron	[no description available]	low	0	methoxy-1,3,5-triazine; monochlorobenzenes; N-sulfonylurea	agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide
metazachlor	[no description available]	low	0	aromatic amide; organochlorine compound; pyrazoles	environmental contaminant; herbicide; xenobiotic
4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acid	[no description available]	low	0	aminopyridine; aromatic ether; monocarboxylic acid; organochlorine compound; organofluorine compound	environmental contaminant; herbicide; xenobiotic
fomesafen	[no description available]	medium	0	aromatic ether; C-nitro compound; monochlorobenzenes; N-sulfonylcarboxamide; organofluorine compound; phenols	agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
sulfometuron methyl	[no description available]	low	0	benzoate ester; N-sulfonylurea; pyrimidines	EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide
metsulfuron methyl	[no description available]	low	0	1,3,5-triazines; benzoate ester; N-sulfonylurea	environmental contaminant; herbicide; xenobiotic
clomazone	[no description available]	low	0	isoxazolidinone; monochlorobenzenes	agrochemical; carotenoid biosynthesis inhibitor; environmental contaminant; herbicide; xenobiotic
methyl bensulfuron	[no description available]	low	0	aromatic ether; methyl ester; N-sulfonylurea; pyrimidines	agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide
prosulfocarb	[no description available]	low	0	benzenes; monothiocarbamic ester	environmental contaminant; herbicide; xenobiotic
nicosulfuron	[no description available]	low	0	N-sulfonylurea; pyridines; pyrimidines	environmental contaminant; herbicide; xenobiotic
triasulfuron	[no description available]	low	0	1,3,5-triazines; aromatic ether; N-sulfonylurea; organochlorine compound	agrochemical; herbicide
thifensulfuron methyl	[no description available]	low	0	1,3,5-triazines; methyl ester; N-sulfonylurea; thiophenes	agrochemical; environmental contaminant; herbicide; xenobiotic
picloram-methyl	[no description available]	low	0	aminopyridine; chloropyridine; methyl ester	herbicide
a 8947	[no description available]	low	0	aromatic ether; biaryl; N-sulfonylurea; pyrazole pesticide; tetrazoles	EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide
n-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1h-1,2,4-triazol-1-yl)phenyl)methanesulfonamide	[no description available]	medium	0	dichlorobenzene; organofluorine compound; sulfonamide; triazoles	agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
foe 5043	[no description available]	low	0	aromatic amide; monofluorobenzenes; thiadiazoles	environmental contaminant; herbicide; xenobiotic
cloransulam-methyl	[no description available]	medium	0	methyl ester; monochlorobenzenes; organofluorine compound; sulfonamide; triazolopyrimidines	agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide
raiser	[no description available]	low	0	(trifluoromethyl)benzenes; organochlorine compound; pyrrolidines	agrochemical; carotenoid biosynthesis inhibitor; herbicide
mefenacet	[no description available]	low	0	benzothiazoles; tertiary carboxamide	antimitotic; herbicide
diflufenican	[no description available]	low	0	(trifluoromethyl)benzenes; aromatic ether; pyridinecarboxamide	carotenoid biosynthesis inhibitor; environmental contaminant; herbicide; xenobiotic
quinclorac	[no description available]	low	0	monocarboxylic acid; organochlorine compound; quinolinemonocarboxylic acid	agrochemical; herbicide; synthetic auxin
methyl 2-(((((4-ethoxy-6-(methylamino)-1,3,5-triazin-2-yl)amino)carbonyl)amino)sulfonyl)benzoate	[no description available]	low	0	aromatic ether; benzoate ester; diamino-1,3,5-triazine; methyl ester; N-sulfonylurea	EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide
sulcotrione	[no description available]	low	0	aromatic ketone; beta-triketone; cyclohexanones; sulfone	carotenoid biosynthesis inhibitor; environmental contaminant; herbicide; xenobiotic
dpx e9636	[no description available]	low	0	aromatic ether; N-sulfonylurea; pyridines; pyrimidines; sulfone	environmental contaminant; herbicide; xenobiotic
aclonifen	[no description available]	medium	0	aromatic ether; C-nitro compound; monochlorobenzenes; primary amino compound; substituted aniline	agrochemical; carotenoid biosynthesis inhibitor; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
s 53482	[no description available]	low	0	benzoxazine; dicarboximide; organofluorine compound; terminal acetylenic compound	agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide; teratogenic agent
clodinafop-propargyl	[no description available]	low	0	aromatic ether; carboxylic ester; organochlorine compound; organofluorine compound; propyzamide; pyridines	agrochemical; EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; herbicide
metsulfuron methyl	[no description available]	low	0	methoxy-1,3,5-triazine; methyl ester; N-sulfonylurea	herbicide
mesotrione	[no description available]	medium	0	aromatic ketone; beta-triketone; C-nitro compound; sulfone	carotenoid biosynthesis inhibitor; EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor; environmental contaminant; herbicide; xenobiotic
cafenstrole	[no description available]	low	0	benzenes; sulfone; triazoles	agrochemical; antimitotic; herbicide
aminopyralid	[no description available]	medium	0	aromatic amine; organochlorine pesticide; pyridines	herbicide
bispyribac	[no description available]	low	0	aromatic ether; benzoic acids; monocarboxylic acid; pyrimidines	herbicide
sodium arsenite	[no description available]	low	0	arsenic molecular entity; inorganic sodium salt	antibacterial agent; antifungal agent; antineoplastic agent; carcinogenic agent; herbicide; insecticide; rodenticide
sodium chlorate	[no description available]	low	0	chlorate salt; inorganic sodium salt	herbicide
cornexistin	[no description available]	low	0	cyclic dicarboxylic anhydride; organic heterobicyclic compound; secondary alpha-hydroxy ketone	herbicide; metabolite
herbimycin	[no description available]	low	0	1,4-benzoquinones; lactam; macrocycle	antimicrobial agent; apoptosis inducer; herbicide; Hsp90 inhibitor; tyrosine kinase inhibitor
cinidon-ethyl	[no description available]	low	0	ethyl ester; isoindoles; monochlorobenzenes	herbicide
potassium cyanate	[no description available]	low	0	cyanate salt; one-carbon compound	herbicide
tembotrione	[no description available]	low	0	aromatic ketone; beta-triketone; cyclic ketone; ether; monochlorobenzenes; organofluorine compound; sulfone	agrochemical; carotenoid biosynthesis inhibitor; EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor; herbicide
butafenacil	[no description available]	low	0	benzoate ester; diester; monochlorobenzenes; olefinic compound; organofluorine compound	EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide
alpha(-(cyclopropylcarbonyl)-2-(methyvlsulfonyl)-beta-oxo-4-(trifluromethyl)benzenepropanenitrile)	[no description available]	low	0	(trifluoromethyl)benzenes; aromatic ketone; beta-diketone; cyclopropanes; nitrile; sulfone	agrochemical; EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor; herbicide
aminocyclopyrachlor	[no description available]	low	0	cyclopropanes; organochlorine pesticide; pyrimidines	herbicide; synthetic auxin
parathion	[no description available]	medium	0	C-nitro compound; organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; mouse metabolite
2,4-dichlorophenoxyacetic acid	[no description available]	low	0	chlorophenoxyacetic acid; dichlorobenzene	agrochemical; defoliant; EC 1.1.1.25 (shikimate dehydrogenase) inhibitor; environmental contaminant; phenoxy herbicide; synthetic auxin
4-(2,4-dichlorophenoxy)butyric acid	[no description available]	low	0	aromatic ether; monocarboxylic acid; organochlorine compound	agrochemical; phenoxy herbicide; synthetic auxin
acephate	[no description available]	low	0	mixed diacylamine; organic thiophosphate; organothiophosphate insecticide; phosphoramide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
azinphosmethyl	[no description available]	low	0	benzotriazines; organic thiophosphate; organothiophosphate insecticide	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor
bendiocarb	[no description available]	low	0	benzodioxoles; carbamate ester	agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
carbofuran	[no description available]	low	0	1-benzofurans; carbamate ester	acaricide; agrochemical; avicide; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; nematicide
chlorpyrifos	[no description available]	low	0	chloropyridine; organic thiophosphate	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; insecticide; xenobiotic
coumaphos	[no description available]	low	0	organic thiophosphate; organochlorine compound; organothiophosphate insecticide	acaricide; agrochemical; antinematodal drug; avicide; EC 3.1.1.8 (cholinesterase) inhibitor
cypermethrin	[no description available]	low	0	aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound	agrochemical; molluscicide; pyrethroid ester acaricide; pyrethroid ester insecticide
diazinon	[no description available]	low	0	organic thiophosphate; pyrimidines	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; nematicide; xenobiotic
dimethoate	[no description available]	low	0	monocarboxylic acid amide; organic thiophosphate	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; insecticide; xenobiotic
disulfoton	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
endosulfan	[no description available]	low	0	cyclic sulfite ester; cyclodiene organochlorine insecticide	acaricide; agrochemical; GABA-gated chloride channel antagonist; persistent organic pollutant
ethion	[no description available]	low	0	organic thiophosphate	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide
ethoprophos	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	agrochemical; antinematodal drug; EC 3.1.1.7 (acetylcholinesterase) inhibitor
fenthion	[no description available]	low	0	organic thiophosphate	acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide
heptachlor	[no description available]	low	0	cyclodiene organochlorine insecticide	agrochemical; antibacterial agent; antifungal agent; GABA-gated chloride channel antagonist; persistent organic pollutant
methamidophos	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide; phosphoramide	acaricide; agrochemical; avicide
methomyl	[no description available]	low	0	aliphatic sulfide; carbamate ester	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; insecticide; nematicide; xenobiotic
methyl parathion	[no description available]	medium	0	C-nitro compound; organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; antifungal agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; environmental contaminant; genotoxin
naled	[no description available]	low	0	dialkyl phosphate; organobromine compound; organochlorine compound; organophosphate insecticide	acaricide; agrochemical; antibacterial agent; antifungal agent; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor
phorate	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor
phosalone	[no description available]	low	0	1,3-benzoxazoles; carbamate ester; organochlorine insecticide; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor
propoxur	[no description available]	low	0	aromatic ether; carbamate ester	acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
resmethrin	[no description available]	low	0	cyclopropanecarboxylate ester; furans	agrochemical; pyrethroid ester insecticide
roxarsone	[no description available]	low	0	2-nitrophenols; organoarsonic acid	agrochemical; animal growth promotant; antibacterial drug; coccidiostat
temefos	[no description available]	low	0	organic sulfide; organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; ectoparasiticide
trichlorfon	[no description available]	low	0	organic phosphonate; organochlorine compound; phosphonic ester	agrochemical; anthelminthic drug; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide
famophos	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	agrochemical; anthelminthic drug; EC 3.1.1.7 (acetylcholinesterase) inhibitor
carbaryl	[no description available]	low	0	carbamate ester; naphthalenes	acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; plant growth retardant
dinitrofluorobenzene	[no description available]	medium	0	C-nitro compound; organofluorine compound	agrochemical; allergen; chromatographic reagent; EC 2.7.3.2 (creatine kinase) inhibitor; protein-sequencing agent; spectrophotometric reagent
glyoxal	[no description available]	low	0	dialdehyde	agrochemical; allergen; pesticide; plant growth regulator
fensulfothion	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide; sulfoxide	agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; nematicide
pyridafenthion	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide; pyridazinone	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
chlorfenvinphos	[no description available]	low	0	dichlorobenzene; organic phosphate; organochlorine acaricide; organochlorine insecticide; organophosphate insecticide	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor
bicuculline	[no description available]	low	0	benzylisoquinoline alkaloid; isoquinoline alkaloid; isoquinolines	agrochemical; central nervous system stimulant; GABA-gated chloride channel antagonist; GABAA receptor antagonist; neurotoxin
carvacrol	[no description available]	low	0	botanical anti-fungal agent; p-menthane monoterpenoid; phenols	agrochemical; antimicrobial agent; flavouring agent; TRPA1 channel agonist; volatile oil component
thiometon	[no description available]	low	0	organic thiophosphate; organosulfur compound; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
phosmet	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide; phthalimides	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
demeton-s-methyl	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
fonofos	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor
methidathion	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
dimethoxon	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
metolcarb	[no description available]	low	0	carbamate ester	acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
nitrapyrin	[no description available]	low	0	chloropyridine	agrochemical; antibacterial agent; nitrification inhibitor
aminocarb	[no description available]	low	0	carbamate ester; toluenes	acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; molluscicide
methiocarb	[no description available]	low	0	aryl sulfide; carbamate ester; methyl sulfide	acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide; molluscicide; xenobiotic
phenylphosphonothioic acid, 2-ethyl 2-(4-nitrophenyl) ester	[no description available]	low	0	organic phosphonate; organothiophosphate insecticide; phosphonic ester	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
quinomethionate	[no description available]	low	0	dithioloquinoxaline; quinoxaline acaricide; quinoxaline antifungal agent	agrochemical
mecarbam	[no description available]	low	0	carbamate ester; organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
phenthoate, (+-)-isomer	[no description available]	low	0	ethyl ester; organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
isoprocarb	[no description available]	low	0	carbamate ester	agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
cyanophos	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
azinphos ethyl	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
mepiquat	[no description available]	low	0	quaternary ammonium ion	agrochemical; Maillard reaction product; plant growth retardant
sulfotepp	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor
chlorpyrifos-methyl	[no description available]	low	0	chloropyridine; organic thiophosphate	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide; xenobiotic
terbufos	[no description available]	low	0	organic thiophosphate; organosulfur compound; organothiophosphate insecticide	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; nematicide
quinalphos	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
fenamiphos	[no description available]	low	0	organophosphate insecticide; organophosphate nematicide; phosphoramidate ester	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
formetanate	[no description available]	low	0	carbamate ester	acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
fenitrothion	[no description available]	medium	0	C-nitro compound; organic thiophosphate	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide
pirimicarb	[no description available]	medium	0	aminopyrimidine; carbamate ester; tertiary amino compound	agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide; xenobiotic
triazophos	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; nematicide
2,6-diisopropylnaphthalene	[no description available]	low	0	naphthalenes	agrochemical; plant growth retardant
isofenphos	[no description available]	low	0	isopropyl ester; organic phosphonate; organothiophosphate insecticide; phosphonic ester; salicylates	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
pirimiphos methyl	[no description available]	low	0	aminopyrimidine; organic thiophosphate	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; environmental contaminant; insecticide
croneton	[no description available]	low	0	carbamate ester	agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
prothiophos	[no description available]	low	0	dichlorobenzene; organic thiophosphate; organosulfur compound	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; insecticide
sulprofos	[no description available]	low	0	organic thiophosphate; organosulfur compound; organothiophosphate insecticide	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
cyphenothrin	[no description available]	low	0	cyclopropanecarboxylate ester	agrochemical; pyrethroid ester insecticide
profenofos	[no description available]	low	0	monochlorobenzenes; organic thiophosphate; organochlorine insecticide; organophosphate insecticide	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
permethrin	[no description available]	low	0	cyclopropanecarboxylate ester; cyclopropanes	agrochemical; ectoparasiticide; pyrethroid ester acaricide; pyrethroid ester insecticide; scabicide
decamethrin	[no description available]	low	0	aromatic ether; cyclopropanecarboxylate ester; nitrile; organobromine compound	agrochemical; antifeedant; calcium channel agonist; EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor; pyrethroid ester insecticide
dibutylaminosulfenylcarbofuran	[no description available]	low	0	1-benzofurans; carbamate ester	acaricide; agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor; nematicide
fenpropathrin, (+-)-isomer	[no description available]	low	0	aromatic ether; cyclopropanecarboxylate ester	agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide
deltanit	[no description available]	low	0	1-benzofurans; carbamate ester	agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
fluvalinate	[no description available]	low	0	(trifluoromethyl)benzenes; aromatic ether; monochlorobenzenes; nitrile; organochlorine acaricide; organochlorine insecticide; organofluorine acaricide; organofluorine insecticide	agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide
oxadixyl	[no description available]	low	0	anilide fungicide; aromatic amide; carbohydrazide; ether; oxazolidinone	agrochemical
benfuracarb	[no description available]	low	0	1-benzofurans; carbamate ester; ethyl ester	agrochemical; carbamate insecticide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
chlorimuron ethyl	[no description available]	low	0	aromatic ether; ethyl ester; N-sulfonylurea; organochlorine pesticide; pyrimidines; sulfamoylbenzoate	agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; proherbicide
cuprous chloride	[no description available]	low	0	copper molecular entity; inorganic chloride	agrochemical; molluscicide
heptenophos	[no description available]	low	0	organochlorine compound; organophosphate insecticide; trialkyl phosphate	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
nitarsone	[no description available]	medium	0	C-nitro compound; organoarsonic acid	agrochemical; antiprotozoal drug
azamethiphos	[no description available]	low	0	organic thiophosphate; organochlorine acaricide; organochlorine insecticide; organothiophosphate insecticide	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
isoxaflutole	[no description available]	low	0	(trifluoromethyl)benzenes; aromatic ketone; cyclopropanes; isoxazoles; sulfone	agrochemical; EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor; proherbicide
bay 93820	[no description available]	low	0	isopropyl ester; organic phosphonate; organothiophosphate insecticide; phosphonic ester; salicylates	agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
cadusafos	[no description available]	low	0	organic thiophosphate; organothiophosphate insecticide	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; nematicide
fosthiazate	[no description available]	low	0	organic phosphonate; organothiophosphate insecticide; phosphonic ester	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; nematicide
triflusulfuron-methyl	[no description available]	medium	0	1,3,5-triazines; aromatic ether; benzoate ester; methyl ester; N-sulfonylurea; organofluorine compound; tertiary amino compound	agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; proherbicide
pyraclofos	[no description available]	low	0	monochlorobenzenes; organic thiophosphate; organochlorine insecticide; organosulfur compound; organothiophosphate insecticide; pyrazoles	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
cyfluthrin	[no description available]	low	0	aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound	agrochemical; pyrethroid ester insecticide
1-methylcyclopropene	[no description available]	low	0	cycloalkene; cyclopropenes	agrochemical; plant growth regulator
pinoxaden	[no description available]	low	0	pivalate ester; pyrazolooxadiazepine	agrochemical; EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; environmental contaminant; proherbicide; xenobiotic
tioxazafen	[no description available]	low	0	1,2,4-oxadiazole; thiophenes	agrochemical; nematicide
cyhalothrin	[no description available]	low	0	aromatic ether; cyclopropanecarboxylate ester; nitrile; organochlorine compound; organofluorine compound	agrochemical; pyrethroid ester acaricide; pyrethroid ester insecticide
tetrachlorvinphos	[no description available]	low	0	alkenyl phosphate; dialkyl phosphate; organochlorine insecticide; organophosphate insecticide; trichlorobenzene	acaricide; agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor
dicrotophos	[no description available]	low	0	dialkyl phosphate; organophosphate insecticide	acaricide; agrochemical; avicide; EC 3.1.1.7 (acetylcholinesterase) inhibitor
monocrotophos	[no description available]	low	0	alkenyl phosphate; dialkyl phosphate; monocarboxylic acid amide; organophosphate insecticide	acaricide; agrochemical; avicide; EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor
propetamphos	[no description available]	low	0	isopropyl ester; organophosphate insecticide; phosphoramidate ester	agrochemical; EC 3.1.1.7 (acetylcholinesterase) inhibitor
tolfenpyrad	[no description available]	low	0	aromatic amide; aromatic ether; organochlorine compound; pyrazole insecticide	agrochemical; antifungal agent; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mitochondrial NADH:ubiquinone reductase inhibitor
pydrin, (s-(r,r))-isomer	[no description available]	low	0	fenvalerate	agrochemical; pyrethroid ester insecticide
mefenoxam	[no description available]	low	0	acylamino acid fungicide; anilide fungicide; D-alanine derivative; methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate	agrochemical
fluensulfone	[no description available]	low	0	1,3-thiazoles; olefinic compound; organochlorine pesticide; organofluorine pesticide; sulfone	agrochemical; nematicide
haloxyfop-P-methyl	[no description available]	low	0	methyl 2-(4-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenoxy)propanoate	agrochemical; EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor; proherbicide
cyenopyrafen	[no description available]	low	0	nitrile; pivalate ester; pyrazoles	agrochemical; proacaricide
fluazaindolizine	[no description available]	low	0	aromatic amide; imidazopyridine; monocarboxylic acid amide; monochlorobenzenes; monomethoxybenzene; N-sulfonylcarboxamide; organofluorine pesticide	agrochemical; nematicide
afidopyropen	[no description available]	low	0	cyclopropanecarboxylate ester; organic heterotetracyclic compound; pyridines; secondary alcohol	agrochemical; insecticide; TRPV channel modulator
2-acetylaminofluorene	[no description available]	low	0	2-acetamidofluorenes	antimitotic; carcinogenic agent; epitope; mutagen
myrmicacin	[no description available]	low	0	3-hydroxy fatty acid; medium-chain fatty acid	antimitotic; Escherichia coli metabolite
2-methoxyestradiol	[no description available]	low	0	17beta-hydroxy steroid; 3-hydroxy steroid	angiogenesis modulating agent; antimitotic; antineoplastic agent; human metabolite; metabolite; mouse metabolite
maytansine	[no description available]	low	0	alpha-amino acid ester; carbamate ester; epoxide; maytansinoid; organic heterotetracyclic compound; organochlorine compound	antimicrobial agent; antimitotic; antineoplastic agent; plant metabolite; tubulin modulator
pederin	[no description available]	low	0	cyclic ketal; diol; oxanes; polyketide; secondary alcohol; secondary carboxamide	antimitotic; antineoplastic agent; bacterial metabolite; vesicant
rhizoxin	[no description available]	low	0	1,3-oxazoles; epoxide; macrolide antibiotic	antimitotic; antineoplastic agent; metabolite
laulimalide	[no description available]	low	0	carboxylic ester; epoxide; macrolide; secondary alcohol; secondary allylic alcohol	animal metabolite; antimitotic; antineoplastic agent; marine metabolite; microtubule-stabilising agent
ceratamine a	[no description available]	low	0	alkaloid; aromatic ether; cyclic ketone; organic heterobicyclic compound; organobromine compound; secondary amino compound; tertiary amine	antimitotic; metabolite
1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol	[no description available]	low	0	sulfonamide
amosulalol	[no description available]	low	0	sulfonamide
ampiroxicam	[no description available]	low	0	acetal; aminopyridine; benzothiazine; etabonate ester; monocarboxylic acid amide; sulfonamide	analgesic; antirheumatic drug; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug; prodrug
amsacrine	[no description available]	low	0	acridines; aromatic ether; sulfonamide	antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
azosemide	[no description available]	low	0	monochlorobenzenes; sulfonamide; tetrazoles; thiophenes	loop diuretic
bendroflumethiazide	[no description available]	low	0	benzothiadiazine; sulfonamide	antihypertensive agent; diuretic
benzothiazide	[no description available]	low	0	benzothiadiazine; sulfonamide	antihypertensive agent; diuretic
benzylhydrochlorothiazide	[no description available]	low	0	benzenes; benzothiadiazine; organochlorine compound; secondary amino compound; sulfonamide
bumetanide	[no description available]	low	0	amino acid; benzoic acids; sulfonamide	diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
celecoxib	[no description available]	low	0	organofluorine compound; pyrazoles; sulfonamide; toluenes	cyclooxygenase 2 inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug
chlorthalidone	[no description available]	low	0	isoindoles; monochlorobenzenes; sulfonamide
4-chloro-N-(2,6-dimethyl-1-piperidinyl)-3-sulfamoylbenzamide	[no description available]	low	0	sulfonamide
dichlorphenamide	[no description available]	low	0	dichlorobenzene; sulfonamide	antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor; ophthalmology drug
e 4031	[no description available]	low	0	sulfonamide
ethoxzolamide	[no description available]	low	0	aromatic ether; benzothiazoles; sulfonamide	antiglaucoma drug; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor
famotidine	[no description available]	low	0	1,3-thiazoles; guanidines; sulfonamide	anti-ulcer drug; H2-receptor antagonist; P450 inhibitor
furosemide	[no description available]	low	0	chlorobenzoic acid; furans; sulfonamide	environmental contaminant; loop diuretic; xenobiotic
glimepiride	[no description available]	low	0	sulfonamide
n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide	[no description available]	low	0	isoquinolines; sulfonamide
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide	[no description available]	low	0	bromobenzenes; isoquinolines; olefinic compound; secondary amino compound; sulfonamide	EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor
hydrochlorothiazide	[no description available]	low	0	benzothiadiazine; organochlorine compound; sulfonamide	antihypertensive agent; diuretic; environmental contaminant; xenobiotic
hydroxymethyltolbutamide	[no description available]	low	0	benzyl alcohols; sulfonamide; ureas	metabolite
indapamide	[no description available]	low	0	indoles; organochlorine compound; sulfonamide	antihypertensive agent; diuretic
methazolamide	[no description available]	low	0	sulfonamide; thiadiazoles
metolazone	[no description available]	low	0	organochlorine compound; quinazolines; sulfonamide	antihypertensive agent; diuretic; ion transport inhibitor
monodansylcadaverine	[no description available]	low	0	aminonaphthalene; primary amino compound; sulfonamide; tertiary amino compound	EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor; fluorochrome; protective agent
n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide	[no description available]	low	0	naphthalenes; organochlorine compound; primary amino compound; sulfonamide
naratriptan	[no description available]	low	0	heteroarylpiperidine; sulfonamide; tryptamines	serotonergic agonist; vasoconstrictor agent
nimesulide	[no description available]	low	0	aromatic ether; C-nitro compound; sulfonamide	cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	[no description available]	low	0	aromatic ether; C-nitro compound; sulfonamide	antineoplastic agent; cyclooxygenase 2 inhibitor
5-[3-(benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide	[no description available]	low	0	sulfonamide
phthalylsulfathiazole	[no description available]	low	0	1,3-thiazoles; dicarboxylic acid monoamide; sulfonamide antibiotic; sulfonamide
probenecid	[no description available]	low	0	benzoic acids; sulfonamide	uricosuric drug
sulfadiazine	[no description available]	low	0	pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; antimicrobial agent; antiprotozoal drug; coccidiostat; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic
sotalol	[no description available]	low	0	ethanolamines; secondary alcohol; secondary amino compound; sulfonamide	anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic
SU6656	[no description available]	low	0	oxindoles; sulfonamide	antineoplastic agent; Aurora kinase inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
sulfabenzamide	[no description available]	low	0	benzenes; sulfonamide antibiotic; sulfonamide	antibacterial drug; antimicrobial drug
sulfacytine	[no description available]	low	0	benzenes; sulfonamide
sulfadimethoxine	[no description available]	low	0	aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic
sulfamerazine	[no description available]	low	0	pyrimidines; sulfonamide antibiotic; sulfonamide	antiinfective agent; drug allergen
sulfameter	[no description available]	low	0	pyrimidines; sulfonamide antibiotic; sulfonamide	antiinfective agent; leprostatic drug; renal agent
sulfamethazine	[no description available]	low	0	pyrimidines; sulfonamide antibiotic; sulfonamide	antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic
sulfamethizole	[no description available]	low	0	sulfonamide antibiotic; sulfonamide; thiadiazoles	antiinfective agent; antimicrobial agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
sulfamethoxazole	[no description available]	low	0	isoxazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial agent; antiinfective agent; antimicrobial agent; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; epitope; P450 inhibitor; xenobiotic
sulfamethoxypyridazine	[no description available]	low	0	pyridazines; sulfonamide antibiotic; sulfonamide	antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
sulfamonomethoxine	[no description available]	low	0	benzenes; sulfonamide
sulfanilamide	[no description available]	low	0	substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial agent; drug allergen; EC 4.2.1.1 (carbonic anhydrase) inhibitor
sulfanitran	[no description available]	low	0	sulfonamide
sulfaphenazole	[no description available]	low	0	primary amino compound; pyrazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antibacterial drug; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor; P450 inhibitor
sulfapyridine	[no description available]	low	0	pyridines; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; dermatologic drug; drug allergen; environmental contaminant; xenobiotic
sulfaquinoxaline	[no description available]	low	0	benzenes; sulfonamide
sulfathiazole	[no description available]	low	0	1,3-thiazoles; substituted aniline; sulfonamide antibiotic; sulfonamide	antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic
sulfisomidine	[no description available]	low	0	pyrimidines; sulfonamide antibiotic; sulfonamide	antiinfective agent
sulfisoxazole	[no description available]	low	0	isoxazoles; sulfonamide antibiotic; sulfonamide	antibacterial drug; drug allergen
sulfoxone	[no description available]	low	0	sulfonamide
sulpiride	[no description available]	low	0	benzamides; N-alkylpyrrolidine; sulfonamide	antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist
sumatriptan	[no description available]	low	0	sulfonamide; tryptamines	serotonergic agonist; vasoconstrictor agent
delavirdine	[no description available]	low	0	aminopyridine; indolecarboxamide; N-acylpiperazine; sulfonamide	antiviral drug; HIV-1 reverse transcriptase inhibitor
zonisamide	[no description available]	low	0	1,2-benzoxazoles; sulfonamide	anticonvulsant; antioxidant; central nervous system drug; protective agent; T-type calcium channel blocker
4-toluenesulfonamide	[no description available]	low	0	sulfonamide
n-methyl-n-nitrosotoluene-p-sulfonamide	[no description available]	low	0	sulfonamide
sulfachlorpyridazine	[no description available]	low	0	organochlorine compound; pyridazines; sulfonamide	antibacterial drug; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor
acetyl sulfisoxazole	[no description available]	low	0	benzenes; sulfonamide
sulfaethidole	[no description available]	low	0	benzenes; sulfonamide
benzenesulfonamide	[no description available]	low	0	sulfonamide
carzenide	[no description available]	low	0	sulfonamide
sulfalene	[no description available]	low	0	pyrazines; sulfonamide antibiotic; sulfonamide
thioproperazine	[no description available]	low	0	N-alkylpiperazine; N-methylpiperazine; phenothiazines; sulfonamide	phenothiazine antipsychotic drug
carbutamide	[no description available]	low	0	benzenes; sulfonamide
glymidine	[no description available]	low	0	diether; pyrimidines; sulfonamide	hypoglycemic agent
thiazosulfone	[no description available]	low	0	sulfonamide
glybuthiazol	[no description available]	low	0	benzenes; sulfonamide
sulfanilylurea	[no description available]	low	0	benzenes; sulfonamide
metahexamide	[no description available]	low	0	benzenes; sulfonamide
clopamide	[no description available]	low	0	sulfonamide
tolcyclamide	[no description available]	low	0	sulfonamide
sulfamoxole	[no description available]	low	0	oxazole; sulfonamide antibiotic; sulfonamide	antimicrobial agent; drug allergen
sulfaethoxypyridazine	[no description available]	low	0	sulfonamide	antibacterial agent
4-((diethylamino)sulfonyl)benzoic acid	[no description available]	low	0	sulfonamide
dinsed	[no description available]	low	0	sulfonamide
amidephrine	[no description available]	low	0	sulfonamide
sulfadoxine	[no description available]	low	0	pyrimidines; sulfonamide	antibacterial drug; antimalarial
hydroxyhexamide	[no description available]	low	0	sulfonamide
n-butylbenzenesulfonamide	[no description available]	low	0	sulfonamide	neurotoxin; plant metabolite
glisoxepide	[no description available]	low	0	sulfonamide
perfluidone	[no description available]	low	0	sulfonamide
mefluidide	[no description available]	low	0	sulfonamide
2-aminosulfonyl-benzoic acid methyl ester	[no description available]	low	0	benzoate ester; methyl ester; sulfonamide	marine xenobiotic metabolite
clorsulon	[no description available]	low	0	benzenes; sulfonamide
agreal	[no description available]	low	0	sulfonamide
n-acetylsulfapyridine	[no description available]	low	0	sulfonamide
tirofiban	[no description available]	low	0	L-tyrosine derivative; piperidines; sulfonamide	anticoagulant; fibrin modulating drug; platelet glycoprotein-IIb/IIIa receptor antagonist
n(4)-acetylsulfadiazine	[no description available]	low	0	acetamides; pyrimidines; sulfonamide	marine xenobiotic metabolite
amprenavir	[no description available]	low	0	carbamate ester; sulfonamide; tetrahydrofuryl ester	antiviral drug; HIV protease inhibitor
n(4)-acetylsulfamethoxazole	[no description available]	low	0	isoxazoles; sulfonamide	drug metabolite; marine xenobiotic metabolite
glisentide	[no description available]	low	0	sulfonamide
ebrotidine	[no description available]	low	0	sulfonamide
4-chlorobenzenesulfonamide	[no description available]	low	0	sulfonamide
4-amino-6-chloro-1,3-benzenedisulfonamide	[no description available]	low	0	sulfonamide
N(4)-acetylsulfathiazole	[no description available]	low	0	1,3-thiazoles; acetamides; sulfonamide	marine xenobiotic metabolite
2-benzothiazolesulfonamide	[no description available]	low	0	benzothiazoles; sulfonamide
brinzolamide	[no description available]	low	0	sulfonamide; thienothiazine	antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor
piloty's acid	[no description available]	low	0	sulfonamide
perfluorooctanesulfonamide	[no description available]	low	0	perfluorinated compound; sulfonamide	persistent organic pollutant
uk 68798	[no description available]	low	0	aromatic ether; sulfonamide; tertiary amino compound	anti-arrhythmia drug; potassium channel blocker
glyclopyramide	[no description available]	low	0	sulfonamide
fluoresone	[no description available]	low	0	sulfonamide
2-aminobenzenesulfonamide	[no description available]	low	0	benzenes; sulfonamide
4-chloro-5-sulfamoylanthranilic acid	[no description available]	low	0	benzenes; sulfonamide
sulfluramid	[no description available]	low	0	sulfonamide	acaricide; environmental contaminant; insecticide; xenobiotic
8-(4-tolylsulfonylamino)quinoline	[no description available]	low	0	sulfonamide
sdds	[no description available]	low	0	benzenes; sulfonamide
4-chlorobenzenesulfonylurea	[no description available]	low	0	sulfonamide
n-(2,6-difluorophenyl)-5-methyl(1,2,4)-triazol(1,5-a)pyrimidine-2-sulfonamide	[no description available]	low	0	sulfonamide
flazasulfuron	[no description available]	low	0	pyridines; sulfonamide
4-methyl-N-(phenylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
bosentan anhydrous	[no description available]	low	0	primary alcohol; pyrimidines; sulfonamide	antihypertensive agent; endothelin receptor antagonist
sulfamethoxazole hydroxylamine	[no description available]	low	0	isoxazoles; sulfonamide	allergen; metabolite
gr 113808	[no description available]	low	0	indolyl carboxylate ester; piperidines; sulfonamide	serotonergic antagonist
valdecoxib	[no description available]	low	0	isoxazoles; sulfonamide	antipyretic; antirheumatic drug; cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
ym 12617	[no description available]	low	0	aromatic ether; secondary amino compound; sulfonamide
dansyllysine	[no description available]	low	0	L-lysine derivative; non-proteinogenic L-alpha-amino acid; sulfonamide	epitope
almotriptan	[no description available]	low	0	indoles; sulfonamide; tertiary amine	non-steroidal anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent
4-nitrososulfamethoxazole	[no description available]	low	0	isoxazoles; nitroso compound; sulfonamide	allergen; metabolite
cki 7	[no description available]	low	0	isoquinolines; organochlorine compound; primary amino compound; sulfonamide	EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
fosamprenavir	[no description available]	low	0	sulfonamide	prodrug
metipamide	[no description available]	low	0	sulfonamide
jte 522	[no description available]	low	0	1,3-oxazoles; organofluorine compound; sulfonamide	cyclooxygenase 2 inhibitor
carboxytolbutamide	[no description available]	low	0	sulfonamide
tevenel	[no description available]	low	0	sulfonamide
sulfachlorpyrazine	[no description available]	low	0	sulfonamide
n(4)-acetylsulfadimethoxine	[no description available]	low	0	acetamides; pyrimidines; sulfonamide	marine xenobiotic metabolite
dronedarone	[no description available]	low	0	1-benzofurans; aromatic ether; aromatic ketone; sulfonamide; tertiary amino compound	anti-arrhythmia drug; environmental contaminant; xenobiotic
darunavir	[no description available]	low	0	carbamate ester; furofuran; sulfonamide	antiviral drug; HIV protease inhibitor
cimicoxib	[no description available]	low	0	aromatic ether; imidazoles; organochlorine compound; organofluorine compound; sulfonamide	cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug
dabuzalgron	[no description available]	low	0	aromatic ether; imidazoles; monochlorobenzenes; sulfonamide	alpha-adrenergic agonist
n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide	[no description available]	low	0	chloroindole; organochlorine compound; sulfonamide	antineoplastic agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor
3,4-Dichlorobenzenesulfonamide	[no description available]	low	0	sulfonamide
N-cyclooctyl-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
tolpyrramide	[no description available]	low	0	sulfonamide
acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester	[no description available]	low	0	sulfonamide
1-(benzenesulfonyl)indole	[no description available]	low	0	sulfonamide
tosylphenylalanyl chloromethyl ketone	[no description available]	low	0	alpha-chloroketone; sulfonamide	alkylating agent; serine proteinase inhibitor
rosuvastatin	[no description available]	low	0	dihydroxy monocarboxylic acid; monofluorobenzenes; pyrimidines; statin (synthetic); sulfonamide	anti-inflammatory agent; antilipemic drug; cardioprotective agent; CETP inhibitor; environmental contaminant; xenobiotic
bms 214662	[no description available]	low	0	benzenes; benzodiazepine; imidazoles; nitrile; sulfonamide; thiophenes	antineoplastic agent; apoptosis inducer; EC 2.5.1.58 (protein farnesyltransferase) inhibitor
N-[4-(methanesulfonamido)phenyl]acetamide	[no description available]	low	0	sulfonamide
prinomastat	[no description available]	low	0	aromatic ether; hydroxamic acid; pyridines; sulfonamide; thiomorpholines	antineoplastic agent; EC 3.4.24.35 (gelatinase B) inhibitor; matrix metalloproteinase inhibitor
glucosulfone	[no description available]	low	0	sulfonamide
1-[1-(benzenesulfonyl)-3-pyrrolyl]ethanone	[no description available]	low	0	sulfonamide
1-(4-bromo-2,5-dimethoxyphenyl)sulfonylazepane	[no description available]	low	0	sulfonamide
1-(4-chloro-3-methoxyphenyl)sulfonylazepane	[no description available]	low	0	sulfonamide
6-[(4-methylphenyl)sulfonyl]-6-azabicyclo[3.2.1]octane	[no description available]	low	0	sulfonamide
N-cyclopentyl-4-[[4-[2-furanyl(oxo)methyl]-1-piperazinyl]sulfonyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N4-cyclohexyl-N1-ethyl-N4-(2-pyridinylmethyl)benzene-1,4-disulfonamide	[no description available]	low	0	sulfonamide
2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide	[no description available]	low	0	sulfonamide
1-(3-chloro-4-methoxyphenyl)sulfonyl-N-(3-pyridinyl)-3-piperidinecarboxamide	[no description available]	low	0	sulfonamide
N-(3-ethoxyphenyl)-1-(4-methoxyphenyl)sulfonyl-3-piperidinecarboxamide	[no description available]	low	0	sulfonamide
N-[4-[[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]sulfonyl]phenyl]acetamide	[no description available]	low	0	sulfonamide
N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
4-[2-[1-(4-methoxyphenyl)sulfonyl-2-benzimidazolyl]ethyl]morpholine	[no description available]	low	0	sulfonamide
1-(2,5-dimethoxyphenyl)sulfonyl-N-(phenylmethyl)-4-piperidinecarboxamide	[no description available]	low	0	sulfonamide
1-[2-chloro-5-(trifluoromethyl)phenyl]sulfonylazepane	[no description available]	low	0	sulfonamide
4-[4-[(5,6-dimethyl-1-benzimidazolyl)sulfonyl]phenyl]sulfonylmorpholine	[no description available]	low	0	sulfonamide
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(4-methoxyphenyl)sulfonylpiperazine	[no description available]	low	0	sulfonamide
4-methyl-N-(pyridin-4-ylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[4-(benzenesulfonyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole	[no description available]	low	0	sulfonamide
N-(2-furanylmethyl)-2-[(4-methoxyphenyl)sulfonylamino]benzamide	[no description available]	low	0	sulfonamide
N-[4-(diethylsulfamoyl)phenyl]-2-(2-oxo-1,3-benzothiazol-3-yl)acetamide	[no description available]	low	0	sulfonamide
3-[[4-(1-benzotriazolyl)-1-piperidinyl]sulfonyl]-N-cyclopentylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N,N-dimethyl-4-[[4-(5-methyl-1-benzotriazolyl)-1-piperidinyl]sulfonyl]benzamide	[no description available]	low	0	sulfonamide
4-(4-methoxyphenyl)sulfonyl-N-(phenylmethyl)-1-piperazinecarboxamide	[no description available]	low	0	sulfonamide
N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide	[no description available]	low	0	sulfonamide
N-(4-{[2-(pyridin-3-yl)piperidin-1-yl]sulfonyl}phenyl)acetamide	[no description available]	low	0	acetamides; piperidines; pyridines; sulfonamide
3,4,5-trimethoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide	[no description available]	low	0	sulfonamide
N-(4-phenylmethoxyphenyl)methanesulfonamide	[no description available]	low	0	sulfonamide
3-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
2-[(4-fluoro-3-methylphenyl)sulfonylamino]acetic acid	[no description available]	low	0	sulfonamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-thiophenesulfonamide	[no description available]	low	0	sulfonamide
N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-(2-ethylphenoxy)-N-(4-sulfamoylphenyl)acetamide	[no description available]	low	0	sulfonamide
1-(4-chlorophenyl)-3-(4-sulfamoylphenyl)urea	[no description available]	low	0	sulfonamide
N-(3-chloro-4-hydroxy-2,5-dimethylphenyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[2-(1-cyclohexenyl)ethyl]-2,5-dimethoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
N-(1-ethyl-5-benzimidazolyl)-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
4-methyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-chloro-N-(4-hydrazinyl-6-methyl-2-pyrimidinyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-amino-N-(4-ethoxyphenyl)benzenesulfonamide	[no description available]	low	0	benzenes; sulfonamide
1-(2-nitrophenyl)sulfonylpiperidine	[no description available]	low	0	sulfonamide
N,4-dimethyl-N-(4-methylphenyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2,3,4-trimethyl-N-(3-pyridinyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[[4-(1-pyrrolidinylsulfonyl)phenyl]hydrazinylidene]propanedinitrile	[no description available]	low	0	sulfonamide
N-[1-(benzenesulfonyl)-2,2-dichloroethenyl]acetamide	[no description available]	low	0	sulfonamide
2-(4-fluoro-N-methylsulfonylanilino)-N-(3-methylphenyl)acetamide	[no description available]	low	0	sulfonamide
4-chloro-3-ethoxy-N-(4-ethylphenyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
1-(3-chlorophenyl)sulfonylpyrrolidine	[no description available]	low	0	sulfonamide
1-cyclopropyl-3-(4-sulfamoylphenyl)thiourea	[no description available]	low	0	sulfonamide
N-[3-[methyl(methylsulfonyl)amino]phenyl]-2-phenoxyacetamide	[no description available]	low	0	sulfonamide
4-[methyl(methylsulfonyl)amino]-N-(2-phenylethyl)benzamide	[no description available]	low	0	sulfonamide
2-(2,6-dichloroanilino)-3-pyridinesulfonamide	[no description available]	low	0	pyridines; sulfonamide
4-(4-chloroanilino)-3-pyridinesulfonamide	[no description available]	low	0	pyridines; sulfonamide
1-ethyl-3-(4-methylphenyl)sulfonylthiourea	[no description available]	low	0	sulfonamide
6-chloro-N-(2-hydroxyphenyl)-3-pyridinesulfonamide	[no description available]	low	0	pyridines; sulfonamide
5-chloro-2-methoxy-N,N,4-trimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[(2,5-dimethoxyphenyl)sulfonyl-methylamino]acetic acid	[no description available]	low	0	sulfonamide
N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
4-ethoxy-N-(4-fluorophenyl)-2,3-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[2-(1-cyclohexenyl)ethyl]-4-[methyl(methylsulfonyl)amino]benzamide	[no description available]	low	0	sulfonamide
1-(2,5-dimethoxyphenyl)sulfonyl-4-ethylpiperazine	[no description available]	low	0	sulfonamide
N-[2-(methylthio)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-(4-methoxyphenyl)-4-(methylthio)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-methoxy-5-propan-2-yl-N-(2-pyridinyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2,3,5,6-tetramethyl-N-(2-methyl-1,3-benzothiazol-5-yl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[4-chloro-2-methyl-5-(2-pyridinylsulfamoyl)phenoxy]acetamide	[no description available]	low	0	sulfonamide
N-(3-chlorophenyl)-N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-(3-methyl-N-methylsulfonylanilino)acetamide	[no description available]	low	0	sulfonamide
2-[(5-bromo-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide	[no description available]	low	0	sulfonamide
N-[4-[(2,6-dimethoxy-4-pyrimidinyl)sulfamoyl]phenyl]butanamide	[no description available]	low	0	sulfonamide
2-(3-pyridinyl)-4-[4-(1-pyrrolidinylsulfonyl)phenyl]thiazole	[no description available]	low	0	sulfonamide
5-bromo-6-chloro-N-(4-methyl-2-pyridinyl)-3-pyridinesulfonamide	[no description available]	low	0	pyridines; sulfonamide
4-(4-fluorophenyl)sulfonyl-2-(2-furanyl)-N-phenyl-5-oxazolamine	[no description available]	low	0	sulfonamide
2-[[4-(4-methylphenyl)sulfonyl-1-piperazinyl]methyl]-4-propan-2-ylphenol	[no description available]	low	0	sulfonamide
ethyl 4-{N-[(4-chlorophenyl)sulfonyl]-N-methylglycyl}piperazine-1-carboxylate	[no description available]	low	0	carbamate ester; sulfonamide
N-[(2-chlorophenyl)methyl]-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide	[no description available]	low	0	sulfonamide
N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-thiophen-2-ylacetamide	[no description available]	low	0	sulfonamide
2-[methyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(2-pyridinylmethyl)acetamide	[no description available]	low	0	sulfonamide
2-[(4-ethoxyphenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide	[no description available]	low	0	sulfonamide
1-(4-methylphenyl)sulfonyl-2-benzimidazolamine	[no description available]	low	0	sulfonamide
1-(4-chlorophenyl)sulfonyl-2-benzimidazolamine	[no description available]	low	0	sulfonamide
N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetamide	[no description available]	low	0	sulfonamide
N-[4-(1-piperidinylsulfonyl)phenyl]-2-thiophenesulfonamide	[no description available]	low	0	sulfonamide
N-(1,3-benzothiazol-2-yl)-2-[methyl-(4-methylphenyl)sulfonylamino]acetamide	[no description available]	low	0	sulfonamide
1-cyclohexyl-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea	[no description available]	low	0	sulfonamide
N-(5-chloro-2-hydroxyphenyl)-1,3-dimethyl-2-oxo-5-benzimidazolesulfonamide	[no description available]	low	0	sulfonamide
2,5-dichloro-4-ethoxy-N-(2-pyridinylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-ethoxy-2,3,5-trimethyl-N-(3-pyridinylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[4-[(3,4-dimethoxyphenyl)sulfamoyl]phenyl]acetamide	[no description available]	low	0	sulfonamide
3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide	[no description available]	low	0	sulfonamide
4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide	[no description available]	low	0	sulfonamide
2-[N-(benzenesulfonyl)-4-ethoxyanilino]-N-(2-methoxyphenyl)acetamide	[no description available]	low	0	sulfonamide
1-(2,5-dimethoxyphenyl)sulfonyl-4-(phenylmethyl)piperazine	[no description available]	low	0	sulfonamide
4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide	[no description available]	low	0	sulfonamide
5-bromo-2-methoxy-N-(3-methyl-2-pyridinyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
pyrabactin	[no description available]	low	0	naphthalenes; organobromine compound; pyridines; sulfonamide	abscisic acid receptor agonist; hormone; plant growth regulator
2-(4-methoxyphenyl)-N-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]acetamide	[no description available]	low	0	sulfonamide
1,4-bis[(4-methoxy-2-methylphenyl)sulfonyl]-1,4-diazepane	[no description available]	low	0	sulfonamide
N-(2-furanylmethyl)-4-(1-pyrrolidinylsulfonyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-(benzenesulfonyl)-N-methyl-N-phenyl-1-piperazinecarboxamide	[no description available]	low	0	sulfonamide
2-(3-ethylphenoxy)-N-[4-(2-pyridinylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
N-[[1-(benzenesulfonyl)-4-piperidinyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
1-(1,3-benzodioxol-5-yl)-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea	[no description available]	low	0	sulfonamide
1-(1,3-benzodioxol-5-yl)-3-[4-[(phenylmethyl)sulfamoyl]phenyl]urea	[no description available]	low	0	sulfonamide
1,3-diethyl-6-methyl-N-(2-methylphenyl)-2-oxo-5-benzimidazolesulfonamide	[no description available]	low	0	sulfonamide
N-(1,3-benzodioxol-5-ylmethyl)-4-methyl-3-(1-piperidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide	[no description available]	low	0	sulfonamide
1-methylsulfonyl-N-(6,7,8,9-tetrahydrodibenzofuran-2-yl)-2,3-dihydroindole-5-sulfonamide	[no description available]	low	0	sulfonamide
2-[2-chloro-4-(2,3-dihydroindol-1-ylsulfonyl)phenoxy]-N-(2-pyridinylmethyl)acetamide	[no description available]	low	0	sulfonamide
1-(4-bromo-3-ethoxyphenyl)sulfonyl-3,5-dimethylpyrazole	[no description available]	low	0	sulfonamide
N-(4-hydroxy-3,5-dimethylphenyl)-2,5-dimethyl-3-thiophenesulfonamide	[no description available]	low	0	sulfonamide
5-[(5-tert-butyl-2,3-dimethylphenyl)sulfonylamino]-2-hydroxybenzoic acid	[no description available]	low	0	sulfonamide
1-(4-chloro-2,5-dimethoxyphenyl)sulfonylbenzotriazole	[no description available]	low	0	sulfonamide
2-[4-chloro-5-(cyclopentylsulfamoyl)-2-methylphenoxy]-N-cyclohexylacetamide	[no description available]	low	0	sulfonamide
2-(1,3-benzothiazol-2-ylthio)-N-(4-methylphenyl)sulfonylacetamide	[no description available]	low	0	sulfonamide
2,4-dichloro-5-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
N-cycloheptyl-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide	[no description available]	low	0	sulfonamide
N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide	[no description available]	low	0	sulfonamide
2-[1-(4-tert-butylphenyl)sulfonyl-4-piperidinyl]-6-chloro-1H-benzimidazole	[no description available]	low	0	sulfonamide
2-[[5-(1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-[4-(1-pyrrolidinylsulfonyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
4-[[3-[(2-chlorophenyl)methyl]-5-cyclopropyl-7-triazolo[4,5-d]pyrimidinyl]amino]-N,N-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
7-methyl-2-[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]-3-quinolinecarbonitrile	[no description available]	low	0	sulfonamide
6-amino-5-(benzenesulfonyl)-2-methoxy-3-pyridinecarbonitrile	[no description available]	low	0	sulfonamide
6-amino-5-(4-chlorophenyl)sulfonyl-2-oxo-1H-pyridine-3-carbonitrile	[no description available]	low	0	sulfonamide
2-[benzenesulfonyl(2-pyridinyl)amino]acetic acid	[no description available]	low	0	sulfonamide
2-[(4-chlorophenyl)sulfonyl-(2-pyridinyl)amino]acetic acid	[no description available]	low	0	sulfonamide
2,5-dichloro-N-(1,5,6-trimethyl-4-benzimidazolyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide	[no description available]	low	0	sulfonamide
5-[1-(benzenesulfonyl)-3-pyrazolyl]-2-phenylthiazole	[no description available]	low	0	sulfonamide
5-[1-(4-fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole	[no description available]	low	0	sulfonamide
N-[1-[(3,4-dichlorophenyl)methyl]-6-oxo-3-pyridinyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
2-(benzenesulfonylmethyl)-5-(4-chlorophenyl)cyclohexane-1,3-dione	[no description available]	low	0	sulfonamide
1-(benzenesulfonyl)-3-pyrazolidinone	[no description available]	low	0	sulfonamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-methyl-4-pyrazolesulfonamide	[no description available]	low	0	sulfonamide
N-(4-methoxyphenyl)-2-(3-methylphenoxy)-N-(4-methylphenyl)sulfonylacetamide	[no description available]	low	0	sulfonamide
N-[4-(4-fluorophenyl)-2-thiazolyl]-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[[[4-(diethylsulfamoyl)phenyl]-oxomethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester	[no description available]	low	0	sulfonamide
tosylarginine methyl ester	[no description available]	low	0	guanidines; L-arginine ester; methyl ester; sulfonamide
n-(4-(n-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide	[no description available]	low	0	pyrazines; sulfonamide; thiophenes	necroptosis inhibitor; neuroprotective agent
N-[(benzenesulfonylhydrazo)-sulfanylidenemethyl]-4-methylbenzamide	[no description available]	low	0	sulfonamide
xl147	[no description available]	low	0	aromatic amine; benzothiadiazole; quinoxaline derivative; sulfonamide	antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
7-chloro-2-methyl-4-(4-methylphenyl)sulfonylthiazolo[5,4-b]indole	[no description available]	low	0	sulfonamide
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(4-methyl-1-piperidinyl)sulfonyl]benzamide	[no description available]	low	0	sulfonamide
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[methyl-(phenylmethyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
4-(4-bromophenyl)sulfonyl-2-(2-furanyl)-5-(methylthio)oxazole	[no description available]	low	0	sulfonamide
4-(4-morpholinylsulfonyl)-N-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-fluorophenyl)thio]ethanone	[no description available]	low	0	sulfonamide
4-methoxy-N-(3-methylbutyl)-3-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
N-(1,3-benzothiazol-2-yl)-3-(2,3-dihydroindol-1-ylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
N-(1H-benzimidazol-2-yl)-3-[phenyl(prop-2-enyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
1-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-2-[(5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)thio]ethanone	[no description available]	low	0	sulfonamide
3-[4-(4-morpholinylsulfonyl)phenyl]propanoic acid [2-[(5-chloro-2-pyridinyl)amino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]thio]ethanone	[no description available]	low	0	sulfonamide
2,5-difluoro-N-[2-(4-morpholinylmethyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
N-(2-methyl-1,3-benzothiazol-6-yl)-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
3-[(4-acetyl-1-piperazinyl)sulfonyl]-N-(1H-benzimidazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
3-[(3-hydroxy-5-benzotriazolyl)sulfonylamino]benzoic acid	[no description available]	low	0	sulfonamide
3-[(5-chloro-2,4-dimethoxyphenyl)-methylsulfamoyl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
2-(2-fluorophenoxy)-N-[4-(2-furanylmethylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
3-[[[5-[3-(1-piperidinylsulfonyl)phenyl]-1,3,4-oxadiazol-2-yl]thio]methyl]-1,2,3-benzotriazin-4-one	[no description available]	low	0	sulfonamide
N-(1H-benzimidazol-2-yl)-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
2,6-dichloro-N-[2-(methylthio)-1,3-benzothiazol-6-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
4-fluoro-3-methoxy-N-(2-pyridinyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
N-(5-ethyl-1,3,4-oxadiazol-2-yl)-4-[methyl(phenyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
4-[bis(2-methoxyethyl)sulfamoyl]-N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
4-(dipropylsulfamoyl)-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
4-[butyl(methyl)sulfamoyl]-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
4-[ethyl-(phenylmethyl)sulfamoyl]-N-(5-methyl-1,3,4-oxadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
4-[ethyl-(phenylmethyl)sulfamoyl]-N-[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
4-[bis(2-methylpropyl)sulfamoyl]-N-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-methyl-2-thiazolyl)thio]ethanone	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]ethanone	[no description available]	low	0	sulfonamide
N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-4-nitrobenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[(5-butyl-1H-1,2,4-triazol-3-yl)thio]-N-(4-sulfamoylphenyl)acetamide	[no description available]	low	0	sulfonamide
2-ethoxy-N-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
N-[4-(dibutylsulfamoyl)phenyl]-2-thiophen-2-ylacetamide	[no description available]	low	0	sulfonamide
2,3-dichloro-4-methoxy-N-(3-methoxypropyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[(3-cyano-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-2-yl)thio]-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]acetamide	[no description available]	low	0	sulfonamide
N-(2-furanylmethyl)-2-[4-(propylsulfamoyl)phenoxy]acetamide	[no description available]	low	0	sulfonamide
4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide	[no description available]	low	0	sulfonamide
4-methyl-N-[2-(phenylmethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[4-chloro-5-(cyclohexylsulfamoyl)-2-methylphenoxy]-N-(1,3,4-thiadiazol-2-yl)acetamide	[no description available]	low	0	sulfonamide
N-[2-(cyclohexylthio)ethyl]-4-methyl-3-[(4-methylphenyl)sulfamoyl]benzamide	[no description available]	low	0	sulfonamide
1-(3-chlorophenyl)-3-[3-[methyl(methylsulfonyl)amino]phenyl]urea	[no description available]	low	0	sulfonamide
N-[4-(cyanomethyl)phenyl]-4-cyclohexylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-(4-ethoxyphenyl)-4-[[4-(methylthio)phenyl]sulfonylamino]benzenesulfonamide	[no description available]	low	0	sulfonamide
2-(methanesulfonamido)-N-[2-(phenylmethylthio)ethyl]benzamide	[no description available]	low	0	sulfonamide
N-(2-fluorophenyl)-4-methoxy-2,5-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[benzenesulfonyl-(phenylmethyl)amino]-N-ethylacetamide	[no description available]	low	0	sulfonamide
4-[benzenesulfonyl(methyl)amino]-N-[2-[(4-chlorophenyl)methylthio]ethyl]benzamide	[no description available]	low	0	sulfonamide
N-(3,4-dimethyl-2-sulfanylidene-5-thiazolyl)carbamic acid 2-[(2,5-dimethylphenyl)sulfonylamino]ethyl ester	[no description available]	low	0	sulfonamide
2-[cyclohexyl-(4-methylphenyl)sulfonylamino]-N-(3-methoxypropyl)acetamide	[no description available]	low	0	sulfonamide
N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide	[no description available]	low	0	sulfonamide
N-(1H-benzimidazol-2-yl)-4-(dimethylsulfamoyl)benzamide	[no description available]	low	0	sulfonamide
1-(3-chlorophenyl)-3-[2-(thiophen-2-ylsulfonylamino)phenyl]urea	[no description available]	low	0	sulfonamide
2-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-1,2-benzothiazol-3-one	[no description available]	low	0	sulfonamide
N-(1H-benzimidazol-2-ylmethyl)-3-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
2-[(4-fluoro-2-methylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)benzamide	[no description available]	low	0	sulfonamide
2-[(4-cyanophenyl)methylthio]-N-(2-methoxyphenyl)-1,3-benzoxazole-5-sulfonamide	[no description available]	low	0	sulfonamide
2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[4-(4-morpholinylsulfonyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
3-(1-azepanylsulfonyl)-4-chloro-N-(1H-1,2,4-triazol-5-yl)benzamide	[no description available]	low	0	sulfonamide
sr 3335	[no description available]	low	0	sulfonamide
N-(1H-benzimidazol-2-ylmethyl)-4-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
2-[(4-chlorophenyl)methylthio]-5-[3-(1-piperidinylsulfonyl)phenyl]-1,3,4-oxadiazole	[no description available]	low	0	sulfonamide
4-chloro-3-[(4-chlorophenyl)sulfamoyl]-N-(1H-1,2,4-triazol-5-yl)benzamide	[no description available]	low	0	sulfonamide
1-(2-fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester	[no description available]	low	0	sulfonamide
3-[(4-methyl-1-piperazinyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)benzamide	[no description available]	low	0	sulfonamide
N-(2-methoxyphenyl)-2-(2-oxopropylthio)-1,3-benzoxazole-5-sulfonamide	[no description available]	low	0	sulfonamide
2-[5-(1-pyrrolidinylsulfonyl)-2-thiophenyl]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide	[no description available]	low	0	sulfonamide
1-(4-fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester	[no description available]	low	0	sulfonamide
3-(2-chlorophenyl)sulfonylpropanoic acid [2-[(3,5-dichloro-6-methyl-2-pyridinyl)amino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
2-[4-[benzenesulfonyl(methyl)amino]phenoxy]-N-(1,3-benzothiazol-2-yl)acetamide	[no description available]	low	0	sulfonamide
N-(6-methoxy-1,3-benzothiazol-2-yl)-3-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
N-cyclopentyl-3,4-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
6-amino-1-(2-methoxyethyl)-N-(4-methylphenyl)sulfonyl-2,4-dioxo-5-pyrimidinecarboxamide	[no description available]	low	0	sulfonamide
3-(benzenesulfonyl)propanoic acid [2-[(3,5-dichloro-4-methyl-2-pyridinyl)amino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
N-[[2-cyanoethyl(methyl)amino]-sulfanylidenemethyl]-4-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
[4-methoxy-3-(4-morpholinylsulfonyl)phenyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone	[no description available]	low	0	sulfonamide
[4-(4-bromo-2-chlorophenyl)sulfonyl-1-piperazinyl]-(2-sulfanylidene-1H-pyridin-3-yl)methanone	[no description available]	low	0	sulfonamide
[1-(4-fluorophenyl)sulfonyl-4-piperidinyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone	[no description available]	low	0	sulfonamide
N-[(1S)-1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
1-[4-(3-chloro-2,4,6-trifluorophenyl)sulfonyl-1-piperazinyl]ethanone	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone	[no description available]	low	0	sulfonamide
2-(4-methoxyphenyl)-N-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
N1-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide	[no description available]	low	0	sulfonamide
2-(benzenesulfonylmethyl)-5-(4-methoxyphenyl)cyclohexane-1,3-dione	[no description available]	low	0	sulfonamide
2-[bis(2-methylpropoxy)phosphoryl]-3,3,3-trifluoro-2-[(4-methylphenyl)sulfonylamino]propanoic acid ethyl ester	[no description available]	low	0	sulfonamide
N1-{3-[2-(2-pyridyl)ethyl]phenyl}-4-chlorobenzene-1-sulfonamide	[no description available]	low	0	sulfonamide
ethyl 1-[4-(4-chlorobenzenesulfonamido)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate	[no description available]	low	0	ethyl ester; monochlorobenzenes; organofluorine compound; pyrazoles; sulfonamide
2,3-dichloro-N'-[4-(trifluoromethyl)-2-pyrimidinyl]benzenesulfonohydrazide	[no description available]	low	0	sulfonamide
1-(4-ethyl-2-pyridinyl)-3-(4-methylphenyl)sulfonylurea	[no description available]	low	0	sulfonamide
1-(3,5-dimethylphenyl)-3-[5-(dimethylsulfamoyl)-2-methylphenyl]urea	[no description available]	low	0	sulfonamide
N-{5-[(dimethylamino)sulfonyl]-2-methylphenyl}cyclohexanecarboxamide	[no description available]	low	0	sulfonamide
1-tert-butyl-3-[(4-methylphenyl)sulfonylamino]thiourea	[no description available]	low	0	sulfonamide
2-[(4-methylphenyl)sulfonylamino]pentanoic acid	[no description available]	low	0	sulfonamide
3-methyl-4,7-bis(methylsulfonyl)-3a,5,6,7a-tetrahydro-1H-imidazo[4,5-b]pyrazin-2-one	[no description available]	low	0	imidazopyrazine; sulfonamide; ureas
N-(3-acetyl-2-methyl-5-benzofuranyl)-N-(4-chloro-3-nitrophenyl)sulfonylacetamide	[no description available]	low	0	sulfonamide
2-[(4-chlorophenyl)thio]-N-[4-[(2,4-dimethylphenyl)sulfamoyl]phenyl]propanamide	[no description available]	low	0	sulfonamide
4-chloro-N-[2-(4-morpholinyl)cyclohexyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene	[no description available]	low	0	C-nitro compound; sulfonamide; toluenes	bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector
[4-(benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone	[no description available]	low	0	sulfonamide
N-[3-(2-furanyl)-3-phenylpropyl]-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[4-(butylsulfamoyl)phenyl]-2-phenyl-2-(phenylthio)acetamide	[no description available]	low	0	sulfonamide
N-[2,6-dimethyl-3-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N,4-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid	[no description available]	low	0	sulfonamide
N-[4-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-thiazolyl]-2,3-dihydro-1,4-benzodioxin-3-carboxamide	[no description available]	low	0	sulfonamide
4-(5-(4-methoxyphenyl)-3-phenyl-4,5-dihydro-1h-pyrazol-1-yl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-[oxo-[1-(2,4,6-trimethylphenyl)sulfonyl-4-piperidinyl]methyl]-1-piperazinecarboxylic acid ethyl ester	[no description available]	low	0	sulfonamide
N,4-dimethyl-N-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[2-(1-phenylethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]methanesulfonamide	[no description available]	low	0	sulfonamide
N-[1-(4-chlorophenyl)sulfonyl-2-pyrrolidinyl]-4-methyl-1-piperazinecarboxamide	[no description available]	low	0	sulfonamide
1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[[1-(2-methylpropyl)-2-benzimidazolyl]thio]ethanone	[no description available]	low	0	sulfonamide
N-[4-[(4-hydroxyphenyl)-methylsulfamoyl]phenyl]acetamide	[no description available]	low	0	sulfonamide
6-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-N-ethyl-N-phenyl-3-pyridinesulfonamide	[no description available]	low	0	pyridines; sulfonamide
4-chloro-N-(1-propyl-2-benzimidazolyl)-3-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
2,3-dihydro-1,4-benzodioxin-3-yl-[4-(3,4-dimethylphenyl)sulfonyl-1-piperazinyl]methanone	[no description available]	low	0	sulfonamide
N-(1-propyl-2-benzimidazolyl)-3-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
1-(benzenesulfonyl)-2-benzimidazolamine	[no description available]	low	0	sulfonamide
1-(4-nitrophenyl)sulfonyl-2-benzimidazolamine	[no description available]	low	0	sulfonamide
sulfatolamide	[no description available]	low	0	benzenes; sulfonamide
e 7010	[no description available]	low	0	sulfonamide
deracoxib	[no description available]	low	0	organofluorine compound; pyrazoles; sulfonamide	cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
diclosulam	[no description available]	low	0	sulfonamide
benzene-1-3-disulfonamide	[no description available]	low	0	sulfonamide
N-[2-[(2-chloro-1-oxopropyl)hydrazo]-2-oxoethyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
3-nitro-N-(pyridin-4-ylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[2-[(4-acetamidophenyl)sulfonylamino]-4-thiazolyl]acetic acid ethyl ester	[no description available]	low	0	sulfonamide
1-[3-(benzenesulfonyl)-2-(1-piperidinyl)propyl]piperidine	[no description available]	low	0	sulfonamide
6-(2-furanyl)-4-[4-(methanesulfonamido)phenyl]-2-oxo-1-cyclohex-3-enecarboxylic acid ethyl ester	[no description available]	low	0	sulfonamide
3-(benzenesulfonyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]propanamide	[no description available]	low	0	sulfonamide
1-(2-furanylmethyl)-3-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]thiourea	[no description available]	low	0	sulfonamide
N1-butan-2-yl-N4-[2-(3,4-dimethoxyphenyl)ethyl]-N4-(thiophen-2-ylmethyl)benzene-1,4-disulfonamide	[no description available]	low	0	sulfonamide
1-(4-chlorophenyl)sulfonyl-N'-[oxo-[4-(1-piperidinylsulfonyl)phenyl]methyl]-4-piperidinecarbohydrazide	[no description available]	low	0	sulfonamide
N,N-dimethyl-4-[[3-[3-(5-methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]sulfonyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
1-(4-methylphenyl)sulfonyl-3-methylsulfonylimidazolidine	[no description available]	low	0	sulfonamide
1-(4-bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane	[no description available]	low	0	sulfonamide
2-[[4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]imino-3,4-dimethyl-5-thiazolecarboxylic acid ethyl ester	[no description available]	low	0	sulfonamide
1-(4-chlorophenyl)sulfonyl-N-(2-thiazolyl)-1-cyclopropanecarboxamide	[no description available]	low	0	sulfonamide
1-methyl-N-[4-(trifluoromethyl)phenyl]-4-imidazolesulfonamide	[no description available]	low	0	sulfonamide
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methylanilino]acetamide	[no description available]	low	0	sulfonamide
N,N-diethyl-4-[[5-oxo-6-(phenylmethyl)-7H-pyrrolo[3,4-b]pyridin-7-yl]amino]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-(1,3-benzodioxol-5-yl)-5-bromo-1-[cyclopropyl(oxo)methyl]-N-ethyl-2,3-dihydroindole-7-sulfonamide	[no description available]	low	0	sulfonamide
N-(3,4-dimethylphenyl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methoxyanilino]acetamide	[no description available]	low	0	sulfonamide
3,4-dimethoxy-N-[3-(methylthio)phenyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-methylanilino]acetamide	[no description available]	low	0	sulfonamide
cyclopentanecarboxylic acid [4-(benzenesulfonyl)-2-tert-butyl-5-methyl-3-pyrazolyl] ester	[no description available]	low	0	sulfonamide
4-[[(4-acetamidophenyl)sulfonylamino]methyl]-N-(3-methoxypropyl)benzamide	[no description available]	low	0	sulfonamide
4-methyl-N-[2,4,6-trioxo-1-phenyl-5-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
6-ethyl-2-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide	[no description available]	low	0	sulfonamide
4-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-3-nitrobenzenesulfonamide	[no description available]	low	0	benzenes; sulfonamide
4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide	[no description available]	low	0	sulfonamide
2-[(5-chloro-1,3-benzothiazol-2-yl)thio]-N-[3-(4-morpholinylsulfonyl)phenyl]propanamide	[no description available]	low	0	sulfonamide
N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-methoxy-3-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
2-ethoxy-3-pyridinecarboxylic acid [2-[2-methyl-5-(4-morpholinylsulfonyl)anilino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
N-[4-[2-(2-ethyl-1-oxobutyl)-3-phenyl-3,4-dihydropyrazol-5-yl]phenyl]methanesulfonamide	[no description available]	low	0	sulfonamide
N-[3-[(2-chlorophenyl)sulfamoyl]-4-methoxyphenyl]-4-oxo-4-thiophen-2-ylbutanamide	[no description available]	low	0	sulfonamide
2-(4-methyl-N-(4-methylphenyl)sulfonylanilino)-N-[(1-methyl-4-piperidinylidene)amino]acetamide	[no description available]	low	0	sulfonamide
fh535	[no description available]	low	0	sulfonamide
1-[4-chloro-3-[(2-methoxyphenyl)sulfamoyl]phenyl]-3-(2-methoxyphenyl)urea	[no description available]	low	0	sulfonamide
N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-2-(2-pyrimidinylthio)acetamide	[no description available]	low	0	sulfonamide
2-[[[5-(dimethylsulfamoyl)-2-methylanilino]-sulfanylidenemethyl]hydrazo]-2-oxoacetamide	[no description available]	low	0	sulfonamide
1-(4-butylphenyl)-3-[4-chloro-3-(dimethylsulfamoyl)phenyl]thiourea	[no description available]	low	0	sulfonamide
6-methyl-2-[[oxo-[4-(1-pyrrolidinylsulfonyl)phenyl]methyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide	[no description available]	low	0	sulfonamide
2-(1,3-benzothiazol-2-ylthio)-N-[2-hydroxy-5-(4-morpholinylsulfonyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
1-butyl-4,6-dimethyl-3-(2-methylphenyl)sulfonyl-2-pyridinone	[no description available]	low	0	sulfonamide
4-(4-methylphenyl)sulfonyl-3-phenyl-2,3-dihydro-1,4-benzoxazine	[no description available]	low	0	sulfonamide
N-[3-(4-methyl-1-piperazinyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide	[no description available]	low	0	1,4-naphthoquinones; piperazines; sulfonamide
N-(2,2,4-trimethyl-3H-benzofuran-7-yl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-furanyl-[4-(4-propan-2-ylphenyl)sulfonyl-1-piperazinyl]methanone	[no description available]	low	0	sulfonamide
5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamide	[no description available]	low	0	benzenes; sulfonamide
N-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-4-fluoro-3-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[5-(diethylsulfamoyl)-2-methoxyphenyl]-2-[(2,5-dimethylphenyl)thio]acetamide	[no description available]	low	0	sulfonamide
2-[(5-anilino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-[3-(1-imidazolyl)propyl]benzamide	[no description available]	low	0	sulfonamide
2-[[3-(3-oxo-1,2-benzothiazol-2-yl)phenyl]sulfonylamino]benzoic acid	[no description available]	low	0	sulfonamide
N-[(1,2-dimethyl-5-indolyl)methyl]-4-methoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
N,6-dimethyl-2-[[[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide	[no description available]	low	0	sulfonamide
N-cyclopropyl-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[1-(1H-benzimidazol-2-yl)ethyl]-3-(dimethylsulfamoyl)benzamide	[no description available]	low	0	sulfonamide
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(3-methyl-1-piperidinyl)sulfonyl]benzamide	[no description available]	low	0	sulfonamide
N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide	[no description available]	low	0	sulfonamide
2,3-dihydro-1,4-benzodioxin-3-carboxylic acid [2-[2-methyl-5-(4-morpholinylsulfonyl)anilino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
2-(1,3-benzothiazol-2-ylthio)-N-[2-chloro-5-(4-morpholinylsulfonyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
1-[3-(dimethylsulfamoyl)phenyl]-3-(2-furanylmethyl)thiourea	[no description available]	low	0	sulfonamide
5-nitro-2-furancarboxylic acid [2-oxo-2-[3-(1-piperidinylsulfonyl)anilino]ethyl] ester	[no description available]	low	0	sulfonamide
N-[2-(4-methoxyphenyl)ethyl]-2-nitro-4-(1-pyrrolidinylsulfonyl)aniline	[no description available]	low	0	benzenes; sulfonamide
N-(2-ethoxyphenyl)-2,1,3-benzothiadiazole-4-sulfonamide	[no description available]	low	0	sulfonamide
N-[3-[2-(4-fluorophenyl)sulfonyl-3-thiophen-2-yl-3,4-dihydropyrazol-5-yl]phenyl]ethanesulfonamide	[no description available]	low	0	sulfonamide
N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-[(2-methyl-1-piperidinyl)sulfonyl]benzamide	[no description available]	low	0	sulfonamide
N-[(3,5-dimethyl-1-piperidinyl)-sulfanylidenemethyl]-2-methyl-5-(4-morpholinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
4-[bis(2-methoxyethyl)sulfamoyl]-N-[5-(methoxymethyl)-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
2-(benzenesulfonamido)-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid propan-2-yl ester	[no description available]	low	0	isopropyl ester; sulfonamide
2-(3,4-dichlorophenyl)-N-[3-(dimethylsulfamoyl)-4-methylphenyl]acetamide	[no description available]	low	0	sulfonamide
N-Cyclopentyl-2-(N-methyl3-chlorobenzenesulfonamido)acetamide	[no description available]	low	0	sulfonamide	anticoronaviral agent
N-[5-(1-azepanylsulfonyl)-2-chlorophenyl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]acetamide	[no description available]	low	0	sulfonamide
1-(4-methoxyphenyl)-3-[3-(1-piperidinylsulfonyl)phenyl]thiourea	[no description available]	low	0	sulfonamide
1-[2-(trifluoromethyl)phenyl]sulfonyl-4-piperidinecarboxylic acid [2-[(4-fluorophenyl)methylamino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid [2-[4-methyl-3-(1-piperidinylsulfonyl)anilino]-2-oxoethyl] ester	[no description available]	low	0	sulfonamide
3-[4-(4-butan-2-ylphenyl)sulfonyl-1-piperazinyl]butanoic acid	[no description available]	low	0	sulfonamide
3-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-(5-methyl-2-thiazolyl)benzamide	[no description available]	low	0	sulfonamide
2-[[4-(2-methoxyphenyl)sulfonyl-1-piperazinyl]sulfonyl]benzonitrile	[no description available]	low	0	sulfonamide
2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(diethylsulfamoyl)phenyl]acetamide	[no description available]	low	0	sulfonamide
3-[(4-methyl-1-piperazinyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)-N-prop-2-enylbenzamide	[no description available]	low	0	sulfonamide
1-(7-methyloctyl)-3-[4-(4-morpholinylsulfonyl)phenyl]thiourea	[no description available]	low	0	sulfonamide
5-[(5-bromo-2-ethoxyphenyl)sulfonylamino]-2-chloro-N,N-dimethylbenzenesulfonamide	[no description available]	low	0	sulfonamide
2-[[5-[(4-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-N-(3-sulfamoylphenyl)acetamide	[no description available]	low	0	sulfonamide
N,N-dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-(1-pyrrolidinylsulfonyl)benzamide	[no description available]	low	0	sulfonamide
4-(dimethylsulfamoyl)-N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]benzamide	[no description available]	low	0	sulfonamide
N-methyl-2-[[[4-[methyl(phenyl)sulfamoyl]phenyl]-oxomethyl]amino]-6-propyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide	[no description available]	low	0	sulfonamide
1-[4-chloro-3-(4-morpholinylsulfonyl)phenyl]-3-phenylurea	[no description available]	low	0	sulfonamide
dorzolamide	[no description available]	low	0	sulfonamide; thiophenes	antiglaucoma drug; antihypertensive agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor
3-(4-methylphenyl)sulfonyl-3-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid	[no description available]	low	0	sulfonamide
N-(3,4-difluorophenyl)-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-ethoxyanilino]acetamide	[no description available]	low	0	sulfonamide
5-[(4-methoxyphenyl)sulfonylmethyl]-N-(3-methoxypropyl)-2-furancarboxamide	[no description available]	low	0	sulfonamide
N-cyclohexyl-N-ethyl-1,3-dimethyl-2,4-dioxo-5-pyrimidinesulfonamide	[no description available]	low	0	pyrimidone; sulfonamide
1,3-dimethyl-2,4-dioxo-N-(4-propan-2-ylphenyl)-5-pyrimidinesulfonamide	[no description available]	low	0	sulfonamide
2,5-dimethoxy-N-[[2-(4-methoxyphenyl)-4-thiazolyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
kn 93	[no description available]	low	0	monochlorobenzenes; monomethoxybenzene; primary alcohol; sulfonamide; tertiary amino compound	EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor; geroprotector
ro 4-6790	[no description available]	low	0	benzenes; sulfonamide
jnj-7706621	[no description available]	low	0	sulfonamide
sultan	[no description available]	low	0	sulfonamide
1-[2-furanyl(oxo)methyl]-N-[4-[(3-methyl-1-piperidinyl)sulfonyl]phenyl]-4-piperidinecarboxamide	[no description available]	low	0	sulfonamide
sb 269970	[no description available]	low	0	sulfonamide
belinostat	[no description available]	low	0	hydroxamic acid; olefinic compound; sulfonamide	antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor
2-bromo-N-(phenylmethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
2-(2,5-dichlorophenyl)sulfonyl-N-methyl-N-[(2-methylphenyl)methyl]ethanamine	[no description available]	low	0	sulfonamide
((3z)-n-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1h-pyrrol-2-yl)methylene)-n-methyl-2-oxo-2,3-dihydro-1h-indole-5-sulfonamide)	[no description available]	low	0	sulfonamide
N-[2-methyl-5-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
5-chloro-N-[4-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2-thiophenesulfonamide	[no description available]	low	0	sulfonamide
4-methyl-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide	[no description available]	low	0	organofluorine compound; pyrazoles; sulfonamide	cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug
bm 567	[no description available]	low	0	benzenes; sulfonamide
mre 269	[no description available]	low	0	aromatic amine; ether; monocarboxylic acid; pyrazines; sulfonamide; tertiary amino compound	drug metabolite; orphan drug; platelet aggregation inhibitor; prostacyclin receptor agonist; vasodilator agent
pazopanib	[no description available]	low	0	aminopyrimidine; indazoles; sulfonamide	angiogenesis modulating agent; antineoplastic agent; tyrosine kinase inhibitor; vascular endothelial growth factor receptor antagonist
azd2858	[no description available]	low	0	aromatic amine; N-methylpiperazine; pyrazines; pyridines; secondary carboxamide; sulfonamide	antineoplastic agent; bone density conservation agent; EC 2.7.11.26 (tau-protein kinase) inhibitor; Wnt signalling activator
4-(2-((1r)-1-(((4-chlorophenyl)sulfonyl)-2,5-difluoroanilino)ethyl)-5-fluorophenyl)butanoic acid	[no description available]	low	0	sulfonamide
apratastat	[no description available]	low	0	sulfonamide
N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide	[no description available]	low	0	sulfonamide
florasulam	[no description available]	low	0	sulfonamide
(1S,2R)-2-[[4-[(2,4-dimethylphenyl)sulfamoyl]anilino]-oxomethyl]-1-cyclohexanecarboxylic acid	[no description available]	low	0	sulfonamide
3-[1-(4-bromophenyl)sulfonyl-3,6-dihydro-2H-pyridin-4-yl]-1,2-dimethylindole	[no description available]	low	0	sulfonamide
4-[3-(3-fluorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
2-[[[4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]amino]-3-thiophenecarboxamide	[no description available]	low	0	sulfonamide
4-[3-(4-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[5-[ethyl(phenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide	[no description available]	low	0	sulfonamide
calcium crimson	[no description available]	low	0	ammonium betaine; sulfonamide	fluorochrome
4-methoxy-N-[[1-[(3-methyl-2-thiophenyl)-oxomethyl]-3-piperidinyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N'-[[3-(4-methylphenyl)sulfonyl-2-oxazolidinyl]methyl]-N-[2-(4-sulfamoylphenyl)ethyl]oxamide	[no description available]	low	0	sulfonamide
tg101209	[no description available]	low	0	N-alkylpiperazine; N-arylpiperazine; pyrimidines; secondary amino compound; sulfonamide	antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
fedratinib	[no description available]	low	0	sulfonamide
WAY-316606	[no description available]	low	0	(trifluoromethyl)benzenes; piperidines; secondary amino compound; sulfonamide; sulfone	secreted frizzled-related protein 1 inhibitor
azd5438	[no description available]	low	0	sulfonamide
gdc 0941	[no description available]	low	0	indazoles; morpholines; piperazines; sulfonamide; thienopyrimidine	EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
4-methoxy-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[5-[methyl-(3-methylphenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide	[no description available]	low	0	sulfonamide
gsk 1016790a	[no description available]	low	0	1-benzothiophenes; aromatic primary alcohol; dichlorobenzene; N-acylpiperazine; sulfonamide; tertiary carboxamide	TRPV4 agonist
plx 4720	[no description available]	low	0	aromatic ketone; difluorobenzene; organochlorine compound; pyrrolopyridine; sulfonamide	antineoplastic agent; B-Raf inhibitor
gsk 2126458	[no description available]	low	0	aromatic ether; difluorobenzene; pyridazines; pyridines; quinolines; sulfonamide	anticoronaviral agent; antineoplastic agent; autophagy inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor; radiosensitizing agent
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(4-fluorophenyl)sulfonylpiperazine	[no description available]	low	0	sulfonamide
(2R)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine	[no description available]	low	0	sulfonamide
[4-(2,6-difluorophenyl)sulfonyl-1-piperazinyl]-(2,3-dihydro-1,4-benzodioxin-6-yl)methanone	[no description available]	low	0	sulfonamide
(2R)-1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine	[no description available]	low	0	sulfonamide
(2S)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine	[no description available]	low	0	sulfonamide
(2S)-1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine	[no description available]	low	0	sulfonamide
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-pyridinylsulfonyl)piperazine	[no description available]	low	0	pyridines; sulfonamide
N-[1-(2,6-difluorophenyl)sulfonyl-4-piperidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepane	[no description available]	low	0	sulfonamide
N-[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[3-(trifluoromethyl)phenyl]sulfonylpiperazine	[no description available]	low	0	sulfonamide
N-[[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-azetidinyl]methyl]-2,6-difluorobenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[[1-(2,6-difluorophenyl)sulfonyl-3-azetidinyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-pyrrolidinyl]-2,6-difluorobenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[3-[(2,6-difluorophenyl)sulfonylamino]propyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[5-[(2,6-difluorophenyl)sulfonylamino]pentyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[6-[(2,6-difluorophenyl)sulfonylamino]hexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[2-[(2,6-difluorophenyl)sulfonylamino]ethyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[1-(2,6-difluorophenyl)sulfonyl-3-pyrrolidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
N-[4-[(2,6-difluorophenyl)sulfonylamino]butyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-nitrophenyl)sulfonylpiperazine	[no description available]	low	0	sulfonamide
4-[4-(4-methylphenyl)sulfonyl-1-piperazinyl]-2-thiophen-2-ylquinazoline	[no description available]	low	0	sulfonamide
plx4032	[no description available]	low	0	aromatic ketone; difluorobenzene; monochlorobenzenes; pyrrolopyridine; sulfonamide	antineoplastic agent; B-Raf inhibitor
N-[[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide	[no description available]	low	0	sulfonamide
1-(3-chlorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine	[no description available]	low	0	sulfonamide
1-(3-bromophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine	[no description available]	low	0	sulfonamide
(1S,4S)-2-(2,6-difluorophenyl)sulfonyl-5-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2,5-diazabicyclo[2.2.1]heptane	[no description available]	low	0	sulfonamide
1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2,4,6-trifluorophenyl)sulfonylpiperazine	[no description available]	low	0	sulfonamide
N-(1-cyano-3-pyrrolidinyl)-3-methoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
N-(1-cyano-3-pyrrolidinyl)-4-(trifluoromethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
N-(1-cyano-4-piperidinyl)-4-(trifluoromethyl)benzenesulfonamide	[no description available]	low	0	sulfonamide
4-[3-(3-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
4-[3-(3-bromophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
1-cyclohexyl-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea	[no description available]	low	0	sulfonamide
N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide	[no description available]	low	0	sulfonamide
N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide	[no description available]	low	0	sulfonamide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide	[no description available]	low	0	sulfonamide
N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[(2R,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide	[no description available]	low	0	sulfonamide
3-cyclohexyl-1-[[(2S,3S)-8-[(4-fluorophenyl)sulfonylamino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea	[no description available]	low	0	sulfonamide
3-cyclohexyl-1-[[(2R,3R)-10-[(4-fluorophenyl)sulfonylamino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea	[no description available]	low	0	sulfonamide
4-chloro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
1-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea	[no description available]	low	0	sulfonamide
N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide	[no description available]	low	0	sulfonamide
4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide	[no description available]	low	0	sulfonamide
1-[(2R,3R)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea	[no description available]	low	0	sulfonamide
baricitinib	[no description available]	low	0	azetidines; nitrile; pyrazoles; pyrrolopyrimidine; sulfonamide	anti-inflammatory agent; antirheumatic drug; antiviral agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; immunosuppressive agent
1-(4-methoxyphenyl)sulfonyl-2-benzimidazolamine	[no description available]	low	0	sulfonamide
5,6-dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolamine	[no description available]	low	0	sulfonamide
sr1001	[no description available]	low	0	sulfonamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
dabrafenib	[no description available]	low	0	1,3-thiazoles; aminopyrimidine; organofluorine compound; sulfonamide	anticoronaviral agent; antineoplastic agent; B-Raf inhibitor
3-[[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl]aniline	[no description available]	low	0	benzenes; sulfonamide
4-[[(4-ethylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide	[no description available]	low	0	sulfonamide
EG00229	[no description available]	low	0	benzothiadiazole; dicarboxylic acid monoamide; L-arginine derivative; secondary carboxamide; sulfonamide; thiophenes	angiogenesis inhibitor; antineoplastic agent; neuropilin receptor antagonist
gsk0660	[no description available]	low	0	sulfonamide
xl765	[no description available]	low	0	aromatic amine; aromatic ether; benzamides; quinoxaline derivative; sulfonamide	antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor
N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-[(4-methyl-1-piperazinyl)-oxomethyl]-1H-pyrrol-2-yl]methylidene]-N-methyl-2-oxo-1H-indole-5-sulfonamide	[no description available]	low	0	sulfonamide
tipranavir	[no description available]	low	0	sulfonamide	antiviral drug; HIV protease inhibitor
abt-333	[no description available]	low	0	aromatic ether; naphthalenes; pyrimidone; sulfonamide	antiviral drug; nonnucleoside hepatitis C virus polymerase inhibitor
pik 75	[no description available]	low	0	sulfonamide
vx-970	[no description available]	low	0	sulfonamide
pf-543	[no description available]	low	0	sulfonamide
ML355	[no description available]	low	0	benzothiazoles; monomethoxybenzene; phenols; secondary amino compound; substituted aniline; sulfonamide	EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; platelet aggregation inhibitor
sr9243	[no description available]	low	0	bromobenzenes; sulfonamide; sulfone	antineoplastic agent; apoptosis inducer; liver X receptor inverse agonist
sildenafil	[no description available]	low	0	piperazines; pyrazolopyrimidine; sulfonamide	EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent
da 8159	[no description available]	low	0	sulfonamide
3-[[2-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-2-oxoethyl]thio]-6-methyl-2H-1,2,4-triazin-5-one	[no description available]	low	0	sulfonamide
N-tert-butyl-3-(3-tert-butyl-1-methyl-7-oxo-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonamide	[no description available]	low	0	sulfonamide
N-[4-[2-[3-(dimethylsulfamoyl)anilino]-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide	[no description available]	low	0	sulfonamide
N-[2-[(4-chlorophenyl)methylthio]-4-oxo-1H-pyrimidin-6-yl]benzenesulfonamide	[no description available]	low	0	sulfonamide
N-[2-[(2-chlorophenyl)methylthio]-4-oxo-1H-pyrimidin-6-yl]-4-methylbenzenesulfonamide	[no description available]	low	0	sulfonamide
N-(4-methoxyphenyl)-2-[[6-[(4-methylphenyl)sulfonylamino]-4-oxo-1H-pyrimidin-2-yl]thio]acetamide	[no description available]	low	0	sulfonamide
mirodenafil	[no description available]	low	0	aromatic ether; N-alkylpiperazine; primary alcohol; pyrrolopyrimidine; sulfonamide	EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent
da-8164	[no description available]	low	0	sulfonamide
dinitrochlorobenzene	[no description available]	low	0	C-nitro compound; monochlorobenzenes	allergen; epitope; sensitiser
levoplast	[no description available]	low	0	C-nitro compound
4-nitrobenzaldehyde	[no description available]	low	0	benzaldehydes; C-nitro compound
3-nitropropionic acid	[no description available]	low	0	C-nitro compound	antimycobacterial drug; EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor; mycotoxin; neurotoxin
aristolochic acid i	[no description available]	low	0	aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound	carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin
azathioprine	[no description available]	low	0	aryl sulfide; C-nitro compound; imidazoles; thiopurine	antimetabolite; antineoplastic agent; carcinogenic agent; DNA synthesis inhibitor; hepatotoxic agent; immunosuppressive agent; prodrug
bay-k-8644	[no description available]	low	0	(trifluoromethyl)benzenes; C-nitro compound; dihydropyridine; methyl ester
dimetridazole	[no description available]	low	0	C-nitro compound; imidazoles	antiparasitic agent; antiprotozoal drug
etanidazole	[no description available]	low	0	C-nitro compound; imidazoles; monocarboxylic acid amide	alkylating agent; antineoplastic agent; prodrug; radiosensitizing agent
flunitrazepam	[no description available]	low	0	1,4-benzodiazepinone; C-nitro compound; monofluorobenzenes	anxiolytic drug; GABAA receptor agonist; sedative
metronidazole	[no description available]	low	0	C-nitro compound; imidazoles; primary alcohol	antiamoebic agent; antibacterial drug; antimicrobial agent; antiparasitic agent; antitrichomonal drug; environmental contaminant; prodrug; radiosensitizing agent; xenobiotic
nicardipine	[no description available]	low	0	benzenes; C-nitro compound; diester; dihydropyridine; methyl ester; tertiary amino compound
niclosamide	[no description available]	low	0	benzamides; C-nitro compound; monochlorobenzenes; salicylanilides; secondary carboxamide	anthelminthic drug; anticoronaviral agent; antiparasitic agent; apoptosis inducer; molluscicide; piscicide; STAT3 inhibitor
nifedipine	[no description available]	low	0	C-nitro compound; dihydropyridine; methyl ester	calcium channel blocker; human metabolite; tocolytic agent; vasodilator agent
nilutamide	[no description available]	low	0	(trifluoromethyl)benzenes; C-nitro compound; imidazolidinone	androgen antagonist; antineoplastic agent
nimetazepam	[no description available]	low	0	1,4-benzodiazepinone; C-nitro compound	anticonvulsant; antispasmodic drug; GABA modulator; sedative
nimodipine	[no description available]	low	0	2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester	antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent
nisoldipine	[no description available]	low	0	C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; methyl ester
nitrazepam	[no description available]	low	0	1,4-benzodiazepinone; C-nitro compound	anticonvulsant; antispasmodic drug; drug metabolite; GABA modulator; sedative
nitrendipine	[no description available]	low	0	C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; ethyl ester; methyl ester	antihypertensive agent; calcium channel blocker; geroprotector; vasodilator agent
nizatidine	[no description available]	low	0	1,3-thiazoles; C-nitro compound; carboxamidine; organic sulfide; tertiary amino compound	anti-ulcer drug; cholinergic drug; H2-receptor antagonist
oxamniquine	[no description available]	low	0	aromatic primary alcohol; C-nitro compound; quinolines; secondary amino compound
4-nitrophenylacetic acid	[no description available]	low	0	C-nitro compound; phenylacetic acids
ronidazole	[no description available]	low	0	C-nitro compound; carbamate ester; imidazoles	antiparasitic agent; antiprotozoal drug
4-nitroquinoline-1-oxide	[no description available]	low	0	C-nitro compound; quinoline N-oxide	carcinogenic agent
chloramphenicol	[no description available]	low	0	C-nitro compound; carboxamide; diol; organochlorine compound	antibacterial drug; antimicrobial agent; Escherichia coli metabolite; geroprotector; Mycoplasma genitalium metabolite; protein synthesis inhibitor
niridazole	[no description available]	low	0	1,3-thiazoles; C-nitro compound
nifenalol	[no description available]	low	0	C-nitro compound
chloropicrin	[no description available]	low	0	C-nitro compound; one-carbon compound; organochlorine compound	antifungal agrochemical; fumigant insecticide; nematicide
quintozene	[no description available]	low	0	aromatic fungicide; C-nitro compound; pentachlorobenzenes	antifungal agrochemical
musk ambrette (artificial)	[no description available]	low	0	C-nitro compound
1-chloro-2-nitrobenzene	[no description available]	low	0	C-nitro compound; monochlorobenzenes
picryl chloride	[no description available]	low	0	C-nitro compound; monochlorobenzenes	allergen; epitope; explosive; hapten
picric acid	[no description available]	low	0	C-nitro compound	antiseptic drug; explosive; fixative
2,4-dinitrobenzenesulfonic acid	[no description available]	low	0	arenesulfonic acid; C-nitro compound
2-nitro-4-methylaniline	[no description available]	low	0	C-nitro compound
3,5-dinitrobenzoic acid	[no description available]	low	0	benzoic acids; C-nitro compound
5-nitro-2-toluidine	[no description available]	low	0	C-nitro compound
4-chloronitrobenzene	[no description available]	low	0	C-nitro compound
4-nitrobenzyl chloride	[no description available]	low	0	benzyl chlorides; C-nitro compound	mutagen
4-nitroacetophenone	[no description available]	low	0	acetophenones; C-nitro compound
tecnazene	[no description available]	low	0	aromatic fungicide; C-nitro compound; tetrachlorobenzene	antifungal agrochemical
4-amino-2-nitrotoluene	[no description available]	low	0	C-nitro compound
2-amino-5-nitrothiazole	[no description available]	low	0	C-nitro compound; thiazoles
naphthol yellow	[no description available]	low	0	C-nitro compound; naphthalenesulfonic acid; naphthols	histological dye
azomycin	[no description available]	low	0	C-nitro compound; imidazoles	antitubercular agent
trinitrobenzenesulfonic acid	[no description available]	low	0	arenesulfonic acid; C-nitro compound	epitope; explosive; reagent
2-nitrobenzaldehyde	[no description available]	low	0	benzaldehydes; C-nitro compound
1-bromo-2,4-dinitrobenzene	[no description available]	low	0	C-nitro compound; organobromine compound
3,5-dinitrosalicylic acid	[no description available]	low	0	C-nitro compound; monohydroxybenzoic acid	hapten
3,5-dinitrotoluene	[no description available]	low	0	C-nitro compound
2-methyl-5-nitroimidazole	[no description available]	low	0	C-nitro compound; imidazoles
5-nitro-2-furaldehyde	[no description available]	low	0	C-nitro compound; furans
4-nitrophenyl acetate	[no description available]	low	0	C-nitro compound; phenyl acetates
methylparaoxon	[no description available]	low	0	C-nitro compound
dinobuton	[no description available]	low	0	C-nitro compound
pyrrolnitrin	[no description available]	low	0	alkaloid; C-nitro compound; monochlorobenzenes; pyrroles	antifungal drug; bacterial metabolite
dinoterb	[no description available]	low	0	C-nitro compound; phenols
2,4-dinitrothiocyanatobenzene	[no description available]	low	0	C-nitro compound; thiocyanates	hapten; tolerogen
n-methylamino-2-nitro-4-n',n'-bis(2-hydroxyethyl)aminobenzene	[no description available]	low	0	C-nitro compound
4-nitroimidazole	[no description available]	low	0	C-nitro compound; imidazoles
2-(alpha-thenoylamino)-2-nitro-5-thiazole	[no description available]	low	0	1,3-thiazoles; C-nitro compound
nitroxoline	[no description available]	low	0	C-nitro compound; monohydroxyquinoline	antifungal agent; antiinfective agent; antimicrobial agent; renal agent
1,2-epoxy-3-(p-nitrophenoxy)propane	[no description available]	low	0	aromatic ether; C-nitro compound; epoxide
nimorazole	[no description available]	low	0	C-nitro compound; imidazoles
4-chloro-7-nitrobenzofurazan	[no description available]	low	0	benzoxadiazole; C-nitro compound; organochlorine compound	EC 1.4.3.4 (monoamine oxidase) inhibitor; EC 3.6.1.3 (adenosinetriphosphatase) inhibitor; fluorescent probe; fluorochrome
ipronidazole	[no description available]	low	0	C-nitro compound; imidazoles
ornidazole	[no description available]	low	0	C-nitro compound; imidazoles; organochlorine compound; secondary alcohol	antiamoebic agent; antibacterial drug; antiinfective agent; antiprotozoal drug; antitrichomonal drug; epitope
benzonidazole	[no description available]	low	0	C-nitro compound; imidazoles; monocarboxylic acid amide	antiprotozoal drug
N-(3-methyl-1,1-dioxo-1,4-thiazinan-4-yl)-1-(5-nitro-2-furanyl)methanimine	[no description available]	low	0	C-nitro compound; furans
3-nitro-1-propanol	[no description available]	low	0	C-nitro compound
amoscanate	[no description available]	low	0	C-nitro compound; isothiocyanate; secondary amino compound	schistosomicide drug
hc blue no. 2	[no description available]	low	0	C-nitro compound
bromethalin	[no description available]	low	0	C-nitro compound
bmy 25067	[no description available]	low	0	C-nitro compound; organic disulfide	antineoplastic agent
2-Amino-5-(5-nitro-2-furyl)-1,3,4-thiadiazole	[no description available]	low	0	C-nitro compound; furans
musk xylene	[no description available]	low	0	C-nitro compound	carcinogenic agent; explosive; fragrance
4-nitrophenylalanine	[no description available]	low	0	C-nitro compound
4-nitrobenzyl bromide	[no description available]	low	0	benzyl bromides; C-nitro compound	allergen; sensitiser
5'-nitro-2'-propoxyacetanilide	[no description available]	low	0	aromatic ether; C-nitro compound
cinitapride	[no description available]	low	0	aromatic ether; C-nitro compound
5-nitrouracil	[no description available]	low	0	C-nitro compound
3-nitrobenzyl alcohol	[no description available]	low	0	C-nitro compound
4-nitrobenzyl alcohol	[no description available]	low	0	benzyl alcohols; C-nitro compound	xenobiotic metabolite
secnidazole	[no description available]	low	0	C-nitro compound; imidazoles; secondary alcohol	epitope
4-nitrophenyl palmitate	[no description available]	low	0	C-nitro compound; hexadecanoate ester
4-nitrophenyl butyrate	[no description available]	low	0	butyrate ester; C-nitro compound
2-nitrophenylacetic acid	[no description available]	low	0	C-nitro compound; phenylacetic acids
4-nitrophenyl sulfate	[no description available]	low	0	aryl sulfate; C-nitro compound	human metabolite
4-nitrophenyl-alpha-l-fucoside	[no description available]	low	0	alpha-L-fucoside; C-nitro compound	chromogenic compound
4-nitrophenylglucuronide	[no description available]	low	0	beta-D-glucosiduronic acid; C-nitro compound	chromogenic compound
chloramphenicol stearate	[no description available]	low	0	C-nitro compound
4,5-dimethoxy-2-nitrobenzaldehyde	[no description available]	low	0	aromatic ether; C-nitro compound
4-nitrophenyl beta-d-xyloside	[no description available]	low	0	C-nitro compound; xyloside	chromogenic compound
fluazinam	[no description available]	low	0	(trifluoromethyl)benzenes; aminopyridine; C-nitro compound; chloropyridine; monochlorobenzenes; secondary amino compound	allergen; antifungal agrochemical; apoptosis inducer; environmental contaminant; xenobiotic
2-nitropropanol	[no description available]	low	0	C-nitro compound
4-nitrophenyl beta-d-glucoside	[no description available]	low	0	beta-D-glucoside; C-nitro compound	chromogenic compound
4-nitrophenyl alpha-glucoside	[no description available]	low	0	alpha-D-glucoside; C-nitro compound; monosaccharide derivative	chromogenic compound
bnps-skatole	[no description available]	low	0	aryl sulfide; bromoindole; C-nitro compound	reagent
nitrophenylgalactosides	[no description available]	low	0	beta-D-galactoside; C-nitro compound	chromogenic compound
6-n-(2,4-dinitrophenyl)aminohexanoic acid	[no description available]	low	0	C-nitro compound
5-nitro-2-(1-piperidinyl)pyridine	[no description available]	low	0	C-nitro compound
s-(4-nitrobenzyl)glutathione	[no description available]	low	0	C-nitro compound; organic sulfide; S-substituted glutathione
4-nitrophenyl-2-acetamido-2-deoxy-beta-d-glucopyranoside	[no description available]	low	0	C-nitro compound; N-acetyl-beta-D-glucosaminide	chromogenic compound
miserotoxin	[no description available]	low	0	beta-D-glucoside; C-nitro compound	phytotoxin
aristolochic acid ii	[no description available]	low	0	aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound	carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin
nitisinone	[no description available]	low	0	(trifluoromethyl)benzenes; C-nitro compound; cyclohexanones; mesotrione	EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor
efonidipine	[no description available]	low	0	C-nitro compound; carboxylic ester; dihydropyridine; tertiary amino compound
1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole	[no description available]	low	0	C-nitro compound; imidazoles
pyrrolomycin a	[no description available]	low	0	antibiotic antifungal agent; C-nitro compound; organochlorine compound; pyrroles	antibacterial agent; bacterial metabolite
2,8-dinitroimipramine	[no description available]	low	0	C-nitro compound; dibenzoazepine; tertiary amino compound
7-nitrobenzoxadiazole-6-aminohexanoic acid	[no description available]	low	0	benzoxadiazole; C-nitro compound; epsilon-amino acid; secondary amino compound	fluorochrome
aristolochic acid D	[no description available]	low	0	aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound	carcinogenic agent; metabolite; nephrotoxin; toxin
ag 3-5	[no description available]	low	0	C-nitro compound
thymidine 5'-4-nitrophenyl phosphate	[no description available]	low	0	aryl phosphate; C-nitro compound; pyrimidine 2'-deoxyribonucleoside 5'-monophosphate
aristolochic acid c	[no description available]	low	0	aristolochic acids; aromatic ether; C-nitro compound; cyclic acetal; monocarboxylic acid; organic heterotetracyclic compound	carcinogenic agent; metabolite; mutagen; nephrotoxin; toxin
4-[4-(3-methyl-4-nitrophenoxy)butoxy]benzonitrile	[no description available]	low	0	aromatic ether; C-nitro compound
N-(4-nitrophenyl)-2-phenoxyacetamide	[no description available]	low	0	C-nitro compound
rubitecan	[no description available]	low	0	C-nitro compound; delta-lactone; pyranoindolizinoquinoline; semisynthetic derivative; tertiary alcohol	antineoplastic agent; EC 5.99.1.2 (DNA topoisomerase) inhibitor; prodrug
2-(3-nitrophenyl)-5-phenyl-1,3,4-oxadiazole	[no description available]	low	0	C-nitro compound
7-nitro-5-indeno[1,2-b]pyridinone	[no description available]	low	0	C-nitro compound
5-(4-nitrophenyl)-4-phenyl-2-thiazolamine	[no description available]	low	0	C-nitro compound
N1-(4H-1,2,4-triazol-4-yl)-4-nitrobenzamide	[no description available]	low	0	C-nitro compound
2-methoxy-4-[(4-methyl-1,4-diazepan-1-yl)methyl]-6-nitrophenol	[no description available]	low	0	aromatic ether; C-nitro compound
N-(6-methyl-2-pyridinyl)-5-nitro-2-furancarboxamide	[no description available]	low	0	C-nitro compound; furans
(3,5-dimethyl-1-pyrazolyl)-(2-ethyl-4-nitro-3-pyrazolyl)methanone	[no description available]	low	0	C-nitro compound
N-(4-methyl-2-pyridinyl)-5-nitro-2-furancarboxamide	[no description available]	low	0	C-nitro compound; furans
4,5-dimethyl-2-[4-(3-nitrophenyl)-2-thiazolyl]-1H-pyrazol-3-one	[no description available]	low	0	C-nitro compound
N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide	[no description available]	low	0	aromatic ether; C-nitro compound
N-[2-(4-fluorophenyl)ethyl]-4-nitrobenzamide	[no description available]	low	0	C-nitro compound
N-(2-fluoro-5-nitrophenyl)-2,2-dimethylbutanamide	[no description available]	low	0	C-nitro compound
3-(2-methoxyphenyl)-6-(3-nitrophenyl)-1,4-dihydropyrimidin-2-one	[no description available]	low	0	C-nitro compound
3-ethyl-6-(4-nitrophenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine	[no description available]	low	0	C-nitro compound
5-hydroxy-7-(4-nitrophenyl)-1,3-benzoxathiol-2-one	[no description available]	low	0	C-nitro compound
1-(3,4-dimethoxyphenyl)-3-(2-methoxy-5-nitrophenyl)urea	[no description available]	low	0	aromatic ether; C-nitro compound
N-(1-ethyl-2-benzimidazolyl)-5-[(4-methyl-2-nitrophenoxy)methyl]-2-furancarboxamide	[no description available]	low	0	aromatic ether; C-nitro compound
2-[[cyclohexyl(oxo)methyl]amino]-4-(3-nitrophenyl)-3-thiophenecarboxylic acid ethyl ester	[no description available]	low	0	C-nitro compound
1-(3-methoxy-5-nitrophenyl)-3-(4-methylphenyl)urea	[no description available]	low	0	aromatic ether; C-nitro compound
N-(5-tert-butyl-3-isoxazolyl)-3-nitrobenzamide	[no description available]	low	0	C-nitro compound
2-[[5-(4-nitrophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(2-pyridinyl)acetamide	[no description available]	low	0	C-nitro compound
N-(2-methyl-5-nitrophenyl)-4,6-bis(1-pyrrolidinyl)-1,3,5-triazin-2-amine	[no description available]	low	0	C-nitro compound
4-methoxy-N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]benzamide	[no description available]	low	0	C-nitro compound
4-methyl-2-(4-nitrophenyl)-5-thiazolecarboxylic acid	[no description available]	low	0	C-nitro compound
5-carbamoyl-4-methyl-2-[[(3-nitrophenyl)-oxomethyl]amino]-3-thiophenecarboxylic acid methyl ester	[no description available]	low	0	C-nitro compound
4-(3,5-dimethyl-4-nitro-1-pyrazolyl)butanoic acid	[no description available]	low	0	C-nitro compound
1-(3-fluorophenyl)-4-(4-hydroxy-3-methoxy-5-nitrophenyl)-4H-pyridine-3,5-dicarboxylic acid diethyl ester	[no description available]	low	0	aromatic ether; C-nitro compound
N-[5-(4-methoxyphenyl)-4-(4-nitrophenyl)-2-thiazolyl]-4-methylbenzamide	[no description available]	low	0	C-nitro compound
1,3-dimethyl-5-[[2-[2-(4-nitrophenoxy)ethoxy]phenyl]methylidene]-1,3-diazinane-2,4,6-trione	[no description available]	low	0	aromatic ether; C-nitro compound
stattic	[no description available]	low	0	1-benzothiophenes; C-nitro compound; sulfone	antineoplastic agent; radiosensitizing agent; STAT3 inhibitor
2-fluoro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]acetamide	[no description available]	low	0	aromatic ether; C-nitro compound
2-amino-4-(4,5-dimethoxy-2-nitrophenyl)-7,7-dimethyl-5-oxo-6,8-dihydro-4H-1-benzopyran-3-carbonitrile	[no description available]	low	0	aromatic ether; C-nitro compound
2,4-dichloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide	[no description available]	low	0	aromatic ether; C-nitro compound
N2-tert-butyl-6-ethoxy-N4-(4-nitrophenyl)-1,3,5-triazine-2,4-diamine	[no description available]	low	0	C-nitro compound
N-[4-methyl-5-[2-(3-nitroanilino)-4-thiazolyl]-2-thiazolyl]acetamide	[no description available]	low	0	C-nitro compound
2-methyl-N-[5-(4-nitrophenyl)sulfonyl-2-thiazolyl]pentanamide	[no description available]	low	0	C-nitro compound
N-[(2-ethyl-1-piperidinyl)-sulfanylidenemethyl]-4-nitrobenzamide	[no description available]	low	0	C-nitro compound
4-[[3-methoxy-4-[(4-nitrophenyl)methoxy]phenyl]-(3-methyl-5-oxo-1,2-dihydropyrazol-4-yl)methyl]-5-methyl-1,2-dihydropyrazol-3-one	[no description available]	low	0	C-nitro compound
N-(4-chloro-3-nitrophenyl)-3-phenylbutanamide	[no description available]	low	0	C-nitro compound
2-[(4-chlorophenyl)sulfonyl-methylamino]-N-(4-methoxy-2-nitrophenyl)acetamide	[no description available]	low	0	aromatic ether; C-nitro compound
1-(2-fluorophenyl)-3-(4-methoxy-2-nitrophenyl)urea	[no description available]	low	0	aromatic ether; C-nitro compound
5-(2-nitrophenyl)-N-(2-thiazolyl)-2-furancarboxamide	[no description available]	low	0	C-nitro compound
ranitidine	[no description available]	low	0	C-nitro compound; furans; organic sulfide; tertiary amino compound	anti-ulcer drug; drug allergen; environmental contaminant; H2-receptor antagonist; xenobiotic
carnidazole	[no description available]	low	0	C-nitro compound; imidazoles
3-chloro-N-[2,2,2-trichloro-1-[[(4-methoxy-2-nitroanilino)-sulfanylidenemethyl]amino]ethyl]benzamide	[no description available]	low	0	aromatic ether; C-nitro compound
N-methyl-5-nitro-N-(phenylmethyl)-2-furancarboxamide	[no description available]	low	0	C-nitro compound; furans
3-nitro-N'-(2,4,6-trichlorophenyl)benzohydrazide	[no description available]	low	0	C-nitro compound
2-(2,2-dimethyl-4-oxanyl)-4-(4-nitrophenyl)thiazole	[no description available]	low	0	C-nitro compound
5-methyl-N-(3-methylphenyl)-4-nitro-1H-pyrazol-3-amine	[no description available]	low	0	C-nitro compound
3-nitro-N-[(1-oxopentylhydrazo)-sulfanylidenemethyl]benzamide	[no description available]	low	0	C-nitro compound
N-[[[2-(2-methylphenoxy)-1-oxoethyl]hydrazo]-sulfanylidenemethyl]-2-nitrobenzamide	[no description available]	low	0	C-nitro compound
N-(4-fluorophenyl)-5-nitro-2-pyridinamine	[no description available]	low	0	C-nitro compound
2-(4-chlorophenoxy)-N-(5-nitro-2-thiazolyl)acetamide	[no description available]	low	0	C-nitro compound; thiazoles
3-methyl-4-nitro-N-(1H-1,2,4-triazol-5-yl)benzamide	[no description available]	low	0	C-nitro compound
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-(1-phenylethylamino)ethyl] ester	[no description available]	low	0	C-nitro compound; thiophenes
2-[(5-amino-1H-1,2,4-triazol-3-yl)thio]-N-(2-bromo-4-nitrophenyl)acetamide	[no description available]	low	0	C-nitro compound
4-nitrophenylhydrazine	[no description available]	low	0	C-nitro compound; phenylhydrazines	mutagen
4-(1-azepanyl)-6-hydrazinyl-N-(4-nitrophenyl)-1,3,5-triazin-2-amine	[no description available]	low	0	C-nitro compound
2-amino-7-methyl-4-(5-nitro-2-furanyl)-5-oxo-4H-pyrano[3,2-c]pyran-3-carbonitrile	[no description available]	low	0	C-nitro compound; furans
N4-(1,1-dioxo-3-thiolanyl)-5-nitropyrimidine-4,6-diamine	[no description available]	low	0	C-nitro compound
N4-(3-chlorophenyl)-N2-methyl-5-nitropyrimidine-2,4,6-triamine	[no description available]	low	0	C-nitro compound
4-nitrocatechol	[no description available]	low	0	C-nitro compound; catechols	human xenobiotic metabolite; lipoxygenase inhibitor
1-(1-naphthalenyl)-3-[[2-(2-nitrophenoxy)-1-oxoethyl]amino]urea	[no description available]	low	0	aromatic ether; C-nitro compound
nefurthiazole	[no description available]	low	0	C-nitro compound; furans
N-[5-(2,3-dihydro-1,4-dioxin-5-yl)-1,3,4-oxadiazol-2-yl]-5-nitro-2-thiophenecarboxamide	[no description available]	low	0	C-nitro compound; thiophenes
2-[(4-aminophenyl)thio]-N-(3-nitrophenyl)acetamide	[no description available]	low	0	C-nitro compound
3-[4-(2-hydroxyethylamino)-3-nitrophenyl]-4-methyl-4,5-dihydro-1H-pyridazin-6-one	[no description available]	low	0	C-nitro compound
2-[[6-amino-2-(3-methylanilino)-5-nitro-4-pyrimidinyl]amino]ethanol	[no description available]	low	0	C-nitro compound
N4-(3-fluorophenyl)-N2-[3-(4-morpholinyl)propyl]-5-nitropyrimidine-2,4,6-triamine	[no description available]	low	0	C-nitro compound
3-nitro-N-(2-phenylethyl)-2-pyridinamine	[no description available]	low	0	C-nitro compound
2-(4-nitrophenyl)-4-thiazolecarboxylic acid ethyl ester	[no description available]	low	0	C-nitro compound
N-(4-bromophenyl)-5-methyl-4-nitro-1H-pyrazol-3-amine	[no description available]	low	0	C-nitro compound
2,4-dinitrophenylhydrazine	[no description available]	low	0	C-nitro compound; phenylhydrazines	reagent
3-methyl-N-[[[(4-nitrophenyl)-oxomethyl]hydrazo]-sulfanylidenemethyl]butanamide	[no description available]	low	0	C-nitro compound
5-methyl-2-[[(4-nitrophenyl)-oxomethyl]hydrazo]-4-thiazolecarboxylic acid ethyl ester	[no description available]	low	0	C-nitro compound
N-(2-chlorophenyl)-4-[[(2-methoxy-4-nitroanilino)-sulfanylidenemethyl]hydrazo]-4-oxobutanamide	[no description available]	low	0	aromatic ether; C-nitro compound
5-nitro-2-thiophenecarboxylic acid [1-[(3,5-dichloro-2-pyridinyl)amino]-1-oxopropan-2-yl] ester	[no description available]	low	0	C-nitro compound; thiophenes
N-[2-[(4-methyl-1,2,5-oxadiazol-3-yl)oxy]ethyl]-4-nitroaniline	[no description available]	low	0	C-nitro compound
4-nitrocaramiphen	[no description available]	low	0	C-nitro compound
4-[(3-methyl-5-nitro-4-imidazolyl)amino]phenol	[no description available]	low	0	C-nitro compound; imidazoles
N-(2-methoxy-4-nitrophenyl)-2-[(1-methyl-2-imidazolyl)thio]acetamide	[no description available]	low	0	aromatic ether; C-nitro compound
N2-(3-methylphenyl)-6-(4-morpholinyl)-5-nitropyrimidine-2,4-diamine	[no description available]	low	0	C-nitro compound
sb 415286	[no description available]	low	0	C-nitro compound; maleimides; monochlorobenzenes; phenols; secondary amino compound; substituted aniline	antioxidant; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; neuroprotective agent
N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide	[no description available]	low	0	C-nitro compound; secondary carboxamide; tertiary carboxamide; trifluoroacetamide
2-[[6-amino-2-[3-(dimethylamino)propylamino]-5-nitro-4-pyrimidinyl]amino]ethanol	[no description available]	low	0	C-nitro compound
4-(3-chlorophenyl)sulfonyl-N-cyclohexyl-N-methyl-3-nitrobenzamide	[no description available]	low	0	C-nitro compound
6-(2-methyl-1-piperidinyl)-5-nitro-4-pyrimidinamine	[no description available]	low	0	C-nitro compound
1-(5-nitro-2-thiophenyl)piperidine	[no description available]	low	0	C-nitro compound; thiophenes
N-[2-(2,4,6-trinitrophenyl)ethyl]aniline	[no description available]	low	0	C-nitro compound
2-nitro-4-phenylenediamine	[no description available]	low	0	C-nitro compound; primary amino compound
N2-(2-furanylmethyl)-5-nitro-6-(1-pyrrolidinyl)pyrimidine-2,4-diamine	[no description available]	low	0	C-nitro compound
1-(2,5-dimethyl-1-prop-2-enyl-3-pyrrolyl)-2-[(6-methyl-2-nitro-3-pyridinyl)oxy]ethanone	[no description available]	low	0	C-nitro compound
N-(2-bromo-4-nitrophenyl)-2-[(5-propan-2-yl-1H-1,2,4-triazol-3-yl)thio]acetamide	[no description available]	low	0	C-nitro compound
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester	[no description available]	low	0	C-nitro compound; thiophenes
2-(2,3-dihydroxypropylamino)-5-nitro-3-pyridinecarbonitrile	[no description available]	low	0	C-nitro compound
2-[(2-nitrophenyl)thio]-1-cyclooctanone	[no description available]	low	0	C-nitro compound
5-nitro-2-thiophenecarboxylic acid [2-oxo-2-[[oxo-[(phenylmethyl)amino]methyl]amino]ethyl] ester	[no description available]	low	0	C-nitro compound; thiophenes
N2-(2-furanylmethyl)-6-(3-methyl-1-piperidinyl)-5-nitropyrimidine-2,4-diamine	[no description available]	low	0	C-nitro compound
N'-(4-nitrophenyl)-9-oxo-3-bicyclo[3.3.1]nonanecarbohydrazide	[no description available]	low	0	C-nitro compound
alsterpaullone	[no description available]	low	0	C-nitro compound; caprolactams; organic heterotetracyclic compound	anti-HIV-1 agent; antineoplastic agent; apoptosis inducer; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; EC 2.7.11.26 (tau-protein kinase) inhibitor
2-(4-fluoro-3-nitrophenyl)-4,4-dimethyl-5H-oxazole	[no description available]	low	0	C-nitro compound
1,2-diamino-4-nitrobenzene	[no description available]	low	0	C-nitro compound; primary amino compound
N'-[2-[(4-methyl-1,2,4-triazol-3-yl)sulfanyl]acetyl]-4-nitrobenzohydrazide	[no description available]	low	0	C-nitro compound
furylfuramide	[no description available]	low	0	acrylamides; C-nitro compound; nitrofuran antibiotic; primary carboxamide
cilnidipine	[no description available]	low	0	2-methoxyethyl ester; C-nitro compound; dihydropyridine	antihypertensive agent; calcium channel blocker; cardiovascular drug
ro 61-8048	[no description available]	low	0	C-nitro compound
meptyldinocap	[no description available]	low	0	C-nitro compound; enoate ester
l796778	[no description available]	low	0	benzenes; C-nitro compound; L-lysine derivative; L-phenylalanine derivative; methyl ester; oligopeptide; secondary carboxamide; ureas	somatostatin receptor agonist
amocarzine	[no description available]	low	0	C-nitro compound; N-methylpiperazine; secondary amino compound; thioureas	antinematodal drug
nitrovin	[no description available]	low	0	C-nitro compound; furans
dihydroxymethylfuratrizine	[no description available]	low	0	C-nitro compound; furans
nifurpirinol	[no description available]	low	0	C-nitro compound; furans
azanidazole	[no description available]	low	0	C-nitro compound; imidazoles
aureothin	[no description available]	low	0	4-pyranones; C-nitro compound; ketene acetal; olefinic compound; oxolanes	antibacterial agent; antifungal agent; antineoplastic agent; antiparasitic agent; bacterial metabolite; EC 1.6.5.3 [NADH:ubiquinone reductase (H(+)-translocating)] inhibitor
nidroxyzone	[no description available]	low	0	C-nitro compound; furans
nifurzide	[no description available]	low	0	C-nitro compound; thiophenes
abt-737	[no description available]	low	0	aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound	anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor
5-(5-nitrothiazol-2-ylthio)-1,3,4-thiadiazol-2-amine	[no description available]	low	0	1,3-thiazoles; C-nitro compound; organic sulfide; primary amino compound; thiadiazoles	antibacterial agent; c-Jun N-terminal kinase inhibitor
[4-(2-chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone	[no description available]	low	0	C-nitro compound
2-[[5-(2-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-(2-nitrophenyl)acetamide	[no description available]	low	0	C-nitro compound
2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate	[no description available]	low	0	C-nitro compound; spiroketal	antagonist
2-(4-morpholinyl)-N'-[(2-nitrophenyl)-oxomethyl]-4-thiazolecarbohydrazide	[no description available]	low	0	C-nitro compound
N'-[(2-methyl-3-nitrophenyl)-oxomethyl]-2-(4-morpholinyl)-4-thiazolecarbohydrazide	[no description available]	low	0	C-nitro compound
ML-210	[no description available]	low	0	C-nitro compound; diarylmethane; isoxazoles; monochlorobenzenes; N-acylpiperazine; N-alkylpiperazine; tertiary carboxamide	antineoplastic agent; EC 1.11.1.9 (glutathione peroxidase) inhibitor; ferroptosis inducer; prodrug
abt-199	[no description available]	low	0	aromatic ether; C-nitro compound; monochlorobenzenes; N-alkylpiperazine; N-arylpiperazine; N-sulfonylcarboxamide; oxanes; pyrrolopyridine	antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor
chir 98014	[no description available]	low	0	aminopyrimidine; C-nitro compound; diaminopyridine; dichlorobenzene; imidazoles; secondary amino compound	antineoplastic agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; hypoglycemic agent; tau aggregation inhibitor; Wnt signalling activator
acenocoumarol	[no description available]	low	0	C-nitro compound; hydroxycoumarin; methyl ketone	anticoagulant; EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor
8-nitroguanosine 3',5'-cyclic monophosphate	[no description available]	low	0	3',5'-cyclic purine nucleotide; C-nitro compound	biomarker; Brassica napus metabolite; human metabolite; signalling molecule
pd 173074	[no description available]	low	0	aromatic amine; biaryl; dimethoxybenzene; pyridopyrimidine; tertiary amino compound; ureas	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; fibroblast growth factor receptor antagonist
4-aminopyridine	[no description available]	low	0	aminopyridine; aromatic amine	avicide; orphan drug; potassium channel blocker
5-(n,n-hexamethylene)amiloride	[no description available]	low	0	aromatic amine; azepanes; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines	antineoplastic agent; apoptosis inducer; odorant receptor antagonist; sodium channel blocker
ethylisopropylamiloride	[no description available]	low	0	aromatic amine; guanidines; monocarboxylic acid amide; organochlorine compound; pyrazines; tertiary amino compound	anti-arrhythmia drug; neuroprotective agent; sodium channel blocker
tacrine	[no description available]	low	0	acridines; aromatic amine	EC 3.1.1.7 (acetylcholinesterase) inhibitor
tyrphostin ag957	[no description available]	low	0	aromatic amine
ambroxol	[no description available]	low	0	aromatic amine
dan 2163	[no description available]	low	0	aromatic amide; aromatic amine; benzamides; pyrrolidines; sulfone	environmental contaminant; second generation antipsychotic; xenobiotic
antazoline	[no description available]	low	0	aromatic amine; imidazolines; tertiary amino compound	cholinergic antagonist; H1-receptor antagonist; xenobiotic
cgs 15943	[no description available]	low	0	aromatic amine; biaryl; furans; organochlorine compound; primary amino compound; quinazolines; triazoloquinazoline	adenosine A1 receptor antagonist; adenosine A2A receptor antagonist; antineoplastic agent; central nervous system stimulant
chlorambucil	[no description available]	low	0	aromatic amine; monocarboxylic acid; nitrogen mustard; organochlorine compound; tertiary amino compound	alkylating agent; antineoplastic agent; carcinogenic agent; drug allergen; immunosuppressive agent
diclofenac	[no description available]	low	0	amino acid; aromatic amine; dichlorobenzene; monocarboxylic acid; secondary amino compound	antipyretic; drug allergen; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
doxazosin	[no description available]	low	0	aromatic amine; benzodioxine; monocarboxylic acid amide; N-acylpiperazine; N-arylpiperazine; quinazolines	alpha-adrenergic antagonist; antihyperplasia drug; antihypertensive agent; antineoplastic agent; vasodilator agent
isothipendyl	[no description available]	low	0	aromatic amine; tertiary amino compound
lavendustin a	[no description available]	low	0	aromatic amine
2-hydroxy-5-(2,5-dihydrobenzyl)aminobenzoic acid	[no description available]	low	0	aromatic amine
6-anilino-5,8-quinolinedione	[no description available]	low	0	aminoquinoline; aromatic amine; p-quinones; quinolone	antineoplastic agent; EC 4.6.1.2 (guanylate cyclase) inhibitor
mafenide	[no description available]	low	0	aromatic amine
mesalamine	[no description available]	low	0	amino acid; aromatic amine; monocarboxylic acid; monohydroxybenzoic acid; phenols	non-steroidal anti-inflammatory drug
pargyline	[no description available]	low	0	aromatic amine
pd 153035	[no description available]	low	0	aromatic amine; aromatic ether; bromobenzenes; quinazolines; secondary amino compound	EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; epidermal growth factor receptor antagonist
pd 158780	[no description available]	low	0	aromatic amine; bromobenzenes; diamine; pyridopyrimidine; secondary amino compound	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
pd 98059	[no description available]	low	0	aromatic amine; monomethoxyflavone	EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector
phenoxybenzamine	[no description available]	low	0	aromatic amine
ag 1879	[no description available]	low	0	aromatic amine; monochlorobenzenes; pyrazolopyrimidine	beta-adrenergic antagonist; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector
imatinib	[no description available]	low	0	aromatic amine; benzamides; N-methylpiperazine; pyridines; pyrimidines	antineoplastic agent; apoptosis inducer; tyrosine kinase inhibitor
tripelennamine	[no description available]	low	0	aromatic amine
4-aminodiphenylamine	[no description available]	low	0	aromatic amine; secondary amino compound	allergen
4,4'-diaminodiphenylmethane	[no description available]	low	0	aromatic amine	allergen; carcinogenic agent
dibenzylamine	[no description available]	low	0	aromatic amine
benzoquinonium	[no description available]	low	0	aromatic amine
N-[(2-chlorophenyl)methyl]-1-[4-[[(2-chlorophenyl)methylamino]methyl]cyclohexyl]methanamine	[no description available]	low	0	aromatic amine
neutral red base	[no description available]	low	0	aromatic amine; phenazines; primary amino compound; tertiary amino compound	acid-base indicator; dye; two-colour indicator
diphenylamine	[no description available]	low	0	aromatic amine; bridged diphenyl fungicide; secondary amino compound	antifungal agrochemical; antioxidant; carotogenesis inhibitor; EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor; ferroptosis inhibitor; radical scavenger
prothipendyl	[no description available]	low	0	aromatic amine; tertiary amino compound
guanazole	[no description available]	low	0	aromatic amine; triazoles	antineoplastic agent; DNA synthesis inhibitor; EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor
amiloride	[no description available]	low	0	aromatic amine; guanidines; organochlorine compound; pyrazines	diuretic; sodium channel blocker
6-aminonicotinic acid	[no description available]	low	0	aminonicotinic acid; aminopyridine; aromatic amine	metabolite
trimetazidine	[no description available]	low	0	aromatic amine
2-amino-3,8-dimethylimidazo(4,5-f)quinoxaline	[no description available]	low	0	aromatic amine; imidazoquinoxaline	carcinogenic agent; genotoxin; Maillard reaction product; mutagen
acridine orange	[no description available]	low	0	aminoacridines; aromatic amine; tertiary amino compound	fluorochrome; histological dye
nile red	[no description available]	low	0	aromatic amine; cyclic ketone; organic heterotetracyclic compound; tertiary amino compound	fluorochrome; histological dye
4-(diethylamino)benzaldehyde	[no description available]	low	0	aromatic amine; benzaldehydes; tertiary amino compound	EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor
dibenzthione	[no description available]	low	0	aromatic amine
8-azaadenine	[no description available]	low	0	aromatic amine; nucleobase analogue; triazolopyrimidines	EC 1.17.3.2 (xanthine oxidase) inhibitor; Mycoplasma genitalium metabolite
lamtidine	[no description available]	low	0	aromatic amine
bamipine	[no description available]	low	0	aromatic amine
methyl 3-aminopyrazine-2-carboxylate	[no description available]	low	0	aromatic amine; methyl ester; pyrazines
p-Aminosalicylic acid methyl ester	[no description available]	low	0	aromatic amine
trimetazidine dihydrochloride	[no description available]	low	0	aromatic amine
phenylisopropyladenosine	[no description available]	low	0	aromatic amine; benzenes; hydrocarbyladenosine; purine nucleoside; secondary amino compound	adenosine A1 receptor agonist; neuroprotective agent
4-hydroxybenzylamine	[no description available]	low	0	aromatic amine
pomalidomide	[no description available]	low	0	aromatic amine; dicarboximide; isoindoles; piperidones	angiogenesis inhibitor; antineoplastic agent; immunomodulator
hydromethylthionine	[no description available]	low	0	aromatic amine; phenothiazines; tertiary amino compound	bacterial xenobiotic metabolite; fluorochrome; mouse metabolite; rat metabolite
8-amino-8-demethylriboflavin	[no description available]	low	0	aromatic amine; benzopteridine; primary amino compound; tetrol
lenalidomide	[no description available]	low	0	aromatic amine; dicarboximide; isoindoles; piperidones	angiogenesis inhibitor; antineoplastic agent; immunomodulator
5-aminonicotinic acid	[no description available]	low	0	aminonicotinic acid; aminopyridine; aromatic amine	metabolite
1-[4-[4-[(4-methylphenyl)methylamino]phenyl]-1-piperazinyl]ethanone	[no description available]	low	0	aromatic amine
4-[2-[[4-(dimethylamino)phenyl]methylamino]ethyl]-2,2-dimethyl-4-oxanol	[no description available]	low	0	aromatic amine
1-[4-[4-[(phenylmethyl)amino]phenyl]-1-piperazinyl]ethanone	[no description available]	low	0	aromatic amine
7-(2-methyl-2,3-dihydroindol-1-yl)-3-(phenylmethyl)triazolo[4,5-d]pyrimidine	[no description available]	low	0	aromatic amine; tertiary amino compound
1-(4-chlorophenyl)-N-(2-furanylmethyl)-N-[[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]methanamine	[no description available]	low	0	aromatic amine
N-[(1-cyclohexyl-5-tetrazolyl)-thiophen-2-ylmethyl]-N-(phenylmethyl)ethanamine	[no description available]	low	0	aromatic amine
5-[[4-(2-amino-2-oxoethoxy)-3-methoxyphenyl]methylamino]-2-(4-morpholinyl)benzoic acid	[no description available]	low	0	aromatic amine
5-(2-phenylethyl)-1,3,4-thiadiazol-2-amine	[no description available]	low	0	aromatic amine; thiadiazoles
iFSP1	[no description available]	low	0	aromatic amine; nitrile; primary amino compound; pyridobenzimidazole; toluenes	antineoplastic agent; ferroptosis inducer; ferroptosis suppressor protein 1 inhibitor
N-(3-fluorophenyl)-2-(pyridin-4-yl)quinazolin-4-amine	[no description available]	low	0	aromatic amine; monofluorobenzenes; pyridines; quinazolines; secondary amino compound; substituted aniline
2-amino-4-(cyanomethyl)-6-(N-methylanilino)pyridine-3,5-dicarbonitrile	[no description available]	low	0	aromatic amine; tertiary amino compound
5-amino-3-(4-methoxyphenyl)-7-methyl-4-oxo-1-thieno[3,4-d]pyridazinecarboxylic acid methyl ester	[no description available]	low	0	aromatic amine; thiophenes
4-[bis(phenylmethyl)amino]-2-(dimethylamino)-3-pyridinecarbonitrile	[no description available]	low	0	aromatic amine
2-[(3-fluorophenyl)methyl-(phenylmethyl)amino]ethanol	[no description available]	low	0	aromatic amine
2-methoxy-4-[[2-(methylthio)anilino]methyl]phenol	[no description available]	low	0	aromatic amine
1-(4-ethylphenyl)-N-(3-pyridinylmethyl)methanamine	[no description available]	low	0	aromatic amine
N-[(2,3-dimethoxyphenyl)methyl]-4-(4-methyl-1-piperidinyl)aniline	[no description available]	low	0	aromatic amine
2-amino-5-[diethylamino(oxo)methyl]-4-methyl-3-thiophenecarboxylic acid propan-2-yl ester	[no description available]	low	0	aromatic amine; isopropyl ester; tertiary carboxamide; thiophenes
4-(2,3-dihydro-1H-indol-1-yl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine	[no description available]	low	0	aromatic amine; tertiary amino compound
N-[(2-methoxyphenyl)methyl]-4-(1-piperidinyl)aniline	[no description available]	low	0	aromatic amine
4-[methyl-(4-thiophen-2-yl-2-thiazolyl)amino]phenol	[no description available]	low	0	aromatic amine; tertiary amino compound
N-[(3-bromo-4,5-diethoxyphenyl)methyl]-4-(4-morpholinyl)aniline	[no description available]	low	0	aromatic amine
4-[[5-chloro-2-[(4-fluorophenyl)methoxy]phenyl]methylamino]benzenesulfonamide	[no description available]	low	0	aromatic amine
2-[[2-[(2-fluorophenyl)methoxy]-3-methoxyphenyl]methylamino]phenol	[no description available]	low	0	aromatic amine
1-(4-acetyl-3,5-dimethyl-1H-pyrrol-2-yl)-2-[[4-(difluoromethoxy)-3-methoxyphenyl]methyl-methylamino]ethanone	[no description available]	low	0	aromatic amine
(3-hydroxyphenyl)-[4-(phenylmethyl)-1-piperazinyl]methanethione	[no description available]	low	0	aromatic amine
N-[4-[(3-bromo-5-methoxy-4-prop-2-enoxyphenyl)methylamino]-2-methoxyphenyl]-2-methylpropanamide	[no description available]	low	0	aromatic amine
2-chloro-N-[4-(N-propan-2-ylanilino)phenyl]acetamide	[no description available]	low	0	aromatic amine; tertiary amino compound
6-[[(2-chlorophenyl)methyl-methylamino]methyl]-N2-(2-methylphenyl)-1,3,5-triazine-2,4-diamine	[no description available]	low	0	aromatic amine
2-chloro-1-[4-[(3-methylphenyl)methyl]-1-piperazinyl]ethanone	[no description available]	low	0	aromatic amine
N-{3-[(2-phenylquinazolin-4-yl)amino]phenyl}acetamide	[no description available]	low	0	acetamide; aromatic amine; quinazolines; secondary amino compound; substituted aniline
1-(Benzylamino)-3-(3,4-dimethylphenoxy)propan-2-ol	[no description available]	low	0	aromatic amine
3-(4-ethyl-1-piperazinyl)-5-methylpyridazino[3,4-b][1,4]benzoxazine	[no description available]	low	0	aromatic amine; tertiary amino compound
5-amino-3-[[[1-(2-furanylmethyl)-5-oxo-3-pyrrolidinyl]-oxomethoxy]methyl]thiophene-2,4-dicarboxylic acid dimethyl ester	[no description available]	low	0	aromatic amine; thiophenes
1-(1-tert-butyl-5-tetrazolyl)-N-(phenylmethyl)-1-(3-pyridinyl)-N-(thiophen-2-ylmethyl)methanamine	[no description available]	low	0	aromatic amine
3-[[4,6-bis(4-morpholinyl)-1,3,5-triazin-2-yl]amino]-3-(2-chlorophenyl)propanoic acid ethyl ester	[no description available]	low	0	1,3,5-triazines; aromatic amine
2-(N-ethylanilino)-4-thieno[3,2-d][1,3]thiazinone	[no description available]	low	0	aromatic amine; tertiary amino compound
N4-ethyl-N6,1,2-trimethyl-N4-phenylpyrimidin-1-ium-4,6-diamine	[no description available]	low	0	aromatic amine; tertiary amino compound
N-(3-{[2-(2-fluorophenyl)quinazolin-4-yl]amino}phenyl)acetamide	[no description available]	low	0	acetamide; aromatic amine; monofluorobenzenes; quinazolines; secondary amino compound; substituted aniline
N-(1-benzylpiperidin-4-yl)-2-(pyridin-3-yl)quinazolin-4-amine	[no description available]	low	0	aromatic amine; piperidines; pyridines; quinazolines; secondary amino compound; tertiary amino compound
5-nitro-2-[(phenylmethyl)amino]benzoic acid [2-(cyclohexylamino)-2-oxoethyl] ester	[no description available]	low	0	aromatic amine
GSK3-XIII	[no description available]	low	0	aromatic amine; pyrazoles; quinazolines; secondary amino compound	EC 2.7.11.26 (tau-protein kinase) inhibitor
b 43	[no description available]	low	0	aromatic amine; aromatic ether; cyclopentanes; primary amino compound; pyrrolopyrimidine	EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; geroprotector
2-(1-adamantyl)-4-chloro-5-[(4-fluorophenyl)methylamino]-3-pyridazinone	[no description available]	low	0	aromatic amine
1-cyclohexyl-3-[1-[4-(phenylmethyl)-1-piperazinyl]-1-thiophen-2-ylpropan-2-yl]urea	[no description available]	low	0	aromatic amine
r 115866	[no description available]	low	0	aromatic amine; benzothiazoles; secondary amino compound; triazoles
nsc 716970	[no description available]	low	0	aromatic amine; aromatic ether; indolecarboxamide; organochlorine compound	antineoplastic agent
n-methylbenzylamine hydrochloride	[no description available]	low	0	aromatic amine
pi103	[no description available]	low	0	aromatic amine; morpholines; organic heterotricyclic compound; phenols; tertiary amino compound	antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor
selexipag	[no description available]	low	0	aromatic amine; ether; monocarboxylic acid amide; N-sulfonylcarboxamide; pyrazines; tertiary amino compound	orphan drug; platelet aggregation inhibitor; prodrug; prostacyclin receptor agonist; vasodilator agent
sch 51344	[no description available]	low	0	aromatic amine; aromatic ether; primary alcohol; pyrazoloquinoline; secondary amino compound	antineoplastic agent
ageladine a	[no description available]	low	0	alkaloid; aromatic amine; imidazopyridine; organobromine compound; pyrroles	angiogenesis inhibitor; antineoplastic agent; matrix metalloproteinase inhibitor; metabolite
4-aminopyridine-3-methanol	[no description available]	low	0	aminopyridine; aromatic amine; aromatic primary alcohol	potassium channel blocker
8,5'-cyclo-2'-deoxyadenosine	[no description available]	low	0	aromatic amine; bridged compound; diol; N-glycosyl compound; organic heterotetracyclic compound	Mycoplasma genitalium metabolite
ethaboxam	[no description available]	low	0	1,3-thiazoles; aromatic amide; aromatic amine; nitrile; secondary amino compound; thiophenes
abt 869	[no description available]	low	0	aromatic amine; indazoles; phenylureas	angiogenesis inhibitor; antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
gw9508	[no description available]	low	0	aromatic amine
idelalisib	[no description available]	low	0	aromatic amine; organofluorine compound; purines; quinazolines; secondary amino compound	antineoplastic agent; apoptosis inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
trametinib	[no description available]	low	0	acetamides; aromatic amine; cyclopropanes; organofluorine compound; organoiodine compound; pyridopyrimidine; ring assembly	anticoronaviral agent; antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor; geroprotector
ametoctradin	[no description available]	low	0	aromatic amine; triazolopyrimidines	antifungal agrochemical; mitochondrial cytochrome-bc1 complex inhibitor
vizamyl	[no description available]	low	0	(18)F radiopharmaceutical; aromatic amine; benzothiazoles; secondary amino compound	radioactive imaging agent
2-[(2-chloro-4-nitroanilino)methyl]-6-methoxyphenol	[no description available]	low	0	aromatic amine
[(2S,4S)-4-(4-bromophenyl)-2-[[4-(hydroxymethyl)phenyl]methoxy]-3,4-dihydro-2H-pyran-6-yl]-[4-(phenylmethyl)-1-piperazinyl]methanone	[no description available]	low	0	aromatic amine
pamapimod	[no description available]	low	0	aromatic amine; aromatic ether; difluorobenzene; diol; primary alcohol; pyridopyrimidine; secondary amino compound	antirheumatic drug; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
gdc-0973	[no description available]	low	0	aromatic amine; difluorobenzene; N-acylazetidine; organoiodine compound; piperidines; secondary amino compound; tertiary alcohol	antineoplastic agent; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
gsk690693	[no description available]	low	0	1,2,5-oxadiazole; acetylenic compound; aromatic amine; aromatic ether; imidazopyridine; piperidines; primary amino compound; tertiary alcohol	antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
3-[[2-(4-bromophenyl)-1-oxoethyl]amino]-3-[4-[(4-fluorophenyl)methylamino]-3-nitrophenyl]propanamide	[no description available]	low	0	aromatic amine
2-[4-[(4-cyclopentyloxyphenyl)methyl]-1-propan-2-yl-2-piperazinyl]ethanol	[no description available]	low	0	aromatic amine
pci 32765	[no description available]	low	0	acrylamides; aromatic amine; aromatic ether; N-acylpiperidine; pyrazolopyrimidine; tertiary carboxamide	antineoplastic agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
PP121	[no description available]	low	0	aromatic amine; cyclopentanes; pyrazolopyrimidine; pyrrolopyridine	antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; tyrosine kinase inhibitor
asp3026	[no description available]	low	0	aromatic amine; diamino-1,3,5-triazine; monomethoxybenzene; N-methylpiperazine; piperidines; secondary amino compound; sulfone	antimalarial; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; EC 6.1.1.6 (lysine--tRNA ligase) inhibitor
1-[4-[4-[(3-methylphenyl)methylamino]phenyl]-1-piperazinyl]ethanone	[no description available]	low	0	aromatic amine
mrt67307	[no description available]	low	0	aromatic amine
GS-441524	[no description available]	low	0	aromatic amine; C-nucleoside; nitrile; pyrrolotriazine	anticoronaviral agent; antiviral agent; drug metabolite
lrrk2-in1	[no description available]	low	0	aromatic amine; aromatic ether; N-acylpiperidine; N-alkylpiperazine; pyrimidobenzodiazepine; secondary amino compound; tertiary amino compound	antineoplastic agent; EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
gilteritinib	[no description available]	low	0	aromatic amine; monomethoxybenzene; N-methylpiperazine; oxanes; piperidines; primary carboxamide; pyrazines; secondary amino compound	antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
ML240	[no description available]	low	0	aromatic amine; aromatic ether; benzimidazoles; primary amino compound; quinazolines; secondary amino compound	antineoplastic agent
GS-443902	[no description available]	low	0	aromatic amine; C-nucleoside; nitrile; organic triphosphate; pyrrolotriazine	anticoronaviral agent; antiviral drug; drug metabolite
acp-196	[no description available]	low	0	aromatic amine; benzamides; imidazopyrazine; pyridines; pyrrolidinecarboxamide; secondary carboxamide; tertiary carboxamide; ynone	antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
ly3009120	[no description available]	low	0	aminotoluene; aromatic amine; biaryl; monofluorobenzenes; phenylureas; pyridopyrimidine; secondary amino compound	antineoplastic agent; apoptosis inducer; autophagy inducer; B-Raf inhibitor; necroptosis inhibitor
enasidenib	[no description available]	low	0	1,3,5-triazines; aminopyridine; aromatic amine; organofluorine compound; secondary amino compound; tertiary alcohol	antineoplastic agent; EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
s 8932	[no description available]	low	0	aromatic amine; C-nucleoside; carboxylic ester; nitrile; phosphoramidate ester; pyrrolotriazine	anticoronaviral agent; antiviral drug; prodrug
can 508	[no description available]	low	0	aromatic amine; monoazo compound; phenols; pyrazoles	angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
tirapazamine	[no description available]	low	0	aromatic amine; benzotriazines; N-oxide	antibacterial agent; antineoplastic agent; apoptosis inducer
pp242	[no description available]	low	0	aromatic amine; biaryl; hydroxyindoles; phenols; primary amino compound; pyrazolopyrimidine	antineoplastic agent; mTOR inhibitor
8,5'-cyclo-2'-deoxyguanosine	[no description available]	low	0	aromatic amine; bridged compound; diol; N-glycosyl compound; organic heterotetracyclic compound	Mycoplasma genitalium metabolite
quinacrine	[no description available]	low	0	acridines; aromatic ether; organochlorine compound; tertiary amino compound	antimalarial; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
8-hydroxy-2-(di-n-propylamino)tetralin	[no description available]	low	0	phenols; tertiary amino compound; tetralins	serotonergic antagonist
sk&f 77434	[no description available]	low	0	benzazepine; catechols; tertiary amino compound	dopamine agonist
methylbufotenin	[no description available]	low	0	aromatic ether; tertiary amino compound; tryptamine alkaloid	hallucinogen; plant metabolite
ro 48-8071	[no description available]	low	0	aromatic ether; aromatic ketone; bromobenzenes; monofluorobenzenes; olefinic compound; tertiary amino compound	antineoplastic agent; EC 5.4.99.7 (lanosterol synthase) inhibitor
amiodarone	[no description available]	low	0	1-benzofurans; aromatic ketone; organoiodine compound; tertiary amino compound	cardiovascular drug
amodiaquine	[no description available]	low	0	aminoquinoline; organochlorine compound; phenols; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; drug allergen; EC 2.1.1.8 (histamine N-methyltransferase) inhibitor; non-steroidal anti-inflammatory drug; prodrug
azelastine	[no description available]	low	0	monochlorobenzenes; phthalazines; tertiary amino compound	anti-allergic agent; anti-asthmatic drug; bronchodilator agent; EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor; H1-receptor antagonist; platelet aggregation inhibitor
biperiden	[no description available]	low	0	piperidines; tertiary alcohol; tertiary amino compound	antidote to sarin poisoning; antidyskinesia agent; antiparkinson drug; muscarinic antagonist; parasympatholytic
bromhexine	[no description available]	low	0	organobromine compound; substituted aniline; tertiary amino compound	mucolytic
bromodiphenhydramine	[no description available]	low	0	organobromine compound; tertiary amino compound	antimicrobial agent; H1-receptor antagonist; muscarinic antagonist
bupivacaine	[no description available]	low	0	aromatic amide; piperidinecarboxamide; tertiary amino compound
carbinoxamine	[no description available]	low	0	monochlorobenzenes; pyridines; tertiary amino compound	anti-allergic agent; antiparkinson drug; H1-receptor antagonist; muscarinic antagonist
chlorpheniramine	[no description available]	low	0	monochlorobenzenes; pyridines; tertiary amino compound	anti-allergic agent; antidepressant; antipruritic drug; H1-receptor antagonist; histamine antagonist; serotonin uptake inhibitor
citalopram	[no description available]	low	0	2-benzofurans; cyclic ether; nitrile; organofluorine compound; tertiary amino compound
clofedanol	[no description available]	low	0	diarylmethane; tertiary amino compound	antitussive
cyclopentolate	[no description available]	low	0	carboxylic ester; tertiary alcohol; tertiary amino compound	diagnostic agent; muscarinic antagonist; mydriatic agent; parasympatholytic
cycrimine	[no description available]	low	0	piperidines; tertiary alcohol; tertiary amino compound	antidyskinesia agent; antiparkinson drug; muscarinic antagonist
dibucaine	[no description available]	low	0	aromatic ether; monocarboxylic acid amide; tertiary amino compound	topical anaesthetic
dilacor xr	[no description available]	low	0	acetate ester; aromatic ether; benzothiazepine; lactam; tertiary amino compound
diphenhydramine	[no description available]	low	0	ether; tertiary amino compound	anti-allergic agent; antidyskinesia agent; antiemetic; antiparkinson drug; antipruritic drug; antitussive; H1-receptor antagonist; local anaesthetic; muscarinic antagonist; oneirogen; sedative
dipyridamole	[no description available]	low	0	piperidines; pyrimidopyrimidine; tertiary amino compound; tetrol	adenosine phosphodiesterase inhibitor; EC 3.5.4.4 (adenosine deaminase) inhibitor; platelet aggregation inhibitor; vasodilator agent
disopyramide	[no description available]	low	0	monocarboxylic acid amide; pyridines; tertiary amino compound	anti-arrhythmia drug
1-phenyl-2-palmitoylamino-3-morpholino-1-propanol	[no description available]	low	0	benzyl alcohols; fatty amide; morpholines; secondary alcohol; tertiary amino compound
doxepin	[no description available]	low	0	dibenzooxepine; tertiary amino compound	antidepressant
profenamine	[no description available]	low	0	phenothiazines; tertiary amino compound	adrenergic antagonist; antidyskinesia agent; antiparkinson drug; histamine antagonist; muscarinic antagonist
flavoxate	[no description available]	low	0	carboxylic ester; flavones; piperidines; tertiary amino compound	antispasmodic drug; muscarinic antagonist; parasympatholytic
flurazepam	[no description available]	low	0	1,4-benzodiazepinone; monofluorobenzenes; organochlorine compound; tertiary amino compound	anticonvulsant; anxiolytic drug; GABAA receptor agonist; sedative
vanoxerine	[no description available]	low	0	ether; N-alkylpiperazine; organofluorine compound; tertiary amino compound	dopamine uptake inhibitor
gbr 12935	[no description available]	low	0	ether; N-alkylpiperazine; tertiary amino compound	dopamine uptake inhibitor
hydroxychloroquine	[no description available]	low	0	aminoquinoline; organochlorine compound; primary alcohol; secondary amino compound; tertiary amino compound	anticoronaviral agent; antimalarial; antirheumatic drug; dermatologic drug
lidocaine	[no description available]	low	0	benzenes; monocarboxylic acid amide; tertiary amino compound	anti-arrhythmia drug; drug allergen; environmental contaminant; local anaesthetic; xenobiotic
ketotifen	[no description available]	low	0	cyclic ketone; olefinic compound; organic heterotricyclic compound; organosulfur heterocyclic compound; piperidines; tertiary amino compound	anti-asthmatic drug; H1-receptor antagonist
lofepramine	[no description available]	low	0	aromatic ketone; dibenzoazepine; monochlorobenzenes; tertiary amino compound	antidepressant
4-(dimethylamino)-n-(7-(hydroxyamino)-7-oxoheptyl)benzamide	[no description available]	low	0	benzamides; hydroxamic acid; secondary carboxamide; tertiary amino compound	antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor
meperidine	[no description available]	low	0	ethyl ester; piperidinecarboxylate ester; tertiary amino compound	antispasmodic drug; kappa-opioid receptor agonist; mu-opioid receptor agonist; opioid analgesic
mesoridazine	[no description available]	low	0	phenothiazines; sulfoxide; tertiary amino compound	dopaminergic antagonist; first generation antipsychotic
methadone	[no description available]	low	0	benzenes; diarylmethane; ketone; tertiary amino compound
methiothepin	[no description available]	low	0	aryl sulfide; dibenzothiepine; N-alkylpiperazine; tertiary amino compound	antipsychotic agent; dopaminergic antagonist; geroprotector; serotonergic antagonist
metoclopramide	[no description available]	low	0	benzamides; monochlorobenzenes; substituted aniline; tertiary amino compound	antiemetic; dopaminergic antagonist; environmental contaminant; gastrointestinal drug; xenobiotic
minoxidil	[no description available]	low	0	dialkylarylamine; tertiary amino compound
mosapramine	[no description available]	low	0	azaspiro compound; dibenzoazepine; organochlorine compound; tertiary amino compound
clorgyline	[no description available]	low	0	aromatic ether; dichlorobenzene; terminal acetylenic compound; tertiary amino compound	antidepressant; EC 1.4.3.4 (monoamine oxidase) inhibitor
nefopam	[no description available]	low	0	benzoxazocine; tertiary amino compound
orphenadrine	[no description available]	low	0	ether; tertiary amino compound	antidyskinesia agent; antiparkinson drug; H1-receptor antagonist; muscarinic antagonist; muscle relaxant; NMDA receptor antagonist; parasympatholytic
benoxinate	[no description available]	low	0	amino acid ester; benzoate ester; substituted aniline; tertiary amino compound	drug allergen; local anaesthetic; topical anaesthetic
oxybutynin	[no description available]	low	0	acetylenic compound; carboxylic ester; racemate; tertiary alcohol; tertiary amino compound	antispasmodic drug; calcium channel blocker; local anaesthetic; muscarinic antagonist; muscle relaxant; parasympatholytic
pheniramine	[no description available]	low	0	pyridines; tertiary amino compound
pipamperone	[no description available]	low	0	aromatic ketone; bipiperidines; monocarboxylic acid amide; organofluorine compound; tertiary amino compound	dopaminergic antagonist; first generation antipsychotic; serotonergic antagonist
piromidic acid	[no description available]	low	0	monocarboxylic acid; pyridopyrimidine; pyrrolidines; quinolone antibiotic; tertiary amino compound	antibacterial drug; DNA synthesis inhibitor
pj-34	[no description available]	low	0	phenanthridines; secondary carboxamide; tertiary amino compound	angiogenesis inhibitor; anti-inflammatory agent; antiatherosclerotic agent; antineoplastic agent; apoptosis inducer; cardioprotective agent; EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor; neuroprotective agent
procaine	[no description available]	low	0	benzoate ester; substituted aniline; tertiary amino compound	central nervous system depressant; drug allergen; local anaesthetic; peripheral nervous system drug
propiomazine	[no description available]	low	0	aromatic ketone; phenothiazines; tertiary amino compound	dopaminergic antagonist; histamine antagonist; muscarinic antagonist; phenothiazine antipsychotic drug; sedative; serotonergic antagonist
psilocin	[no description available]	low	0	hydroxyindoles; phenols; tertiary amino compound; tryptamine alkaloid	drug metabolite; fungal metabolite; hallucinogen; human xenobiotic metabolite; serotonergic agonist
7-chloro-3-methyl-1-phenyl-1,2,4,5-tetrahydro-3-benzazepin-8-ol	[no description available]	low	0	benzazepine; organochlorine compound; tertiary amino compound	dopaminergic antagonist
setiptiline	[no description available]	low	0	tertiary amino compound; tetracyclic antidepressant	alpha-adrenergic antagonist; serotonergic antagonist
sibutramine	[no description available]	low	0	organochlorine compound; tertiary amino compound	anti-obesity agent; serotonin uptake inhibitor
spiperone	[no description available]	low	0	aromatic ketone; azaspiro compound; organofluorine compound; piperidines; tertiary amino compound	alpha-adrenergic antagonist; antipsychotic agent; dopaminergic antagonist; psychotropic drug; serotonergic antagonist
tetracaine	[no description available]	low	0	benzoate ester; tertiary amino compound	local anaesthetic
tilorone	[no description available]	low	0	aromatic ether; diether; fluoren-9-ones; tertiary amino compound	anti-inflammatory agent; antineoplastic agent; antiviral agent; interferon inducer; nicotinic acetylcholine receptor agonist
tosufloxacin	[no description available]	low	0	1,8-naphthyridine derivative; amino acid; aminopyrrolidine; monocarboxylic acid; organofluorine compound; primary amino compound; quinolone antibiotic; tertiary amino compound
n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine	[no description available]	low	0	N-substituted diamine; pyridines; tertiary amino compound	apoptosis inducer; chelator; copper chelator
ultram	[no description available]	low	0	aromatic ether; tertiary alcohol; tertiary amino compound
trimethobenzamide	[no description available]	low	0	benzamides; tertiary amino compound	antiemetic
trimipramine	[no description available]	low	0	dibenzoazepine; tertiary amino compound	antidepressant; environmental contaminant; xenobiotic
venlafaxine	[no description available]	low	0	cyclohexanols; monomethoxybenzene; tertiary alcohol; tertiary amino compound	adrenergic uptake inhibitor; analgesic; antidepressant; dopamine uptake inhibitor; environmental contaminant; serotonin uptake inhibitor; xenobiotic
zotepine	[no description available]	low	0	dibenzothiepine; tertiary amino compound	alpha-adrenergic drug; second generation antipsychotic; serotonergic drug
phentolamine	[no description available]	low	0	imidazoles; phenols; substituted aniline; tertiary amino compound	alpha-adrenergic antagonist; vasodilator agent
vincristine	[no description available]	low	0	acetate ester; formamides; methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; tertiary alcohol; tertiary amino compound; vinca alkaloid	antineoplastic agent; drug; microtubule-destabilising agent; plant metabolite; tubulin modulator
aminopyrine	[no description available]	low	0	pyrazolone; tertiary amino compound	antipyretic; environmental contaminant; non-narcotic analgesic; non-steroidal anti-inflammatory drug; xenobiotic
tetrabenazine	[no description available]	low	0	benzoquinolizine; cyclic ketone; tertiary amino compound
acepromazine	[no description available]	low	0	aromatic ketone; methyl ketone; phenothiazines; tertiary amino compound	phenothiazine antipsychotic drug
egtazic acid	[no description available]	low	0	diether; tertiary amino compound; tetracarboxylic acid	chelator
gramine	[no description available]	low	0	aminoalkylindole; indole alkaloid; tertiary amino compound	antibacterial agent; antiviral agent; plant metabolite; serotonergic antagonist
thenyldiamine	[no description available]	low	0	dialkylarylamine; tertiary amino compound
4-(dimethylamino)benzaldehyde	[no description available]	low	0	benzaldehydes; substituted aniline; tertiary amino compound	chromogenic compound
2-diethylaminoethanol	[no description available]	low	0	ethanolamines; primary alcohol; tertiary amino compound
triethanolamine	[no description available]	low	0	amino alcohol; tertiary amino compound; triol	buffer; surfactant
4-nitrosodimethylaniline	[no description available]	low	0	dimethylaniline; nitroso compound; tertiary amino compound
triethylenediamine	[no description available]	low	0	bridged compound; diamine; saturated organic heterobicyclic parent; tertiary amino compound	antioxidant; catalyst; reagent
galantamine	[no description available]	low	0	benzazepine alkaloid fundamental parent; benzazepine alkaloid; organic heterotetracyclic compound; tertiary amino compound	antidote to curare poisoning; cholinergic drug; EC 3.1.1.7 (acetylcholinesterase) inhibitor; EC 3.1.1.8 (cholinesterase) inhibitor; plant metabolite
beta-erythroidine	[no description available]	low	0	delta-lactone; indole alkaloid; organic heterotetracyclic compound; tertiary amino compound	muscle relaxant; plant metabolite
psilocybin	[no description available]	low	0	organic phosphate; tertiary amino compound; tryptamine alkaloid	fungal metabolite; hallucinogen; prodrug; serotonergic agonist
benzydamine	[no description available]	low	0	aromatic ether; indazoles; tertiary amino compound	analgesic; central nervous system stimulant; hallucinogen; local anaesthetic; non-steroidal anti-inflammatory drug
4-dimethylaminopyridine	[no description available]	low	0	dialkylarylamine; tertiary amino compound
dymanthine	[no description available]	low	0	tertiary amino compound
azaperone	[no description available]	low	0	aminopyridine; aromatic ketone; monofluorobenzenes; N-alkylpiperazine; N-arylpiperazine; tertiary amino compound	antipsychotic agent; dopaminergic antagonist
glaucine	[no description available]	low	0	aporphine alkaloid; organic heterotetracyclic compound; polyether; tertiary amino compound	antibacterial agent; antineoplastic agent; antitussive; muscle relaxant; NF-kappaB inhibitor; plant metabolite; platelet aggregation inhibitor; rat metabolite
glyphosphine	[no description available]	low	0	glycine derivative; phosphonic acids; tertiary amino compound	plant growth retardant
c.i. solvent yellow 56	[no description available]	low	0	azobenzenes; substituted aniline; tertiary amino compound	dye; mutagen
4-dimethylaminophenol	[no description available]	low	0	dialkylarylamine; tertiary amino compound
ethyl 4-dimethylaminobenzoate	[no description available]	low	0	benzoate ester; ethyl ester; tertiary amino compound
mopidamol	[no description available]	low	0	dialkylarylamine; tertiary amino compound
thenalidine	[no description available]	low	0	dialkylarylamine; tertiary amino compound
dihydro-beta-erythroidine	[no description available]	low	0	delta-lactone; organic heterotetracyclic compound; tertiary amino compound	nicotinic antagonist
propamocarb	[no description available]	low	0	carbamate ester; carbamate fungicide; tertiary amino compound	antifungal agrochemical; environmental contaminant; xenobiotic
tridemorph	[no description available]	low	0	morpholines; tertiary amino compound	antifungal agrochemical
amitraz	[no description available]	low	0	formamidines; tertiary amino compound	acaricide; environmental contaminant; insecticide; xenobiotic
butaclamol	[no description available]	low	0	amino alcohol; organic heteropentacyclic compound; tertiary alcohol; tertiary amino compound	dopaminergic antagonist
2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline	[no description available]	low	0	isoquinolinol; tertiary amino compound	human metabolite; neurotoxin; rat metabolite
vx	[no description available]	low	0	organic thiophosphate; tertiary amino compound	EC 3.1.1.7 (acetylcholinesterase) inhibitor; neurotoxin
vindesine	[no description available]	low	0	methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; primary carboxamide; tertiary alcohol; tertiary amino compound; vinca alkaloid	antineoplastic agent
miglustat	[no description available]	low	0	piperidines; tertiary amino compound	anti-HIV agent; EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor
loceryl	[no description available]	low	0	morpholine antifungal drug; tertiary amino compound	EC 1.14.13.132 (squalene monooxygenase) inhibitor; EC 1.3.1.70 (Delta(14)-sterol reductase) inhibitor; EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor
mifepristone	[no description available]	low	0	3-oxo-Delta(4) steroid; acetylenic compound; tertiary amino compound	abortifacient; contraceptive drug; hormone antagonist; synthetic oral contraceptive
carmoxirole	[no description available]	low	0	indolecarboxylic acid; tertiary amino compound; tetrahydropyridine	antihypertensive agent; dopamine agonist; platelet aggregation inhibitor
naxagolide	[no description available]	low	0	organic heterotricyclic compound; phenols; tertiary amino compound	anticonvulsant; antiparkinson drug; dopamine agonist
temafloxacin	[no description available]	low	0	amino acid; monocarboxylic acid; N-arylpiperazine; organofluorine compound; quinolone antibiotic; quinolone; secondary amino compound; tertiary amino compound
tiagabine	[no description available]	low	0	beta-amino acid; piperidinemonocarboxylic acid; tertiary amino compound; thiophenes	anticonvulsant; GABA reuptake inhibitor
eliprodil	[no description available]	low	0	monochlorobenzenes; monofluorobenzenes; piperidines; secondary alcohol; tertiary amino compound
irinotecan	[no description available]	low	0	carbamate ester; delta-lactone; N-acylpiperidine; pyranoindolizinoquinoline; ring assembly; tertiary alcohol; tertiary amino compound	antineoplastic agent; apoptosis inducer; EC 5.99.1.2 (DNA topoisomerase) inhibitor; prodrug
carfentanil	[no description available]	low	0	methyl ester; piperidines; tertiary amino compound; tertiary carboxamide	mu-opioid receptor agonist; opioid analgesic; tranquilizing drug
tenocyclidine	[no description available]	low	0	piperidines; tertiary amino compound; thiophenes	central nervous system stimulant; hallucinogen; neuroprotective agent; NMDA receptor antagonist
nelfinavir	[no description available]	low	0	aryl sulfide; benzamides; organic heterobicyclic compound; phenols; secondary alcohol; tertiary amino compound	antineoplastic agent; HIV protease inhibitor
plerixafor	[no description available]	low	0	azacycloalkane; azamacrocycle; benzenes; crown amine; secondary amino compound; tertiary amino compound	anti-HIV agent; antineoplastic agent; C-X-C chemokine receptor type 4 antagonist; immunological adjuvant
cephalotaxine	[no description available]	low	0	benzazepine alkaloid fundamental parent; benzazepine alkaloid; cyclic acetal; enol ether; organic heteropentacyclic compound; secondary alcohol; tertiary amino compound
d 888	[no description available]	low	0	aromatic ether; nitrile; tertiary amino compound	anti-arrhythmia drug; calcium channel blocker; vasodilator agent
spiramide	[no description available]	low	0	aromatic ether; azaspiro compound; organofluorine compound; piperidines; tertiary amino compound	dopaminergic antagonist; serotonergic antagonist
propildazine	[no description available]	low	0	dialkylarylamine; tertiary amino compound
hp 873	[no description available]	low	0	1,2-benzoxazoles; aromatic ether; aromatic ketone; methyl ketone; monoamine; organofluorine compound; piperidines; tertiary amino compound	dopaminergic antagonist; second generation antipsychotic; serotonergic antagonist
tubulosine	[no description available]	low	0	beta-carbolines; isoquinoline alkaloid; isoquinolines; phenols; secondary amino compound; tertiary amino compound
voacamine	[no description available]	low	0	alkaloid ester; methyl ester; monoterpenoid indole alkaloid; organic heteropentacyclic compound; tertiary amino compound	angiogenesis inhibitor; antineoplastic agent; plant metabolite
dauricine	[no description available]	low	0	aromatic ether; bisbenzylisoquinoline alkaloid; isoquinolines; phenols; tertiary amino compound	plant metabolite
rivastigmine	[no description available]	low	0	carbamate ester; tertiary amino compound	cholinergic drug; EC 3.1.1.8 (cholinesterase) inhibitor; neuroprotective agent
dimethylformamide-dimethylacetal	[no description available]	low	0	acetal; tertiary amino compound	chromatographic reagent
n-(3-(dimethylamino)propyl)methacrylamide	[no description available]	low	0	tertiary amino compound
n,n-diisopropylethylamine	[no description available]	low	0	tertiary amino compound
spiroxamine	[no description available]	low	0	dioxolane; spiroketal; tertiary amino compound	antifungal agrochemical; environmental contaminant; sterol biosynthesis inhibitor; xenobiotic
mor-14	[no description available]	low	0	hydroxypiperidine; piperidine alkaloid; tertiary amino compound	anti-HIV agent; cardioprotective agent; EC 3.2.1.20 (alpha-glucosidase) inhibitor; plant metabolite
allocryptopine	[no description available]	low	0	aromatic ether; cyclic acetal; cyclic ketone; dibenzazecine alkaloid; organic heterotetracyclic compound; tertiary amino compound
sporidesmin	[no description available]	low	0	aromatic ether; cyclic ketone; diketone; organic disulfide; organic heteropentacyclic compound; organochlorine compound; secondary alcohol; tertiary alcohol; tertiary amino compound	mycotoxin; Wnt signalling activator
ecgonine methyl ester	[no description available]	low	0	methyl ester; tertiary amino compound; tropane alkaloid	analgesic; central nervous system depressant; metabolite; mouse metabolite; opioid analgesic; peripheral nervous system drug
ecteinascidin 743	[no description available]	low	0	acetate ester; azaspiro compound; bridged compound; hemiaminal; isoquinoline alkaloid; lactone; organic heteropolycyclic compound; organic sulfide; oxaspiro compound; polyphenol; tertiary amino compound	alkylating agent; angiogenesis modulating agent; anti-inflammatory agent; antineoplastic agent; marine metabolite
aporphine	[no description available]	low	0	aporphine alkaloid; isoquinoline alkaloid fundamental parent; tertiary amino compound
mosapride	[no description available]	low	0	aromatic ether; benzamides; monochlorobenzenes; monofluorobenzenes; morpholines; secondary carboxamide; substituted aniline; tertiary amino compound
n-(4-(7-diethylamino-4-methylcoumarin-3-yl)phenyl)maleimide	[no description available]	low	0	benzenes; coumarins; maleimides; tertiary amino compound	fluorescent dye
gefitinib	[no description available]	low	0	aromatic ether; monochlorobenzenes; monofluorobenzenes; morpholines; quinazolines; secondary amino compound; tertiary amino compound	antineoplastic agent; epidermal growth factor receptor antagonist
lofentanil	[no description available]	low	0	methyl ester; piperidines; tertiary amino compound; tertiary carboxamide	mu-opioid receptor agonist; opioid analgesic
1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine	[no description available]	low	0	1-benzothiophenes; piperidines; tertiary amino compound	dopamine uptake inhibitor
desvenlafaxine	[no description available]	low	0	cyclohexanols; phenols; tertiary amino compound	antidepressant; drug metabolite; marine xenobiotic metabolite
xaliproden	[no description available]	low	0	(trifluoromethyl)benzenes; naphthalenes; tertiary amino compound; tetrahydropyridine	serotonergic agonist
ulipristal acetate	[no description available]	low	0	20-oxo steroid; 3-oxo-Delta(4) steroid; acetate ester; steroid ester; tertiary amino compound	contraceptive drug; progesterone receptor modulator; progestin
sr 57227a	[no description available]	low	0	dialkylarylamine; tertiary amino compound
ivabradine	[no description available]	low	0	aromatic ether; benzazepine; carbobicyclic compound; tertiary amino compound	cardiotonic drug
sk&f 83959	[no description available]	low	0	benzazepine; catechols; organochlorine compound; tertiary amino compound	dopamine agonist
corytuberine	[no description available]	low	0	aporphine alkaloid; aromatic ether; organic heterotetracyclic compound; polyphenol; tertiary amino compound	plant metabolite
5,6-didehydrosparteine	[no description available]	low	0	organic heterotetracyclic compound; quinolizidine alkaloid; tertiary amino compound	human xenobiotic metabolite
stephenanthrine	[no description available]	low	0	cyclic acetal; organic heterotetracyclic compound; tertiary amino compound
nbi 27914	[no description available]	low	0	dialkylarylamine; tertiary amino compound
top 53	[no description available]	low	0	furonaphthodioxole; gamma-lactone; organic heterotetracyclic compound; phenols; tertiary amino compound	antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
antalarmin	[no description available]	low	0	pyrrolopyrimidine; tertiary amino compound	corticotropin-releasing factor receptor antagonist
alpha-putrescinylthymine	[no description available]	low	0	N-substituted putrescine; pyrimidine nucleobase; pyrimidone; secondary amino compound; tertiary amino compound
2-(4-morpholinoanilino)-6-cyclohexylaminopurine	[no description available]	low	0	morpholines; purines; secondary amino compound; tertiary amino compound	adenosine A3 receptor antagonist; antineoplastic agent; Aurora kinase inhibitor; cell dedifferentiation agent
l 778,123	[no description available]	low	0	imidazoles; monochlorobenzenes; nitrile; piperazinone; tertiary amino compound	antineoplastic agent; EC 2.5.1.58 (protein farnesyltransferase) inhibitor; EC 2.5.1.59 (protein geranylgeranyltransferase type I) inhibitor
vincaleukoblastine	[no description available]	low	0	acetate ester; indole alkaloid fundamental parent; methyl ester; organic heteropentacyclic compound; organic heterotetracyclic compound; tertiary alcohol; tertiary amino compound; vinca alkaloid	antineoplastic agent; immunosuppressive agent; microtubule-destabilising agent; plant metabolite
noscapine	[no description available]	low	0	aromatic ether; benzylisoquinoline alkaloid; cyclic acetal; isobenzofuranone; organic heterobicyclic compound; organic heterotricyclic compound; tertiary amino compound	antineoplastic agent; antitussive; apoptosis inducer; plant metabolite
azaleucine	[no description available]	low	0	alanine derivative; leucine derivative; non-proteinogenic alpha-amino acid; tertiary amino compound
nsc 23766	[no description available]	low	0	aminopyrimidine; aminoquinoline; primary amino compound; secondary amino compound; tertiary amino compound	antiviral agent; apoptosis inducer; EC 3.6.5.2 (small monomeric GTPase) inhibitor; muscarinic antagonist
gant 61	[no description available]	low	0	aminal; dialkylarylamine; pyridines; substituted aniline; tertiary amino compound	antineoplastic agent; apoptosis inducer; glioma-associated oncogene inhibitor; Hedgehog signaling pathway inhibitor
conessine	[no description available]	low	0	steroid alkaloid; tertiary amino compound	antibacterial agent; antimalarial; H3-receptor antagonist; plant metabolite
rocuronium	[no description available]	low	0	3alpha-hydroxy steroid; acetate ester; androstane; morpholines; quaternary ammonium ion; tertiary amino compound	drug allergen; muscle relaxant; neuromuscular agent
deltaline	[no description available]	low	0	acetate ester; cyclic acetal; diterpene alkaloid; organic polycyclic compound; tertiary alcohol; tertiary amino compound
oxyacanthine	[no description available]	low	0	bisbenzylisoquinoline alkaloid; isoquinolines; macrocycle; phenols; tertiary amino compound
ergonovine	[no description available]	low	0	ergot alkaloid; monocarboxylic acid amide; organic heterotetracyclic compound; primary alcohol; secondary amino compound; tertiary amino compound	diagnostic agent; fungal metabolite; oxytocic; toxin
colforsin daropate	[no description available]	low	0	acetate ester; carboxylic ester; cyclic ketone; diol; organic heterotricyclic compound; tertiary amino compound	adenylate cyclase agonist; antihypertensive agent; cardiotonic drug; vasodilator agent
cocaine	[no description available]	low	0	benzoate ester; methyl ester; tertiary amino compound; tropane alkaloid	adrenergic uptake inhibitor; central nervous system stimulant; dopamine uptake inhibitor; environmental contaminant; local anaesthetic; mouse metabolite; plant metabolite; serotonin uptake inhibitor; sodium channel blocker; sympathomimetic agent; vasoconstrictor agent; xenobiotic
afimoxifene	[no description available]	low	0	phenols; tertiary amino compound	antineoplastic agent; estrogen receptor antagonist; metabolite
efinaconazole	[no description available]	low	0	conazole antifungal drug; olefinic compound; organofluorine compound; piperidines; tertiary alcohol; tertiary amino compound; triazole antifungal drug	EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
n-nonyl-1-deoxynojirimycin	[no description available]	low	0	hydroxypiperidine; tertiary amino compound	antiviral agent; EC 3.2.1.20 (alpha-glucosidase) inhibitor; EC 3.2.1.45 (glucosylceramidase) inhibitor
3-(4-chlorophenyl)-6-(1-pyrrolidinyl)-1,2,4,5-tetrazine	[no description available]	low	0	dialkylarylamine; tertiary amino compound
n-methylproline	[no description available]	low	0	L-alpha-amino acid zwitterion; L-proline derivative; tertiary amino compound	human metabolite; plant metabolite
5-[3-(dimethylamino)phenyl]-N-methyl-1,3,4-thiadiazol-2-amine	[no description available]	low	0	dialkylarylamine; tertiary amino compound
N4-(2-furanylmethyl)-N2-(3-methylphenyl)-6-(4-morpholinyl)-1,3,5-triazine-2,4-diamine	[no description available]	low	0	dialkylarylamine; tertiary amino compound
tiamulin	[no description available]	low	0	carbotricyclic compound; carboxylic ester; cyclic ketone; organic sulfide; secondary alcohol; semisynthetic derivative; tertiary amino compound; tetracyclic diterpenoid	antibacterial drug
N-[4-(diethylamino)phenyl]-N'-phenylurea	[no description available]	low	0	dialkylarylamine; tertiary amino compound
4-bromo-2-phenyl-5-(1-piperidinyl)-3-pyridazinone	[no description available]	low	0	dialkylarylamine; tertiary amino compound
N4,N4-dimethyl-N1-(4-nitro-1,1-dioxo-2,5-dihydrothiophen-3-yl)benzene-1,4-diamine	[no description available]	low	0	dialkylarylamine; tertiary amino compound
N-methyl-2-(4-methylphenyl)-N-(1-methylpiperidin-4-yl)quinazolin-4-amine	[no description available]	low	0	piperidines; quinazolines; tertiary amino compound; toluenes
4-[[4-bromo-5-(4-morpholinyl)-2-furanyl]methylideneamino]phenol	[no description available]	low	0	dialkylarylamine; tertiary amino compound
4-chloro-5-(dimethylamino)-2-(4-methylphenyl)-3-pyridazinone	[no description available]	low	0	dialkylarylamine; tertiary amino compound
N,N-dibutyl-2-(pyridin-4-yl)quinazolin-4-amine	[no description available]	low	0	pyridines; quinazolines; tertiary amino compound
2-[5-(4-chlorophenyl)-1,3,5-dithiazinan-2-ylidene]-2-diethoxyphosphorylacetonitrile	[no description available]	low	0	dialkylarylamine; tertiary amino compound
2-[[4-(4-chloroanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol	[no description available]	low	0	dialkylarylamine; tertiary amino compound
2-(2,4-dioxo-1H-pyrimidin-6-yl)-N-[2-(4-morpholinyl)ethyl]acetamide	[no description available]	low	0	morpholines; pyrimidone; secondary carboxamide; tertiary amino compound
tamoxifen	[no description available]	low	0	stilbenoid; tertiary amino compound	angiogenesis inhibitor; antineoplastic agent; bone density conservation agent; EC 1.2.3.1 (aldehyde oxidase) inhibitor; EC 2.7.11.13 (protein kinase C) inhibitor; estrogen antagonist; estrogen receptor antagonist; estrogen receptor modulator
3-(1-pyrrolidinyl)-5-(trifluoromethyl)pyridine-2-carbothioamide	[no description available]	low	0	dialkylarylamine; tertiary amino compound
wiskostatin	[no description available]	low	0	carbazoles; organobromine compound; secondary alcohol; tertiary amino compound
2-[[2-oxo-2-[4-[5-(trifluoromethyl)-2-pyridinyl]-1,4-diazepan-1-yl]ethyl]thio]acetic acid	[no description available]	low	0	dialkylarylamine; tertiary amino compound
4-(5,6-diphenyl-1,2,4-triazin-3-yl)morpholine	[no description available]	low	0	dialkylarylamine; tertiary amino compound
3-[[5,5-dimethyl-3-(4-morpholinyl)-1-cyclohex-2-enylidene]amino]-N,N-dimethylaniline	[no description available]	low	0	dialkylarylamine; tertiary amino compound
stenusin	[no description available]	low	0	piperidine alkaloid; tertiary amino compound
tandutinib	[no description available]	low	0	aromatic ether; N-arylpiperazine; N-carbamoylpiperazine; phenylureas; piperidines; quinazolines; tertiary amino compound	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
dasatinib	[no description available]	low	0	1,3-thiazoles; aminopyrimidine; monocarboxylic acid amide; N-(2-hydroxyethyl)piperazine; N-arylpiperazine; organochlorine compound; secondary amino compound; tertiary amino compound	anticoronaviral agent; antineoplastic agent; tyrosine kinase inhibitor
noribogaine	[no description available]	low	0	monoterpenoid indole alkaloid; organic heteropentacyclic compound; secondary amino compound; tertiary amino compound	kappa-opioid receptor agonist; NMDA receptor antagonist; psychotropic drug; serotonin uptake inhibitor
2-[[4-(3-methylanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol	[no description available]	low	0	dialkylarylamine; tertiary amino compound
N-[3-(N-ethylanilino)propyl]-2,4-dimethyl-6-oxo-3-pyrancarboxamide	[no description available]	low	0	dialkylarylamine; tertiary amino compound
5-(1-azepanyl)-1,3,4-thiadiazol-2-amine	[no description available]	low	0	dialkylarylamine; tertiary amino compound
3-(5-chloro-2-methylphenyl)-6-(2,6-dimethyl-4-morpholinyl)-1H-pyrimidine-2,4-dione	[no description available]	low	0	dialkylarylamine; tertiary amino compound
nafadotride	[no description available]	low	0	aromatic ether; naphthalenecarboxamide; nitrile; pyrrolidines; tertiary amino compound	dopaminergic antagonist
clopidogrel carboxylic acid	[no description available]	low	0	monocarboxylic acid; monochlorobenzenes; tertiary amino compound; thienopyridine	drug metabolite; marine xenobiotic metabolite
LY-310762	[no description available]	low	0	aromatic ketone; monofluorobenzenes; oxindoles; piperidines; tertiary amino compound	receptor modulator; serotonergic antagonist
ly 367265	[no description available]	low	0	dihydropyridine; fluoroindole; tertiary amino compound; thiadiazoloquinoline	antidepressant; geroprotector; serotonergic antagonist; serotonin uptake inhibitor
3-[4-(dimethylamino)phenyl]-N-methyl-5-(4-methylphenyl)-3,4-dihydropyrazole-2-carbothioamide	[no description available]	low	0	dialkylarylamine; tertiary amino compound
mycophenolate mofetil	[no description available]	low	0	carboxylic ester; ether; gamma-lactone; phenols; tertiary amino compound	anticoronaviral agent; EC 1.1.1.205 (IMP dehydrogenase) inhibitor; immunosuppressive agent; prodrug
cassaine	[no description available]	low	0	enoate ester; organic hydroxy compound; tertiary amino compound; tricyclic diterpenoid	antihypertensive agent; cardiotonic drug; EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor; local anaesthetic; plant metabolite; poison
josamycin	[no description available]	low	0	acetate ester; aldehyde; disaccharide derivative; glycoside; macrolide antibiotic; tertiary alcohol; tertiary amino compound	antibacterial drug; metabolite
acetylspiramycin	[no description available]	low	0	acetate ester; aldehyde; disaccharide derivative; ether; macrolide; tertiary amino compound	antibacterial drug; antimicrobial agent; bacterial metabolite
n,n-dimethylsphingenine	[no description available]	low	0	aminodiol; sphingoid; tertiary amino compound	EC 2.7.1.91 (sphingosine kinase) inhibitor; metabolite
alvocidib	[no description available]	low	0	dihydroxyflavone; hydroxypiperidine; monochlorobenzenes; tertiary amino compound	antineoplastic agent; antirheumatic drug; apoptosis inducer; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin	[no description available]	low	0	1,4-benzoquinones; ansamycin; carbamate ester; secondary amino compound; tertiary amino compound	Hsp90 inhibitor
morphine	[no description available]	low	0	morphinane alkaloid; organic heteropentacyclic compound; tertiary amino compound	anaesthetic; drug allergen; environmental contaminant; geroprotector; mu-opioid receptor agonist; opioid analgesic; plant metabolite; vasodilator agent; xenobiotic
bosutinib	[no description available]	low	0	aminoquinoline; aromatic ether; dichlorobenzene; N-methylpiperazine; nitrile; tertiary amino compound	antineoplastic agent; tyrosine kinase inhibitor
su 11652	[no description available]	low	0	olefinic compound; organochlorine compound; oxindoles; pyrrolecarboxamide; tertiary amino compound	EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor
palbociclib	[no description available]	low	0	aminopyridine; aromatic ketone; cyclopentanes; piperidines; pyridopyrimidine; secondary amino compound; tertiary amino compound	antineoplastic agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
bedaquiline	[no description available]	low	0	aromatic ether; naphthalenes; organobromine compound; quinolines; tertiary alcohol; tertiary amino compound	antitubercular agent; ATP synthase inhibitor
catharanthine	[no description available]	low	0	alkaloid ester; bridged compound; methyl ester; monoterpenoid indole alkaloid; organic heteropentacyclic compound; tertiary amino compound
oripavine	[no description available]	low	0	ether; morphinane alkaloid; organic heteropentacyclic compound; organic hydroxy compound; tertiary amino compound	bacterial xenobiotic metabolite; opioid analgesic
cinanserin	[no description available]	low	0	aryl sulfide; cinnamamides; secondary carboxamide; tertiary amino compound	anticoronaviral agent; antiviral agent; EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
DPI2	[no description available]	low	0	benzenes; morpholines; secondary carboxamide; tertiary amino compound; thiazolidinone	ferroptosis inducer
7-hydroxy-2-(n-n-propyl-n-(3-iodo-2'-propenyl)-amino)tetralin	[no description available]	low	0	organoiodine compound; phenols; tertiary amino compound; tetralins	dopamine agonist
sdz eaa 494	[no description available]	low	0	monocarboxylic acid; olefinic compound; phosphonic acids; piperazinecarboxylic acid; tertiary amino compound	anticonvulsant; neuroprotective agent; NMDA receptor antagonist
demycarosylturimycin h	[no description available]	low	0	aldehyde; disaccharide derivative; ether; macrolide; tertiary amino compound	antibacterial drug; antimicrobial agent; bacterial metabolite
ro 25-6981	[no description available]	low	0	benzenes; phenols; piperidines; secondary alcohol; tertiary amino compound	anticonvulsant; antidepressant; neuroprotective agent; NMDA receptor antagonist
yunaconitine	[no description available]	low	0	acetate ester; aromatic ether; benzoate ester; bridged compound; diterpene alkaloid; organic heteropolycyclic compound; polyether; secondary alcohol; tertiary alcohol; tertiary amino compound	antifeedant; human urinary metabolite; phytotoxin; plant metabolite; xenobiotic
eaa-090	[no description available]	low	0	dialkylarylamine; tertiary amino compound
prasugrel	[no description available]	low	0	acetate ester; cyclopropanes; ketone; monofluorobenzenes; tertiary amino compound; thienopyridine
bay 58-2667	[no description available]	low	0	aromatic ether; benzoic acids; dicarboxylic acid; tertiary amino compound	antihypertensive agent; soluble guanylate cyclase activator; vasodilator agent
muromonab-cd3	[no description available]	low	0	alkaloid; macrocycle; organic heteropentacyclic compound; organonitrogen heterocyclic compound; oxacycle; tertiary amino compound	antineoplastic agent; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; IP3 receptor antagonist; marine metabolite
px-866	[no description available]	low	0	acetate ester; delta-lactone; organic heterotetracyclic compound; tertiary amino compound	EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
zm 447439	[no description available]	low	0	aromatic ether; benzamides; morpholines; polyether; quinazolines; secondary amino compound; tertiary amino compound	antineoplastic agent; apoptosis inducer; Aurora kinase inhibitor
tofacitinib	[no description available]	low	0	N-acylpiperidine; nitrile; pyrrolopyrimidine; tertiary amino compound	antirheumatic drug; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride	[no description available]	low	0	aromatic ether; hydrochloride; methoxybenzenes; tertiary amino compound	antipsychotic agent; receptor modulator
NNC 55-0396 (free base)	[no description available]	low	0	benzimidazoles; cyclopropanecarboxylate ester; organofluorine compound; tertiary amino compound; tetralins	angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; neuroprotective agent; potassium channel blocker; T-type calcium channel blocker
pateamine a	[no description available]	low	0	1,3-thiazoles; macrodiolide; olefinic compound; primary amino compound; tertiary amino compound	antineoplastic agent; antiviral agent; eukaryotic initiation factor 4F inhibitor; marine metabolite
pimavanserin	[no description available]	low	0	aromatic ether; monofluorobenzenes; piperidines; tertiary amino compound; ureas	5-hydroxytryptamine 2A receptor inverse agonist; antipsychotic agent; serotonergic antagonist
bibw 2992	[no description available]	low	0	aromatic ether; enamide; furans; monochlorobenzenes; organofluorine compound; quinazolines; secondary carboxamide; tertiary amino compound	antineoplastic agent; tyrosine kinase inhibitor
edoxaban	[no description available]	low	0	chloropyridine; monocarboxylic acid amide; tertiary amino compound; thiazolopyridine	anticoagulant; EC 3.4.21.6 (coagulation factor Xa) inhibitor; platelet aggregation inhibitor
akuammicine	[no description available]	low	0	methyl ester; monoterpenoid indole alkaloid; organic heteropentacyclic compound; tertiary amino compound	plant metabolite
crenolanib	[no description available]	low	0	aminopiperidine; aromatic ether; benzimidazoles; oxetanes; quinolines; tertiary amino compound	angiogenesis inhibitor; antineoplastic agent; apoptosis inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
PDGF receptor tyrosine kinase inhibitor III	[no description available]	low	0	aromatic ether; N-arylpiperazine; N-carbamoylpiperazine; phenylureas; quinazolines; tertiary amino compound	EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
azd 8931	[no description available]	low	0	aromatic ether; monochlorobenzenes; monofluorobenzenes; piperidines; quinazolines; secondary amino compound; tertiary amino compound	EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor; epidermal growth factor receptor antagonist
azd 1152	[no description available]	low	0	anilide; monoalkyl phosphate; monofluorobenzenes; pyrazoles; quinazolines; secondary amino compound; secondary carboxamide; tertiary amino compound	antineoplastic agent; Aurora kinase inhibitor; prodrug
pf 00299804	[no description available]	low	0	enamide; monochlorobenzenes; monofluorobenzenes; piperidines; quinazolines; secondary amino compound; secondary carboxamide; tertiary amino compound	antineoplastic agent; epidermal growth factor receptor antagonist
finafloxacin	[no description available]	low	0	cyclopropanes; monocarboxylic acid; nitrile; organofluorine compound; quinolone; secondary amino compound; tertiary amino compound	antibacterial drug; antimicrobial agent
sarpagine	[no description available]	low	0	indole alkaloid; phenols; primary alcohol; secondary amino compound; tertiary amino compound
5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4h-1-benzopyran-4-one	[no description available]	low	0	alkaloid; chromones; hydroxypiperidine; resorcinols; tertiary amino compound	anti-inflammatory agent; anti-ulcer drug; anticholesteremic drug; antileishmanial agent; antineoplastic agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; fungal metabolite; plant metabolite
azd 1152-hqpa	[no description available]	low	0	anilide; monofluorobenzenes; primary alcohol; pyrazoles; quinazolines; secondary amino compound; secondary carboxamide; tertiary amino compound	antineoplastic agent; Aurora kinase inhibitor
ku 0063794	[no description available]	low	0	benzyl alcohols; monomethoxybenzene; morpholines; pyridopyrimidine; tertiary amino compound	antineoplastic agent; mTOR inhibitor
8-{1-[4-(dimethylamino)phenyl]-3-(pyrrolidin-1-yl)propyl}-5,7-dimethoxy-4-pentyl-2H-chromen-2-one	[no description available]	low	0	aromatic ether; coumarins; pyrrolidines; tertiary amino compound
flupyradifurone	[no description available]	low	0	butenolide; enamine; monochloropyridine; organofluorine insecticide; tertiary amino compound	insecticide; nicotinic acetylcholine receptor agonist
alcaftadine	[no description available]	low	0	aldehyde; imidazobenzazepine; piperidines; tertiary amino compound	anti-allergic agent; H1-receptor antagonist
benzoylaconine	[no description available]	low	0	benzoate ester; bridged compound; diterpene alkaloid; organic heteropolycyclic compound; polyether; secondary alcohol; tertiary alcohol; tertiary amino compound; tetrol	phytotoxin; plant metabolite
deoxyaconitine	[no description available]	low	0	acetate ester; benzoate ester; bridged compound; diol; diterpene alkaloid; organic heteropolycyclic compound; polyether; secondary alcohol; tertiary amino compound	plant metabolite
2-[[4-(4-methylanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol	[no description available]	low	0	dialkylarylamine; tertiary amino compound
2-[[4-(2-chloroanilino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]ethanol	[no description available]	low	0	dialkylarylamine; tertiary amino compound
2-[[4-(2-hydroxyethylamino)-6-(1-pyrrolidinyl)-1,3,5-triazin-2-yl]amino]phenol	[no description available]	low	0	dialkylarylamine; tertiary amino compound
vindolinine	[no description available]	low	0	methyl ester; monoterpenoid indole alkaloid; organic heteropentacyclic compound; tertiary amino compound	plant metabolite
tenovin-6	[no description available]	low	0	monocarboxylic acid amide; tertiary amino compound; thioureas	antineoplastic agent; p53 activator; Sir2 inhibitor
lde225	[no description available]	low	0	aminopyridine; aromatic ether; benzamides; biphenyls; morpholines; organofluorine compound; tertiary amino compound	antineoplastic agent; Hedgehog signaling pathway inhibitor; SMO receptor antagonist
benzoylmesaconine	[no description available]	low	0	benzoate ester; bridged compound; diterpene alkaloid; organic heteropolycyclic compound; polyether; secondary alcohol; tertiary alcohol; tertiary amino compound; tetrol	analgesic; antiinfective agent; plant metabolite
sch772984	[no description available]	low	0	biaryl; indazoles; N-acylpiperazine; N-alkylpyrrolidine; N-arylpiperazine; pyridines; pyrimidines; pyrrolidinecarboxamide; secondary carboxamide; tertiary amino compound; tertiary carboxamide	analgesic; antineoplastic agent; apoptosis inducer; EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
navitoclax	[no description available]	low	0	aryl sulfide; monochlorobenzenes; morpholines; N-sulfonylcarboxamide; organofluorine compound; piperazines; secondary amino compound; sulfone; tertiary amino compound	antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor
n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide	[no description available]	low	0	aminopyrimidine; benzamides; morpholines; nitrile; secondary amino compound; tertiary amino compound	anti-anaemic agent; antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
(5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol	[no description available]	low	0	benzyl alcohols; morpholines; pyridopyrimidine; tertiary amino compound	antineoplastic agent; apoptosis inducer; mTOR inhibitor
N-[[(2R,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N-methylmethanesulfonamide	[no description available]	low	0	dialkylarylamine; tertiary amino compound
(2S,3R)-8-(dimethylamino)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one	[no description available]	low	0	dialkylarylamine; tertiary amino compound
N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-N,3,5-trimethyl-4-isoxazolesulfonamide	[no description available]	low	0	dialkylarylamine; tertiary amino compound
(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-3,4-dihydro-2H-1,5-benzoxazocin-6-one	[no description available]	low	0	dialkylarylamine; tertiary amino compound
3-cyclohexyl-1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea	[no description available]	low	0	dialkylarylamine; tertiary amino compound
1-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea	[no description available]	low	0	dialkylarylamine; tertiary amino compound
cblc137	[no description available]	low	0	aromatic ketone; carbazoles; methyl ketone; secondary amino compound; tertiary amino compound	antineoplastic agent; apoptosis inducer; NF-kappaB inhibitor; p53 activator
1-[3-[(5-bromo-2-pyridinyl)-butylamino]propyl]-3-[3-(1H-imidazol-5-yl)propyl]thiourea	[no description available]	low	0	dialkylarylamine; tertiary amino compound
tubastatin a	[no description available]	low	0	hydroxamic acid; pyridoindole; tertiary amino compound	EC 3.5.1.98 (histone deacetylase) inhibitor
pracinostat	[no description available]	low	0	benzimidazole; hydroxamic acid; olefinic compound; tertiary amino compound	antimalarial; antineoplastic agent; apoptosis inducer; EC 3.5.1.98 (histone deacetylase) inhibitor
delgocitinib	[no description available]	low	0	azaspiro compound; N-acylazetidine; nitrile; pyrrolopyrimidine; tertiary amino compound; tertiary carboxamide	anti-inflammatory drug; antipsoriatic; antiseborrheic; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
pf 956980	[no description available]	low	0	N-acylpiperidine; N-acylpyrrolidine; pyrrolopyrimidine; tertiary amino compound	EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
AZD3463	[no description available]	low	0	aminopiperidine; aminopyrimidine; indoles; monomethoxybenzene; organochlorine compound; secondary amino compound; tertiary amino compound	antineoplastic agent; apoptosis inducer; autophagy inducer; EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
gsk2879552	[no description available]	low	0	benzenes; benzoic acids; cyclopropanes; monocarboxylic acid; piperidines; secondary amino compound; tertiary amino compound	antineoplastic agent; EC 1.14.99.66 (lysine-specific histone demethylase 1A) inhibitor
osimertinib	[no description available]	low	0	acrylamides; aminopyrimidine; biaryl; indoles; monomethoxybenzene; secondary amino compound; secondary carboxamide; substituted aniline; tertiary amino compound	antineoplastic agent; epidermal growth factor receptor antagonist
as 1842856	[no description available]	low	0	organofluorine compound; primary amino compound; quinolinemonocarboxylic acid; quinolone; secondary amino compound; tertiary amino compound	anti-obesity agent; antineoplastic agent; apoptosis inducer; autophagy inhibitor; forkhead box protein O1 inhibitor; hypoglycemic agent
MLI-2	[no description available]	low	0	aromatic ether; cyclopropanes; indazoles; morpholines; pyrimidines; tertiary amino compound	EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
ap20187	[no description available]	low	0	aromatic ether; carboxylic ester; N-acylpiperidine; tertiary amino compound	ligand
BDA-366	[no description available]	low	0	anthraquinone; epoxide; secondary alcohol; secondary amino compound; tertiary amino compound	antineoplastic agent; apoptosis inducer
5-(2-chloro-6-fluorobenzyl)-6-methyl-2-morpholinopyrimidin-4-ol	[no description available]	low	0	dialkylarylamine; tertiary amino compound
2-hydroxy-3-(5-((morpholin-4-yl)methyl)pyridin-2-yl)-1h-indole-5-carbonitrile	[no description available]	low	0	hydroxyindoles; morpholines; nitrile; pyridines; tertiary amino compound	antineoplastic agent; apoptosis inducer; EC 2.7.11.26 (tau-protein kinase) inhibitor; tau aggregation inhibitor
sb-590885	[no description available]	low	0	aromatic ether; imidazoles; ketoxime; pyridines; tertiary amino compound
sotorasib	[no description available]	low	0	acrylamides; methylpyridines; monofluorobenzenes; N-acylpiperazine; phenols; pyridopyrimidine; tertiary amino compound; tertiary carboxamide	antineoplastic agent

Condition	Relationship Strength	Studies
Acute Promyelocytic Leukemia	low	1
AML M3	low	1
Cancer of Colon	low	1
Cancer of Lung	low	1
Cancer of the Colon	low	1
Cancer of the Lung	low	1
Carcinosarcoma	low	1
Colon Cancer	low	1
Colon Neoplasms	low	1
Colonic Cancer	low	1
Colonic Neoplasms	low	1
Congenital Zika Syndrome	low	1
Congenital Zika Virus Infection	low	1
Cryptosporidiosis	low	3
Cryptosporidium Infection	low	3
Disease Models, Animal	low	2
Fever, Zika	low	1
Infections, Plasmodium	low	1
Leishmania Infection	low	3
Leishmaniasis	low	3
Leukemia, Acute Promyelocytic	low	1
Leukemia, Myeloid, Acute, M3	low	1
Leukemia, Progranulocytic	low	1
Leukemia, Promyelocytic, Acute	low	1
Lung Cancer	low	1
Lung Neoplasms	low	1
M3 ANLL	low	1
Malaria	low	1
Malaria, Falciparum	low	2
Malignant Melanoma	low	1
Marsh Fever	low	1
Melanoma	low	1
Myeloid Leukemia, Acute, M3	low	1
Neoplasms, Colonic	low	1
Neoplasms, Lung	low	1
Neoplasms, Pulmonary	low	1
Paludism	low	1
Plasmodium falciparum Malaria	low	2
Plasmodium Infections	low	1
Polyploid	low	7
Polyploid Cell	low	7
Polyploidy	low	7
Pregnancy	low	1
Progranulocytic Leukemia	low	1
Promyelocytic Leukemia, Acute	low	1
Pulmonary Cancer	low	1
Pulmonary Neoplasms	low	1
Remittent Fever	low	1
Sensitivity and Specificity	low	1
Tetraploid	low	2
Tetraploidy	low	2
Zika Fever	low	1
Zika Virus Disease	low	1
Zika Virus Infection	low	1
ZikV Infection	low	1

Article	Year
Liposomes versus lipid nanoparticles: comparative study of lipid-based systems as oryzalin carriers for the treatment of leishmaniasis. Journal of biomedical nanotechnology, Volume: 10, Issue: 12	2014
Efficacy of oryzalin and associated histological changes in Cryptosporidium-infected neonatal rats. Parasitology, Volume: 125, Issue: Pt 2	2002
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

oryzalin

Description

Cross-References

Synonyms (68)

Research Excerpts

Overview

Effects

Treatment

Roles (3)

Drug Classes (4)

Protein Targets (55)

Potency Measurements

Inhibition Measurements

Biological Processes (168)

Molecular Functions (50)

Ceullar Components (36)

Bioassays (64)

Research

Studies (235)

Study Types

Research Highlights

Safety/Toxicity (1)

Pharmacokinetics (2)

Bioavailability (2)

Dosage (2)

Article	Year
Toxicity of herbicides in highway runoff. Environmental toxicology and chemistry, Volume: 24, Issue: 9	2005
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Hyperosmotic stress induces formation of tubulin macrotubules in root-tip cells of Triticum turgidum: their probable involvement in protoplast volume control. Plant & cell physiology, Volume: 43, Issue: 8	2002
Pharmacokinetic studies of the herbicide and antitumor compound oryzalin in mice. Journal of chromatography. B, Biomedical sciences and applications, Aug-29, Volume: 696, Issue: 2	1997
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]